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SUMMARY
1. The effects of dsRNA on interferon-treated and control cells, and 
on various cell-free systems, have been characterised, and discussed in 
relation to theories on the role of dsRNA in the control of cell functions.
2. The double-stranded homopolymer, poly rl.rC, used for most of these 
experiments, was characterised in terms of its resistance to ribonucleases 
and its behaviour on cellulose column chromatography.
3. The effects of various homopolymers on protein synthesis in the 
reticulocyte lysate were studied and related to their published effects 
on intact cells. The apparent requirement for high molecular weight is 
discussed in relation to measurements of structural stability.
4. The cytotoxic effect of dsRNA on interferon-treated L929 cells was 
characterised, and a proportion of the cells resistant to the toxicity was 
found to exist. No evidence for a specific biochemical trigger for toxicity 
could be found.
5. A cell-free protein synthesising system from monolayer grown L929 cells 
was developed and characterised.
<L
6. An assay for an interferon and dsRNA dependent inhibitor of protein 
synthesis was developed using reticulocyte lysates. Interferon-treated 
cell cytoplasm was capable of forming an inhibitor of protein synthesis 
when incubated with dsRNA and ATP, which inhibited a specific step in 
protein synthesis initiation. The relevance of this inhibitor to changes 
in protein phosphorylation is discussed.
7. There was no evidence that the inhibitor is generated when interferon- 
treated cells are exposed to dsRNA, so the inhibitor nwjhnot be involved
in the cytotoxic effect.
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1.1. BACKGROUND
1
The subject of this research (section 1.7) was to relate some of 
the in vivo and in vitro effects of interferon and dsRNA in the hope of 
elucidating the cause of the cytotoxicity of dsRNA for interferon-treated 
cells. Before embarking on a detailed review of the relevant literature, 
and in order to put the project in context, this section will briefly 
outline the current state of interferon research. A minimum of references 
will be given, but some of the more contentious points will be discussed 
in detail elsewhere.
Interferon^ wie^ e first recognised by Isaacs and Lindenmann (1957) as 
being a substance which was released by cells which had been treated with 
virus, and which was able to prevent virus replication in other cells.
The early evidence (see Cantell 1973) showed that interferons were a group 
of glycoproteins induced in cell culture or animals by viruses, poly­
nucleotides, and some other compounds, able to protect homologous cell.s 
against infection by a range of viruses by blocking a stage of virus 
replication subsequent to penetration and uncoating. Attemps at 
purification met with little success, and it was clear that biological 
activity resided in only a small fraction of the "interferon" preparation. 
The literature was confused with artefacts resulting from the use of 
crude preparations and from the complex results obtained in experiments 
using whole animals. The use of purer preparations of interferon, and 
of tissue culture cell systems has faciliated work on the molecular aspects 
of interferon, with the following tentative conclusions:
a) Interferons are induced in cell culture by a range of active 
and inactive viruses, and by polyribonucleotides having 
certain molecular characteristics (de Clercq 1974). Other 
inducers probably act on cells of the immune system.
b) Production of interferon requires the induction of a cellular 
gene and the transcription and translation of interferon mRNA.
The mRNA can be translated in heterologous systems and the gene, 
or genes, localised to certain chromosomes. The production is
2regulated either at transcription or translation by unknown 
processes, and "superinduction" can occur by judicious use 
of metabolic inhibitors (Reynolds et al 1975, Creaghan et al 
1975, Tan et al 1970).
, c) Interferons from one source can be very heterogeneous, and 
different cell types from the same species of animal may 
produce different spectra of molecules. The antiviral 
activity of a preparation is always expressed in homologous 
cells, but may also protect cells from unrelated animals.
(Stewart and Desmyter 1975).
d) Interferons have very high specific activities and require 
special methods for purification. It is possible that some 
interferons have now been purified to homogeneity. Estimates 
suggest that the antiviral activity of a pure interferon could
Q
approach 10 u/mg protein. This high specific activity implies 
that only a few molecules are required to protect one cell 
(¡<night 1975).
e) The development of an antiviral state requires interaction of 
interferon with the cell followed by various metabolic processes 
(de Clercq and Stewart 1973).
f) Replication of a range of viruses is inhibited in interferon- 
treated cells to a greater or lesser extent. There may be 
several lesions in a given virus/cell system, or all the effects 
may stem from one primary lesion.
g) Extensively purified preparations of interferons have other, non­
antiviral activities on recipient cells. These include inhibition 
of cell growth, priming of interferon induction, and enhancement 
of the toxicity of dsRNA (de Clercq and Stewart 1973).
The remainder of this introduction will survey the literature on 
the biological activities of interferon and dsRNA, taking into account 
work published up to mid 1976.
1.2. INTERACTION OF dsRNA WITH CELLS AND INTERFERON INDUCTION
This section will consider the interaction of dsRNA with the cell 
surface, and relate this to its effects on intact cells, in particular 
interferon induction. Besides inducing interferon, dsRNA also has and=fc*=ee± 
antiviral effect on the recipient cell, and this has been shown to depend 
on the production of extracellular interferon (Schafer and Lockart 1970, 
Vengris et al 1975), so the two effects can be considered together.
Structural requirements for the inducer
dsRNA was first shown to be an interferon inducer in 1967 when the 
active component in filtrates of PeniciHium funiculosum was found to be 
dsRNA (Lampson et al 1967) and reovirus and synthetic dsRNAs were also 
shown to be active (Tytell et al 1967; Field et al 1967). Since then a 
whole range of chemically modified polymers have been studied, and certain 
molecular requirements have become apparent (de Clercq 1974):
a) Stable secondary structure. Most duplexes with a melting temperature 
of 60°C or above (0.15M salt) are good inducers, providing other 
criteria are met. However, complexes of poly C^A with poly rT and
5
poly br U are exceptions (de Clercq et al 1974), perhaps because 
the helix form is distorted (A.M. Bobst, personal communication 1976).
b) High molecular weight. If the length of one, or both, strands of a 
helix is reduced, the inducing ability is also reduced. The critical 
range for this is from 2S to 5S, and when both strands are greater 
than 5S, interferon induction is maximal (Tytell et al 1970; Niblack 
and McCreary 1971).
c) Resistance to ribonucleases. As the assay for interferon induction 
requires the inducer to reach the cell, it is clear that the dsRNA 
must resist attack by nucleases present in the tissue culture fluid 
and on the cell surface. The increased induction by dsRNA complexed 
with polycations such as DEAE dextran and poly-L-lysine (Dianzani
et al 1968) may result from protection of the dsRNA against nuclease
degradation (Pitha and Carter 1971). Annealling dsRNA in media
4containing divalent metal cations may increase induction by melting 
out local irregularities in structure, hence increasing nuclease 
resistance (de Clercq and Merigan 1971).
d) Presence of 2' hydroxyl groups. Substitution of 2’ (ribose) 
hydroxyl groups on either strand by a range of groups 
(H,F,Cl.N^.OCHj.OCOCH^.etc.) produces inactive molecules. DNA.RNA 
hybrids and dsDNA are inactive. Kleinschmidt (1972) has speculated 
that this is due to a change in flexibility of the helix.
These four criteria overlap considerably, and varying one parameter 
often varies others. However, it does seem that these criteria are adequate 
to define a molecule as a good interferon inducer (de Clercq 1974). Moreover, 
the same requirements probably apply for other biological activities of 
dsRNA: DNA synthesis in Hela cells is inhibited by dsRNA, but not ssRNA or 
dsDNA (Teng et al 1973); interferon-enhanced cytotoxicity is observed with 
dsRNA, but not ssRNA or dsDNA (Stewart et al 1973a); antisera raised against 
dsRNA recognise homopolymers able to induce interferon (Johnston et al 1975); 
and the effects of dsRNA on the reticulocyte lysate protein synthesising 
system are not shown by ssRNA or dsDNA (Hunter et al 1972).
It is thus likely that high molecular weight, stability, nuclease 
re'istance, and 2' hydroxyl groups are the minimum requirements for cellular 
receptors to distinguish dsRNA from normal cellular nucleic acids.
A complication arises when poly rl.rC complexes are considered. Instead 
of the simple size requirements outlined above, the size of the poly rl 
strand appears to be more important than the size of the poly rC strand 
(Tytell et al 1970; Carter et al 1972; Mohr et al 1972). Provided that 
the length of the poly rl strand (or the distance between modified bases in 
that strand) exceeds about 500 nucleotides, the length of the poly rC strand 
can be reduced to 70 nucleotides without affecting interferon production, but 
the converse is not true. The failure of Niblack and McCreary (1971) to 
observe this effect has been attributed to the polydispersity of their 
polynucleotides (de Clercq 1974).
5This requirement is also shown for other biological activities of 
poly rl.rC: interferon-enhanced cytotoxicity and curing of LI210 cell 
leukaemias (Stewart and de Clercq 1974; Mohr et al 1972). These 
similarities can be explained when the thermal stability of the duplexes 
is considered (Mohr et al 1972), because a long poly rl strand is more 
important than a long poly rC strand in conferring a high melting 
temperature. However, Carter et al (1972) showed that even when matched 
for equal thermal stability, complexes of poly rl with oligo rC were more 
active than oligo rl. poly rC. Both these complexes were unstable under 
the conditions for induction and were assayed in the presence of 
poly-L-lysine, so the results are not strictly comparable with those 
obtained using poly rl.rC alone.
Some other evidence suggests that the poly rl strand is intrinsically 
more important than the-poly rC. De Clercq and de Somer (1972) showed that 
although poly rl and poly rC are normally inactive, they can combine at 
the cell surface when added sequentially to cells, and thus induce interferon 
This was most marked when poly rl was added before poly rC, rather than 
vice versa. In the presence of polycations, poly rl may induce even in 
the absence of poly rC (Pitha and Pitha 1974), and poly rl complexed to a 
hydrocarbon carrying cytosine residues on alternate carbon atoms (poly 
(1-vinyl cytosine)) is a good inducer (Pitha and Pitha 1971).
These activities of poly rl might reflect its ability to form multi­
strands, for, even though unstable under the ionic conditions used for 
induction (Michelson et al 1967), macromolecular receptors could favour 
multistrand formation. The ability to form multistrands has been shown 
to correlate with the effects of a range of ssRNAs on the template activity 
of isolated nuclei or chromatin (Brown and Coffey 1972), suggesting that 
multi strand formation may occur in the cell.
The fact that interferon induction, interferon-enchanced cytotoxicity, 
and possibly protein synthesis Inhibition, are all caused by molecules 
having the same structural features does not necessarily mean that the same
receptors are involved. It is likely that the properties recognised in 
the csRNA are the minimum required to distinguish it from normal cellular 
polynucleotides, so the selection pressure for such specificity would be 
high.
Binding sites and uptake of dsRNA
Having considered the molecular requirements for recognition of a 
dsRNA by cellular receptotf, it is necessary to consider the nature of the 
interaction of dsRNA with the cell. Again, this has been investigated 
primarily in the context of interferon induction.
De Clercq et al (1974) used interferon induction as a marker for 
binding to the induction-specific receptor. When ssRNA was used to compete 
for dsRNA binding sites, tsRNA was formed even though the ionic conditions 
would normally have favoured dsRNA (de Clercq et al 1975b). Interferon was 
not induced, and they concluded that tsRNA bound more strongly than dsRNA 
to the induction-specific receptor, so tsRNA was stabilised. This adds 
another molecular requirement to the list of criteria for interferon 
inducers - that disproportionation of dsRNA to tsRNA should be unfavourable 
(de Clercq et al 1974).
The tsRNA > dsRNA > ssRNA affinity is not found when binding is 
performed in the cold (Johnston et al 1976). Instead, ssRNA probably does 
bind to the specific receptor, because cells carrying labelled poly rl.rC 
loose some label and the capacity to produce interferon when treated with 
ssRNA. It is interesting that sequentially added poly rl and poly rC are 
apparently more resistant to displacement by poly rC (Johnston et al 1976).
Apart from these attempts to characterise the binding properties of 
the specific receptor, studies on the interaction of dsRNA with the cell 
have concentrated on two questions. What is the chemical nature of the 
receptor? and, does this receptor trigger induction or merely provide a 
transport system for dsRNA? Experimental approaches have made use of 
modification of the cell surface, following the fate of radioactive dsRNA, 
and insolubilised dsRNA.
Bausek and Merigan (1969) showed that labelled poly rl.rC bound to 
cells at 4°C, and this was enhanced by polycations. The main problem is 
that the bulk of this binding is not required for induction. Thus, induction 
can be prevented by concanavalin A (Harper and Pitha 1974), mild enzyme 
treatment (Pitha et al 1974), or salt washing (Johnston et al 1976), yet all 
these procedures leave a considerable proportion of dsRNA bound to the cell, 
implying that only a small amount of binding is specific.
When cells carrying dsRNA are warmed, a small proportion of the dsRNA 
becomes ribonuclease resistant (Bausek and Merigan 1969). However, it is 
not clear whether this fraction is responsible for induction. Schell (1971) 
showed that poly rl was taken up in preference to poly rC when ascites 
tumour cells were treated with poly rl.rC. If the relative importance 
of the poly rl strand for induction also applies with these cells, these 
results might imply that intracellular RNA triggers induction.
Good evidence that dsRNA can enter the cell without degradation is 
provided by the observation that mengovirus RF is infectious (Perez-Bercoff 
et al 1974a). However, most of the polynucleotides entering the cell are 
probably degraded and may be recycled into cellular RNAs. Clearly, this 
limits the usefulness of autoradiography for localising internal dsRNA,t
because intracellular label must be shown to be not only acid insoluble, 
but also to be dsRNA. Those cell types requiring most dsRNA for induction 
are also most active at degrading it (de Clercq and Stewart 1974).
By contrast with these experiments, the use of insolubilised dsRNA 
attempts to demonstrate that dsRNA can induce without needing to enter the 
cell. However, this approach has been of limited usefulness, because all 
supports are "leaky" and interferon induction could be explained either by 
local high concentrations of free dsRNA, or by the high efficiency of 
dsRNA presented in a form readily absorbed onto cells (de Clercq and de Somer 
1974a). Indeed, Hutchinson and Merigan (1975) concluded that induction 
only occurred when some dsRNA was lost from the support, that is, when 
some free dsRNA was available.
Rather than attempting to ask whether dsRNA can induce interferon 
from the outside of the cell, it would perhaps be more profitable to test 
whether dsRNA can induce from the inside. This could be tested by 
microinjection with liposomes or red cell ghosts to deliver dsRNA to 
the inside of the cell, with ribonucléase added to the medium to destroy 
any dsRNA which might escape to the outside. In the long term, development 
of cell free transcription systems might show whether interferon mRNA 
synthesis is induced by dsRNA or a "second messenger".
The mechanism of interferon induction by viruses is still more 
uncertain and not very relevant to this discussion. However, some points 
concerning the possible role of intracellular dsRNA can be made:
a) RNA viruses are generally better inducers than DNA viruses (de Clercq 
and Stewart 1973). Herpesviruses do not induce, and RNA extracted 
from infected" cells was unable to induce interferon (Perez-Bercoff
et al 1973).
b) Correlating interferon induction with the presence of dsRNA in various 
restrictive systems does not usually give clear cut results. Two 
situations can arise. dsRNA may be detectable but no interferon is 
induced, either because the dsRNA is in a separate compartment, or 
because shut off of host cell protein synthesis is too rapid (eg.
NOV in chick cells, Gandhi and Burke 1970; Dubois 1974), or because 
dsRNA is not the inducer. Alternatively, dsRNA may not be detectable 
even though interferon is induced. Here the problem is with limits 
of detection - Atkins and Lancashire (1976) found some Sindbis virus 
ts mutants which did not produce dsRNA were able to induce interferon 
in chick cells with wild-type kinetics. In this case salt precipitation, 
cellulose columns, radioimmunoassay (G.J. Atkins, personal communication 
1975) or protein synthesis inhibition (J.A.C. and G.J.A., unpublished 
results) were all used to test for dsRNA, but all had a lower limit 
of detection of 1-5% of wild-type levels.
8
9c) It is difficult to think of any other intermediate in virus
replication besides dsRNA, which is common to all the viruses able 
to induce interferon. Alternative theories thus rely on different 
inducers functioning in different systems, for example progeny 
virus (Lai and Joklik 1973) or an early event leading to cytopathic 
effects (Atkins 1976).
If dsRNA is the inducer in virus-infected cells, it suggests that 
exogenousdsRNA either induces by a different route, directly at the outer 
face of the membrane, or needs to be transported across the membrane to 
interact with an intracellular receptor. At present, the only way of 
excluding one of these possibilities would be to find a situation where 
less than one molecule of dsRNA enters each cell yet interferon is still 
induced. Because of the large amount of non-specific binding, it is 
difficult to see how induction at the cell surface could be excluded. 
Purification and characterisation of the surface receptor/transport system 
would be useful, but before this is practical some means of chemically 
distinguishing the "specific" and "non-specific" sites must be found - 
there is no reason to suppose that the "specific" sites will be of higher 
affinity than the others, and the "non-specific" sites may even be specific 
for other activities of dsRNAl
10
1.3. INTERACTION OF INTERFERON WITH CELLS AND THE ANTIVIRAL STATE
This section will consider the interaction of interferon with the 
cell surface, the subsequent changes in the cell, and the stage in virus 
replication which is blocked. Other sections will deal with the changes 
observed in vitro and with the non-antiviral effects of interferon.
The action of interferon on a cell can be split into two stages -
the initial binding and interaction with the cell surface, and the induction
and development of the antiviral state. The triggering of the antiviral
state could occur when the interferon attaches to a surface receptor, 
as for the cAMP mediated effects of insulin (Cuatrecasas 1974), or may 
require transport of some part or all of the interferon molecule to the 
inside of the cell, as with the polypeptide toxins of diphtheria (Gill 
and Dinius 1971) and ricin (Olsnes and Pi hi 1973). The former possibility 
requires a "second messenger", but the latter allows for interferon being 
directly involved in blocking virus replication. An analogous problem 
has already been met in the case of the effects caused by dsRNA (section 1.2). 
Interferon binding
Early experiments suggested that little interferon bound to cells 
(Buckler et al 1966), but these experiments relied on detecting small 
reductions in a large amount of applied interferon, and so were not very 
sensitive. Circumstantial evidence for binding was provided by the observation 
that cells, treated with interferon in the cold, could be washed repeatedly 
before warming, and yet still be resistant to virus infection (Friedman 1967). 
The cold reaction was assumed to represent binding because trypsin treatment, 
after removal of excess interferon, was able to prevent the antiviral state 
developing, and the degree of resistance depended on the interferon 
concentration present in the temperature - independent step (Friedman 1967).
Recovery of applied interferon from cells has enabled binding to be 
demonstrated directly. Stewart et al (1972d) found it was possible to 
detect interferon in sonicates of treated mouse cells, providing large 
numbers of cells were used. Even though no decrease in interferon in the
medium was found (Buckler et al 1966), as much as 30% bound to the cells.
The recovered activity had the characteristics of interferon. The amount 
bound varied according to the cell type, more sensitive cells binding more 
at the saturation doses used (Stewart et al 1972d). This binding was 
temperature dependant, implying that exposure to interferon may induce a 
binding or transport system normally present in limiting quantities 
(Sheaff and Stewart 1969a,b and c).
Using human amnion cells, Berman and Vilcek (1974) found that interferon 
uptake reached the same saturation level whatever the temperature, but the 
rate of uptake was lower in the cold. Most of the bound interferon was in 
a low speed pellet containing membranes, and some of this was released into 
the medium at 37°C but not at 4 C. Stewart (1975) has decided a similar 
phenomenon with L929 cells, in which interferon, bound rapidly in the cold, 
was partly released and partly transported into a subcellular fraction upon 
warming.
It thus seems that the step which can proceed, albeit more slowly, 
in the cold represents superficial binding. This is "specific" in that 
heterologous interferon does not bind, but possibly some binding is to 
receptors other than the one involved in the antiviral state. The temperature- 
dependant step involves some of the interferon being lost from the cells, 
whilst the remainder becomes trypsin resistant and is found in a distinct 
subcellular fraction containing large organelles and membranes. Whether 
the antiviral state is induced by the cell surface interferon which is 
released, or by the interferon which is transported to a trypsin-resistant 
site, cannot be determined from these results, although the demonstration 
that interferon needs to be externalised by a dsRNA-treated cell before 
that cell develops an antiviral state (Vengris et al 1975) implies that cell 
surface interferon is responsible.
Various workers have attempted to immobilise interferons to test 
whether cell surface interferon can induce the antiviral state (Anke.l et al
1973, Knight 1974b). Mouse interferon covalently bound to Sepharose beads
can protect L929 cells against virus challenge, provided direct cell to 
bead contact is allowed (Ankel et al 1973). Very little soluble interferon 
could be detected under these conditions, and the beads lost no activity 
upon serial transfer. However, these controls cannot exclude the 
possibility tnat locally high concentrations of free interferon may 
accumulate close to the cells, and may be responsible for inducing the 
antiviral state.
An alternative approach is to characterise the cell surface receptor. 
Various experiments have suggested that hydrophobic forces are important 
in the binding of interferons to such substrates as albumin (Davey et al
1974) , concanavalin A (Davey et al 1974) and hydrocarbons (Davey et al
1975) . Hydrophobic binding could be important in the cell surface interaction, 
with interferon recognising a lipid such as vitamin A (Blalock and Gifford 
1975) or a specific ganglioside (Besancon and Ankel 1974a). The ganglioside 
binding is specific for a certain ganglioside and a given interferon, so 
could be important for the species specificity of interferons. The interferon 
probably recognises the carbohydrate moiety (Besancon and Ankel 1974a),
which is the part of the molecule exposed at the membrane surface 
(Cuatrecasas 1974).
The relevance of ganglioside binding to the antiviral state was 
recently demonstrated when ganglioside GM,, deficient mouse fibroblast clones 
were found to be relatively insensitive to mouse interferon. Extra GM2 
added to the medium was incorporated into the cells, and sensitivity to 
interferon was increased (Vengris et al 1976). The binding of cholera 
toxin, which binds to gangliosides (van Heyningen 1974), and thyrotropin 
to cells is inhibited by interferon, although the binding of other hormones 
is not. Both compounds diminish the antiviral effect of interferon, 
possibly by competing for binding sites (D. Kohn, personal communication 
1976).
These results need to be interpreted with caution, however, until the 
role of gangliosides in the cell membrane and their interaction with other
lipids is understood (van Heynmgen 1974). The lack of specificity of 
human fibroblast interferon for binding to different gangliosides (Vengris 
et al 1976) means that this mechanism may only be relevant for mouse 
interferon.
The nature of the receptor has also been investigated by treating the 
cell surface with enzymes. For example, phospholipase C, added before 
interferon, prevents the antiviral effect developing (Friedman 1967). 
Phytohemagglutinin can block the receptor in mouse cells, and sensitivity 
to interferon can be restored by absorbing the phytohemagglutinin onto 
fetuin (Besancon and Ankel 1974b). These experiments, and similar ones, 
imply the involvement of lipid and carbohydrate in the binding, but could 
be due to non-specific effects.
A new approach to the nature of the receptor came with the application 
of somatic cell genetics to the analysis of the chromosomes involved in 
interferon induction (reviewed by Creaghan et al 1975) and action. By making 
use of cell hybrid clones , phenotypic characters can be correlated to the 
presence of certain chromosomes. Because of the restricted species 
specificity of interferons, development of the antiviral state in response 
to an interferon active on one of the parental lines implies the presence 
of all gene products necessary for responding to that interferon. Any gene 
products which are not species specific could presumably be provided by 
genes from either parent.
Early work suggested that monkey genes for responding to and producing 
interferon were not on the same chromosome (Cassingena et al 1971). When 
more cloneswere surveyed, the antiviral genes were allocated to a monkey 
chromosome analogous to human chromosome G21 (Chany et al 1973). By 
surveying mouse x human clones, Tan ot al (1973) confirmed the G21 location.
Tan and colleagues (Tan 1975; Tan et al 1975) then showed that the 
sensitivity of human fibroblast mutant lines was related to dosage of 
chromosome 21. Monosomic, disomic and trisomic lines from a range of 
donors were studied, and the dose of interferon required to protect 50%
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of the cells was found to decrease as the number of chromosome 21 copies 
increased. Chany et al (1975) looked at triploid, as well as trisomic, 
lines and found that some other chromosomes reduced sensitivity to interferon, 
so that triploid1 ines were eclually sensitive as diploid. Chromosome E16 
was tentatively identified as carrying genes regulating or antagonising 
G21 genes.
As the species-specific events in the antiviral effect must include 
the recognition of interferon by the cell, but need not necessarily include 
any subsequent steps, chromosome G21 presumably carries at least those genes 
for the cell surface receptor or inducible transport system (Chany et al 
1973; Sheaff and Stewart 1969a,b and c).
This has recently been corroborated by the demonstration that G21 
codes for some cell surface proteins (Revel et al 1976). Antisera raised 
to surface antigens of hybrids carrying only three human chromosomes 
(G21 and two others) inhibit interferon action in human fibrdblasts.
The inhibitory antibodies can be adsorbed onto clones carrying G21, but 
not onto clones carrying the other two chromosomes. However, it seems 
odd that the antiserum inhibited the antiviral effect when added after 
interferon treatment, and it may inhibit a step after interferon binding. 
Metabolic requirements for development of the antiviral state
Following the initial interaction of interferon with the cell, a second 
temperature-dependant step is required for the development of an antiviral 
state. This step can occur very rapidly (Dianzani and Baron 1975), although 
not so rapidly as to preclude de novo RNA and protein synthesis (Palmiter 
1973), and has been variously interpreted as the induction of a new uptake 
system (Sheaff and Stewart 1969a,b and c; Chany et al 1973), active 
transport of the interferon to the interior of the cell (Stewart et al 
1972d), chemical processing of the interferon (Kosower and Koso^er 1975), 
or the synthesis of an "antiviral protein" (Levine 1964; Marcus and Salb 
1966; Chany et al 1971). The concept of an antiviral protein was introduced
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in the light of studies using metabolic inhibitors - it was postulated to 
be induced by interferon treatment, and to mediate the intracellular actions 
of interferon.
The development of the antiviral state is prevented by a range of 
inhibitors including actinomycin D, cycloheximide, puromycin, actinomycin D 
p-fluorophenylalanine (see de Clercq and Stewart 1973) and cordycepin 
(Radke et al 1974). However, under particular conditions actinomycin D 
may have no effect or may even increase the antiviral effect (Chany et al 
1971). A similar situation is found with the "superinduction" of interferon 
(Tan et al 1970; Vilcek and Ng 1971), where it is attributed to the presence 
of a negative control system (Tan et al 1970; Vilcek and Ng 1971). In this, 
de novo synthesis of interferon (Walters et al 1967, de Clercq and Merigan 
1970) is inhibited by the product of a second gene, which is induced by 
interferon. Such a system could also apply for interferon.action (Chany 
et al 1971).
The classical system for superinduction of a gene product is the 
hormonal induction of tyrosine aminotransferase (TAT) in liver cells 
(Tomkins et al 1969). Tomkins et al (1972) have since reviewed 38 different 
metabolic functions which are stimulated by actinomycin D, and 15 stimulated 
by a range of other inhibitors. However, other groups have pointed out that 
actinomycin D can have many side effects (e.g.on turnover of mRNA, Singer 
and Penman 1972; and on initiation of protein synthesis, Schwartz 1973), 
and Tomkin's group have now revaluated superinduction theory in view of 
these effects (Steinberg et al 1975). Protein synthesis inhibitors also 
cause secondary changes in the cell, including a stringent type response 
involving changes in initiation of protein synthesis (Reichman and Penman 
1973) and in rRNA synthesis rates and nucleotide triphosphate pools 
(Grummt and Grummt 1976). Intepretation of superinduction, of either 
interferon itself or the antiviral state, as involving regulation of the 
expression of certain gene products (Tan et al 1970; Chany et al 1971) 
must thus be treated cautiously.
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In view of the problems with metabolic inhibitors, nuclear involvement 
is perhaps better demonstrated by enucleation. Radke et al (1974) showed 
that enucleation at the time of interferon treatment prevented the antiviral 
state developing, whereas interferon added before enucleation can inhibit 
virus growth (Young et al 1975). This implies that the antiviral state 
does involve the nucleus, although functions other than transcription may 
be important. Even if new gene products are required, they may be necessary 
for interferon uptake (Chany et al 1973) rather than directly inhibiting 
virus replication.
The nature of the block in virus replication
Cells in the antiviral state do allow virus penetration and uncoating, 
the block in replication being at some stage in the synthesis of viral RNA 
or protein, or at maturation (early evidence summarised by Sonnabend and 
Friedman 1973). Different viruses differ in their relative sensitivity to 
interferon according to the cells used (Stewart et al 1969), and it is 
possible that interferon causes different lesions according to the virus/ 
cell system under investigation. This section will consider only the 
alphaviruses, vaccinia virus and SV40, and experiments using cell-free 
translation systems will be presented later (section 1.4).
For the alphaviruses, the earliest step which is blocked is the 
translation of the input genomic, (+) RNA to produce the polymerase. Mecs et al 
(1967) showed that all viral RNA synthesis was inhibited, and Friedman et al 
(1967) showed that this included primary transcription. The polymerase 
contains virus polypeptides encoded by the non-structural region of the 
genome (H. Brzeski, J.P. Clewley, J.C.S. Clegg, and S.I.T. Kennedy, 
personal communication 1975). The inhibition of primary transcription 
could thus result from either blocked translation of the genomic RNA, or 
inhibition of the polymerase activity. In vitro polymerase assays suggested 
that polymerase synthesis, but not function, was inhibited (Sonnabend et al 
1967), and the synthesis of some early non-structural proteins is reduced 
by interferon (Friedman 1968).
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that polymerase synthesis, but not function, was inhibited (Sonnabend et al 
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by interferon (Friedman 1968).
Vaccinia virus, a DNA virus which replicates in the cytoplasm, is also
unable to replicate in interferon-treated cells, probably because of a 
block in translation. After "first-stage uncoating", primary transcription 
of some of the DNA occurs using a virion polymerase. Complete uncoating 
requires protein synthesis (Magee et al 1968). Interferon treatment does 
not prevent the early mRNA synthesis, but does prevent the incorporation 
of this RNA into polyribosomes (Joklik and Merigan 1966, Junqwirth et al 
1972, Metz and Esteban 1972). Second stage uncoating does not occur 
(Magee et al 1968) allowing increased production of the early mRNA 
(Jungwirth et al 1972). The lesion in translation appears to be at 
initiation, at a step prior to 40S subunit binding (Metz et al 1975), but 
elongation may also be affected (Metz et al 1975).
It thus seems that for these two types of cytoplasmic viruses, the 
lesion is at translation, rather than at RNA or DNA dependant transcription. 
Work with rhabdoviruses, and other (-) RNA viruses, has suggested that 
primary transcription is the target (Marcus et al 1971), but this relies 
on distinguishing protein synthesis dependant, from protein synthesis 
independant, transcription. More recent work suggests that primary 
transcription is unaffected, but translation is the target (Repik et al 
1974).
SV40 is a DNA virus which requires some nuclear functions for its 
replication, and which can be integrated into the host cell DNA. Oxman 
et al (1967a) showed that SV40 T-antigen synthesis was sensitive to 
interferon in permissive, but not in transformed, cells.Both cell types 
were resistant to VSV infection, and both contained all the information 
required to make infectious progeny SV40. It was possible that the 
difference in sensitivity resulted from integration of the viral DNA into 
the host genome. As a model for integration, SV40 x adenovirus hybrids, 
containing SV40 information covalently attached within an adenovirus genome, 
were used (Oxman et al 1967b). SV40 T-antigen expression during lytic
infection by these hybrids showed the resistance to interferon typical 
of the adenovirus, but not the SV40, parent. These results can be 
explained either by supposing that SV40, integrated into host or adenovirus 
DMA, becomes subject to host or adenovirus transcriptional control, or, 
if the transcribed RNA contains SV40 sequences covalently linked to host. . 
or adenovirus sequences, by control at the level of translation.
Hybridisation show'ed that 27% of the SV40 RNA was indeed covalently 
linked to adenovirus sequences, so could escape SV40-specific translational 
control (Oxman et al 1974). However, when SV40 sequences were quantitated 
in infected cells, mRNA synthesis was found to be inhibited in cells infected 
with SV40, but not in cells infected with the hybrid (Oxman et al 1974).
Viral transcription does not seem to require translation, and mRNA 
degradation is unaltered (Metz et al 1976), suggesting a primary lesion
at transcription. The same conclusion is reached using cell free transcription
systems (D.H.Metz, personal communication 1975)» There is now evidence that 
the primary defect is at uncoatlng (Yamamoto et «1 1975).
On the other hand, interferon treatment after, rather than before, 
infection, can prevent SV40 translation without affecting transcription 
(M. Revel, personal communication 1976). This is in agreement with 
microinjection experiments, in which SV40 T-antigen formation was detected 
in cells injected with SV10 cRNA, when translation was inhibited if the cells 
were pretreated with interferon (Graessmann et al 1974).
In conclusion, this in vivo evidence suggests that interferon inhibits 
viral translation in alphavirus, vaccinia virus, and SV40 infected cells, 
and perhaps also DNA-dependant RNA transcription in SV40 infected cells. . 
Reports of effects on RNA-dependant RNA transcription need to be interpreted 
with caution (Repik et al 1974).
Effects of interferon on virus-induced changes in host cell functions
This section will describe the effect of interferon on the changes in 
host cells observed after infection with vaccinia virus and VSV; the action 
of interferon on uninfected cells is considered elsewhere (section 1.5).
Two situations are possible. If the host function is controlled by an
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intermediate in virus replication before the interferon-sensitive step, 
the virus may induce the change even though complete replication is 
prevented. On the other hand, the change will be sensitive to interferon 
if it is triggered by an intermediate whose formation is blocked by 
interferon treatment.
For vaccinia virus in L929 cells, shut off of host protein synthesis 
is rapid (Metz and Esteban 1972), and occurs even when virus replication 
is prevented by interferon (Joklik and Merigan 1966, Metz and Esteban 1972). 
The inhibition may actually be enhanced in interferon-treated cells (M. Suh, 
personal communication 1975). Shut off could be caused by the input virion 
components, because UV-irradiated virus is inhibitory (Moss 1968) and 
inhibition still occurs in the presence of actinonycin D; although there 
are some virus functions which are resistant to both these treatments 
(Rosemund-Hornbeak and Moss 1975). Vaccinia cores can inhibit reticulocyte 
lysate protein synthesis with the characteristics of dsRNA (H.R.B. Pelham, 
personal communication 1976).
High multiplicity infection with vaccinia normally causes a late 
cytopathic effect, which is dependant on RNA and protein synthesis 
(Bablanian 1970), although it is more resistant than virus multiplication 
to the effects of metabolic inhibitors (Bablanian 1968,1970). If the cells 
were interferon treated, the cytopathic effect occurs earlier and more 
extensively (Joklik and Merigan 1966). It is still sensitive to inhibitors 
(Horak et al 1971), and may result from host cell shut off (Metz and 
ESTeban 1972; M. Suh, personal communication 1975) or from the failure to 
control early mRNA synthesis (Jungwirth et al 1972).
The observation of enhanced cytopathic effects in interferon-treated 
cells lead Joklik and Merigan (1966) to propose a "suicide theory" for 
interferon action. By causing cell death, or complete cessation of a vital 
function such as protein synthesis, interferon could indirectly inhibit 
virus replication. Although this may apply for the particular case of 
vaccinia virus in L929 cells, it is clearly not true for other systems.
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Perhaps the best demonstration that the block in virus translation is
selective and not total is provided by SV40, which does not inhibit
host cell protein synthesis at all. Application of interferon to SV40 infected
cells prevents viral but not host translation (M.Revel.personal communication 76)
Interferon is unable to prevent VSV-induced protein synthesis 
inhibition (Yamazaki and Wagner 1970), which may be caused by input 
virion components (Baxt and Bablanian 1976). On the other hand, interferon 
can prevent virus cytopathic effects providing that the input multiplicity 
is low (Yamazaki and Wagner 1970). It has been suggested that low 
multiplicity cytopathic effects are due to an early product of virus 
replication, but at high multiplicity they are due to "killer particles" 
in the virus stock (Marcus and Sekellick 1974). The early product may be 
virus dsRNA (Marcus and Sekellick 1975) whose formation could be partly 
inhibited by interfer0n (Repik et al 1974).
Yet other cases are known where interferon, at concentrations sufficient 
to inhibit virus replication  ^does not prevent either protein synthesis 
inhibition or the cytopathic effect (Gauntt and Lockart 1968; Haase et al 
1969; Levy 1964). RNA synthesis inhibition may also be resistant (Haase
et al 1969; Levy et al^ 1966). Clearly, a full explanation of these effects
*
will only be possible When the lesion in virus replication is fully 
characterised and the causes of host cell macromolecular synthesis inhibition 
and cytopathic effects are known.
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1.4. CELL-FREE TRANSLATION SYSTEMS FROM INTERFERON-TREATED CELLS
Interferon can inhibit viral replication by inducing a block in viral 
translation. This has been shown for alphaviruses and vaccinia virus (see 
section 1.3) and is probably also true for VSV and influenza virus (Repik 
et al 1974). The replication of SV40 may also be inhibited at this level 
(Graessmann et al 1974; M. Revel, personal communication, 1976).
Various workers have shown changes in the protein synthetic machinery 
of uninfected cells treated with interferon, even though the overall pattern 
of macromolecular synthesis is not altered (Levy and Merigan 1966). For 
example, Levy and Riley (1973) reported that interferon caused a slight 
shift in the molecular weight distribution of polyA(+)mRNA, without affecting 
rRNA or HnRNA. The molecular weights were slightly higher in interferon- 
treated cells. Viral RNA is not modified in interferon-treated cells (Klesel 
et al 1974), so the change in host mRNA may allow the cell to discriminate 
against viral" RNA.
tRNA may also be modified in interferon-treated cells (Truden et al 
Sen et al 1976; F.L. Riley and H.B. Levy, personal communication 1976). Alteration 
of the balance between different isoaccepting tRNAs is probably important 
in the control of protein synthesis in cells (Smith 1975, Sueoka 1966), and 
may account for the cytolytic response of interferon-treated cells to 
arginine starvation (Lee and Rozee 1975).
Ng et al (1968) found that interferon promoted the synthesis of some 
ribosome-associated proteins, but these observations have not been repeated 
(E.M. Martin, I.M. Kerr, and J. Sonnabend, personal communication 1968).
A more direct approach to the problem is to study the activity of 
cell-free protein synthesising systems on added and endogenous mRNA. Once 
changes in function are found, they can be correlated with changes in the 
structure of the machinery in a meaningful way. However, early work was 
unsatisfactory because knowledge of the mechanics of protein synthesis was 
inadequate and crude interferon was used. Marcus and Salb (1966) assumed 
that protein synthesis was occurring when "polyribosomes", formed by
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binding ribosomes to mRNA in the cold, broke down during incubation. The 
ionic conditions are now realised not to be suitable for polyribosome 
formation (Schreierand Staehelin 1973b), and the disaggregation observed 
on warming could be due to ribonucléase activity. Kerr et al (1970 and 
Kerr 1971) could not repeat the observations.
Using more defined systems, some effects have been reproducibly 
observed in extracts of interferon-treated cells (for example, Gupta et al 
1973, Gupta et al 1974a, Falcoff et al 1972, and Content et al 1974), 
although other groups have failed to observe effects unless the cells had 
also been infected (for example, Friedman et al 1972a), or even under any 
conditions at all (G. Hiller, personal communication 1975). The 
possibility that infection is required for full expression of the translational 
defect has led to a basic dichotomy in experimental approach and theory.
On the one hand, P. Lengyel, R. Falcoff, and M. Revel and colleagues 
have concentrated on characterising the defects they find in systems from 
interferon-treated but uninfected cells. To resemble the in vivo situation, 
these in vitro systems are expected to discriminate between viral and host 
mRNAs.
On the other hand, I. Kerr's group has compared systems from interferon- 
treated infected cells, and untreated infected cells. They hypothesize that virus 
infection triggers a defect in translation in interferon-treated cells, not 
present in uninfected cells. Such systems need not discriminate between 
virus and host mRNAs.
These two lines of evidence will be considered in turn, before discussing 
recent developments concerning nuclease acitvity and mRNA modification in 
interferon-treated cell extracts.
Cell-free systems from uninfected cells
Preincubated and gel-filtered cell-free systems, from mouse ascites 
or L929 cells, show a low background of endogenous synthesis and can utilise
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added EMC, mengo, reo or a variety of other virus and cell mRNAs (Gupta 
et al 1973, 1974a, Samuel and Joklik 1974, Falcoff et al 1972). These 
systems show lower efficiency when made from interferon-treated cells, 
but this effect is in all cases most readily seen after preincubation and 
gel-filtration. The significance of this, and the choice of mRNA, will 
become apparent later.
The ascites system of Gupta et al (1973) translates EMC mRNA with 
high efficiency. They found a component in the post-ribosomal supernatant 
of interferon-treated cells, which inhibited protein synthesis in control 
cell extracts. However, when non-preincubated extracts were fractionated 
and tested for inhibitory activity, the inhibitor was found on the ribosomes. 
The inhibitor thus moved off the ribosomes during preincubation (Gupta et al 
1973). It seemed that elongation, rather than initiation, of polypeptide 
chains was inhibited, Decause polysomes from control extracts could not be 
utilised by interferon extracts (Gupta et al 1974b), although there might 
have been a secondary effect on initiation.
The same group, using L929 cells and reovirus mRNAs (Graziadei et al * 
1973a), found a similar inhibitor in interferon-treated cell extracts (Gupta 
et al 1974a). This confirmed the findings of Falcoff et al (1972) using 
mengovirus or globin mRNAs. Unlike the ascites cell inhibitor, the L929 
cell inhibitor was firmly bound to the ribosomes and was not dominant 
(Falcoff et al 1972). Elongation was again the primary site of inhibition 
(Content et al 1974), but a secondary effect on initiation was also 
characterised (Content et al 1975).
None of these results showed any discrimination between viral or host 
mRNA, and the only RNA which escaped the block was poly rU, which is normally 
assayed under conditions where abnormal initiation occurs (Falcoff et al 1973, 
Gupta et al 1974a, Gupta et al 1973). However, when tRNA was added, the
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activity of interferon-treated extracts could be restored to control levels 
(Gupta et ai 1974c, Content et al 1974), and this tRNA dependance was 
critical on the ionic conditions of the assay (Gupta et al 1973, 1974b). 
Different fractions of tRNA restored the translation of globin and mengovirus 
mRNA with different efficiency (Content et al 1974,1975). Thus it was 
possible to create mRNA discriminating systems by the selective addition of 
tRNA, and it was possible that these tRNAs were artefactually lost during 
preparation of the system.
Charging of leucine, lysine, and serine tRNAs is defective in interferon- 
treated extracts (Gupta et al 1974b, Sen et al 1976), and the translation of 
poly(rU.rC), which codes for polyleucine, is strongly inhibited (Falcoff et al 
1976). Synthesis directed by mengovirus mRNA or by poly(rU,rC) is restored 
by a tRNA fraction corresponding to one of the leucine accepting tRNA species 
(Content et al 1974, 1975, Falcoff et al 1976). Synthesis using globin mRNA 
is restored by a different fraction of tRNA.
These effects of interferon showed all the characteristics expected - in 
terms of dose-response, effects of actinomycin D, and persistence of the 
defect after interferon removal (Falcoff et al 1973) - the translation defect 
always paralleling the antiviral effect. It seemed that interferon could act 
by causing a defect in either the tRNA or the charging enzymes, such that 
translation of virus mRNA was impaired whilst host translation continued, so 
inhibiting virus replication. However, there are problems in this hypothesis.
If the tRNA were inactivated by interferon treatment, tRNA extracted 
from interferon-treated cells should be less effective at reversing the 
translation block than tRNA from control cells. This is not the case (Content 
et al 1974, Sen et al 1976). On the other hand, if the tRNA charging enzymes 
were inactivated, addition of purified charging enzymes should overcome the 
block, but they do not (Sen et al 1976).
This was resolved by the finding that tRNA from interferon-treated 
extracts was less effective than tRNA from control extracts, provided that 
the extracts were gel-filtered (Sen et al 1976). This functional inactivation 
was prevented by the addition of a variety of low molecular weight compounds, 
including sodium ions, calcium ions, and polyamines. Polyamines are known 
to be important in other systems for efficient translation (Atkins et al 1975), 
and to stabilise RNA (Kyner et al 1973, Igarashi et al 1974).
Lengyel and colleagues (Sen et al 1976) have concluded that the effects 
observed in preincubated and gel-filtered extracts are not operative in the 
intact cell. There are some changes observable in non-preincubated extracts 
(Sen et al 1976) and these are not reversed by tRNA and operate by a different 
mechanism. The fact remains that one action of interferon is to render 
certain tRNAs more labile under certain conditions, and this could be due to 
activation of a nuclease or alteration in tRNA structure.
It is possible that the report of Samuel and Joklik (1974), that a 
message-discriminating system could be prepared from interferon-treated ascites 
cells, is also due to a tRNA effect. Preincubation was required, and the 
incubations routinely contained added tRNA. Their finding that inhibition 
correlated with the appearance of a 48000 dalton polypeptide in the ribsomal
i
salt wash fraction may thus indicate the molecular basis for the tRNA effect. 
Other explanations for message discrimination in their system will be outlined 
below.
Cell-free systems from infected cells
The initial failure to find any significant difference between non- 
preincubated cell-free systems from interferon-treated and control cells 
(Friedman et al 1972a, Falcoff et al 1972) led Kerr's group to study systems 
from interferon-treated, virus-infected cells (Friedman et al 1972a,b).
The experimental approach was to treat the cell suspension with a low 
dose of partly-purified interferon, infect with vaccinia virus or EMC virus, 
and then make cell-free extracts at a time when viral inhibition of host
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protein synthesis was well advanced (Kerr et al 1973). The systems were 
neither preincubated nor gel-filtered, but added EMC mRNA was translated 
efficiently and gave discrete products (Kerr and Martin 1971 , Esteban and 
Kerr 1974, Smith 1973).
When interferon and control cells were infected, and extracts made, 
there was some inhibition of endogenous translation, and pronounced inhibition 
of EMC mRNA translation. No effects could be detected in uninfected extracts 
(Friedman et al 1972a,b). The difference was induced by a trypsin-sensitive 
component of the interferon preparation, and was evident under a wide range 
of assay conditions. The inhibition was not mRNA specific, and did not 
involve mRNA degradation (Friedman et al 1972b). It was not overcome by 
added tRNA (I.M. Kerr, personal communication 1975).
The lesion was due to an inhibitor which was present mainly in the 
post-ribosomal supernatant (Kerr et al 1974a), and was destroyed by pre­
incubation (Friedman et al 1972b), in contrast to the tRNA defect which 
requires preincubation (Falcoff et al 1972). Analysis of the lesion was 
difficult because EMC mRNA codes for a wide range of polypeptides, produced 
both by post-translational cleavage and by premature termination of polypeptide 
chains (Smith 1973, Esteban and Kerr 1974). However, use of an N-formylated 
initiator tRNA showed that initiation is the primary site of the block 
(M-Esteban, personal communication 1973; Kerr et al 1974a) although there is 
also some inhibition of elongation. The precise nature of the inhibition is 
still uncertain, but it may be an effect on the met tRNAp binding reaction, 
as shown for preincubated extracts by Content et al (1975)
It thus seemed that infection with a virus was able to trigger the 
formation of an inhibitor in interferon-treated cells, so Kerr et al (1973) 
investigated the possibility that other treatments which lowered host cell 
protein synthesis might also trigger the inhibition. Starving cells of 
aminoacids briefly before making cell-free extracts produced systems which 
were rather less active than controls (Kerr et al 1966), but were still able
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to utilise added mRNA (Kerr et al 1973). Interferon treatment, followed by 
starvation, gave systems having the same endogenous synthesis as starved 
control cells, but which were impaired in the translation of added mRNA (Kerr 
et al 1973).
More recent work has suggested a candidate for the 'trigger" in virus- 
infected cell's. Kerr et al (1974b)'showed that extracts from interferon- 
treated, but not infected cells were inhibited by low concentrations of dsRNA, 
whereas dsRNA had little effect on control extracts. The addition of dsRNA 
to the cell-free incubations was thus equivalent to infecting the cells with 
virus. Either viral or synthetic dsRNA was effective, but DNA and ssRNA were 
not. It remains to be seen whether the mechanism of this inhibition is the 
same as that occurring in the virus-infected systems; if so, it would seem 
likely that dsRNA produced as an intermediate in virus replication (Colby and 
Duesberg 1969) could trigger the inhibition of translation.
The dsRNA effect nas now been repeated (Sen et al 1976), and provides 
explanations for a variety of observations in the literature. The ability 
of Gupta et al (1974a) to find inhibition in extracts of interferon-treated, 
uninfected cells, may reflect their use of mRNA preparations synthesised in vitro 
from reovirus cores (Graziadei et al 1973a), because these mRNAs contain dsRNA 
(Brown et al 1976): The microinjection experiments of Graessmamet al (1974), 
in which SV40 cRNA translation is intact cells was shown to be interferon 
sensitive, used cRNA preparations containing about 20% self-anneal 1ing material 
(Peterson et al 1972). On the other hand, Samuel and Joklik (1974) used salt 
precipitation to purify their preparations of in vitro synthesised reovirus 
and vaccinia virus mRNAs, so gross contamination with dsRNA is unlikely.
Other effects relevant to cell-free translation systems
RiDonuclease activity can inhibit cell-free protein synthesis by degrading 
mRNA or interfering with the protein synthesis machinery. Reports that mouse 
interferon itself has endonuclease activity (Graziadei et al 1973b) unfortunately 
cannot be substantiated until repeated with purified preparations (Knight 1975). 
However, there is also evidence that cellular nuclease activity may be stimulated
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by interferon treatment.
Marcus et al (1971 ,1975) investigated the replication of VSV
in interferon-treated chick cells. It appears that viral RNA synthesis,
*
using a virion enzyme, is not inhibited (Marcus et al 1971), but that 
interferon treatment induces a membrane-bound ribonucléase able to 
degrade VSV mRNA (Marcus et al 1975). The alkaline pH optimum and 
magnesium dépendance suggested this was a different activity from that 
found in untreated cells (Marcus et al 1975). The significance of this 
activity is diminished by the observations that protein synthesis is probably the 
target for interferon in VSV-infected chick and mammalian cells (Repik 
et al 1974), and the absence of a similar nuclease in interferon-treated 
monkey cells (Maenner and Brandner 1976).
Brown et al (1976) have reported the existence of a dsRNA-activated 
mRNA-specific ribonucléase in extracts from interferon-treated ascites cells. 
This activity was present in extracts which had not been preincubated or 
gel-filtered, and was readily detected using sedimentation analysis to examine 
the fate of radioactive mRNA. mRNA which had been freed of dsRNA by salt 
precipitation was not degraded, unless dsRNA was added as well (Brown et al 
1976). It is unlikely that the chick cell nuclease is also dsRNA-activated 
because it was active on L cell polyA(+)mRNA, which is unlikely to contain 
much dsRNA contamination (Marcus et al 1975). This work has recently been 
extended to show a requirement for ATP, as well as dsRNA, in activating the 
nuclease (P. Lengyel, personal communication 1976). Once activated, the 
nuclease retains activity even when the dsRNA is destroyed with RNAse III 
and ATP is removed with hexokinase and glucose. The enzyme acts as an 
endonuclease on long, rather than short, mRNAs, and does not degrade rRNA. 
Degradation is not dependent on méthylation of the mRNA or on protein 
synthesis, and so is independent of the other effects of interferon and dsRNA.
The capping and méthylation of mRNA (synthesis of a m^GpppXmp... 
structure at the 5' end) has recently been the subject of much investigation.
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Many eukaryotic mRNAs are capped and methylated (some are listed in Furuichi 
et al 1975) but some are not (for example, poliovirus mRNA, Hewlett et al 
1976). The importance of the modification for translation, once thought to 
be absolute (Both et al 1975, Muthukrishnan et al 1975), is now realised to 
vary according to the cell-free system used (Canaani et al 1976), and perhaps 
even with the ionic conditions (A.E. Smith personal communication 1976).
The methylation of reovirus mRNAs probably requires virion enzymes 
(reviewed by Shatkin and Both 1976), although cellular enzymes could also be 
involved. Sen et al (1975) reported that the methylation of reo mRNA by 
cellular enzymes was defective in interferon-treated, but not control, cell- 
free extracts. This work has recently been developed (P. Lengyel, personal 
communication 1976) to show that the methylation of mRNA de novo synthesised 
by reovirus cores is also inhibited in interferon-treated extracts. The 
inhibition is due to a macromolecular inhibitor and not to degradation of 
either the methyl donor, S-adenosyl methionine (SAM), or the mRNA substrate. 
The inhibitor is labile and destroyed by preincubation.
The significance of impaired methylation in vivo has not yet been 
demonstrated, but it is interesting that VSV mRNA methylation in a coupled 
cell-free transcription/translation system from chick cells is probably not 
inhibited (A. Ball, personal communication 1975). However, the effect is 
useful for explaining published results using protein synthesis systems, 
and the observation that certain viral mRNAs are translated poorly in 
interferon-treated cell extracts may partly be due to their preparation.
In vitro vaccinia and reo mRNAs are not expected to be methylated unless SAM 
is present in the reaction mixture (Ensinger et al 1975, Shatkin and Both 
1976), so the mRNAs used by Gupta et al (1974a) and Samuel and Joklik (1974) 
were probably not methylated. If methylation is defective in cell-free 
extracts from interferon-treated cells (Sen et al 1975a) and if translation 
depends on methylation (Canaani et al 1976), then defective translation
of reovirus and vaccinia virus mRNA is not surprising.
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A final complication to the story is found when mitochondrial protein 
synthesis is examined (Kortsaris et al 1976). Isolated mitochondrial were 
found to synthesise protein and to be stimulated by added EMC virus or 
globin mRNA. Synthesis was probably occurring on 70S ribosomes (i.e.was 
chloramphenicol sensitive and cycloheximide resistant) and some of the 
added mRNA entered the mitochondria, but the products were not characterised 
and may not be meaningful. The reduced activity of mitochondria from 
interferon-treated cells is thus of dubious significance particularly as 
the effects on energy generation and precursor transport were not determined 
(Kortsaris et al 1976).
Conclusions
There are several differences between in vitro systems made from 
interferon-treated and control cells. Certain species of tRNA are more 
rapidly inactivated after gel-filtration (Content et al 1975i Sen et al 
1976); and this prevents elongation of nascent polypeptide chains, with a 
secondary effect on initiation (Content et al 1975). A macromolecular 
inhibitor of mRNA methylation, by both virus and cytoplasmic enzymes, is 
generated (Lengyel et al 1976), and a dsRNA-activated endonuclease (Brown 
et al 1976), and perhaps other nucleases (Marcus et al 1975), are produced. 
Finally, an inhibitor of protein synthesis, probably acting on initiation 
(Kerr et al 1974a), is generated if dsRNA is added to the extract (Kerr 
et al 1974b), or if the extract is made from infected cells (Friedman et al 
1972b).
All these effects are dependant on treatment of the cells with 
homologous interferon, and, when tested, the effects parallel the antiviral 
activity. In no case is purified interferon, added to the cell free system, 
able to reproduce the effect on interferon treatment of the intact cells. 
However, this does not exclude the possibility that suitably modified, 
intracellular, interferon is mediating the in vitro actions.
It is still unclear how the in vitro effects relate to the in vivo
effects - which are causal, which are coincidental, and which have no 
relevance at all in the intact cell. As described above, some of the 
apparent effects seen in vitro are critically dependant on cell type, 
treatment of the cell-free system, source of mRNA, and choice of ionic 
conditions for assay. Even so, it is possible that the variety of in vitro 
actions are related to the variety of antiviral and non-antiviral actions 
of interferon seen in intact cells. Thus Kerr et al (1974b) suggested that 
the dsRNA-dependant inhibition of protein synthesis might relate to the 
cytotoxic effect of dsRNA (Stewart et al 1972a), and R. Falcoff (personal 
communication 1974) described a reduction in in vitro protein synthesis 
activity at high doses of interferon, which might be related to cell growth 
inhibition (Paucker et al 1962).
It is interesting that dsRNA, which is an interferon inducer and 
is more toxic for interferon-treated than control cells, is required for at 
least two of in vitro actions (Kerr et al 1974b, Brown et al 1976). The 
possibility that dsRNA is the key molecule by which a cell senses virus 
infection, and is thus the mediator of a wide range of virus/cell interactions,
is discussed in a later section.
1.5. non-antiviral actions o f  interferon
Only in recent years have effects of interferons on uninfected 
cells become apparent (Levy and Merigan 1966; de Clercq and Stewart 1973). 
Previously such effects had been attributed to contaminants in 
the interferon preparations, or had not been reproducible in other 
laboratories. It now seems that partially-purified interferon preparations 
can produce a number of different physiological effects in whole animals 
and in lymphocyte cultures (reviewed by de Clercq and Stewart 1973, and 
by Carter and de Clercq 1974) and in tissue culture. The component of the 
interferon preparation responsible for the non-antiviral effects is the 
same as that responsible for the antiviral effect, in that it is trypsin 
sensitive, of high molecular weight, stable to low pH, and of restricted 
species specificity.
The tissue culture effects are inhibition of cell growth, blocking 
or priming of interferon induction, enhancement of the toxicity of dsRNA, 
and alteration of the cellular response to some other compounds. Each 
activity will be described individually before considering two questions. 
Firstly, in what ways do the metabolic requirements for developing the non­
antiviral effects differ from the requirements for the antiviral effect?
*
Secondly, in view of the molecular heterogeneity of interferons, is the 
same molecular species involved in causing all the different effects of 
interferons?
Cell growth inhibition
Interferon inhibits the growth and division of cells in suspension 
culture (Paucker et al 1962, Gresser et al 1970) and in monolayers (Lee et al 
1972, O'Shaugnessy et al 1972). Generally it is found that the dose of 
interferon required is relatively high (about 100 times the antiviral dose, 
Paucker et al 1962), and that the doubling time is increased up to about 
two-fold (Paucker et al 1962). Both diploid and aneuploid cells are
affected (Lee et al 1972).
The earliest changes seen in continuous culturearein the incorporation 
of thymidine into DNA and in the proportion of cells in S-phase; after 
treatment of LI210 cells with 6000 u/ml interferon, both parameters drop by 
about 50% in 2 hours, that is, several hours before an increase in generation 
time is apparent (Tovey et al 1975). In this system, the decrease in DNA 
synthesis corresponds to a decrease in the activity of the thymidine pool, 
suggesting either feedback inhibition or a primary action of interferon on 
transport. When synchronised cells are treated with interferon, there is a 
puromycin-sensitive delay at the start of S-phase suggesting that a protein 
inhibiting entry into S-phase may be induced (O'Shaugnessy et al 1972).
Synthesis of RNA and protein is not greatly inhibited in continuous 
culture (Tovey et al 1975), although protein synthesis is inhibited in 
batch culture (Borecky et al 1972). Neither approach is without pitfalls.
The chemostat makes use of glucose limitation to control cell growth, and 
this could have other effects. Batch culture measurements have to be made 
during exponential phase growth, and culture conditions are continuously 
changing. The discrepancy over protein synthesis effects thus may not be 
significant.
The continued presence of interferon may result in the production of 
interferon-resistant cells (Gresser et al 1970, Katz et al 1974, Lackovic 
and Borecky 1976). These cells are able to synthesise RNA and grow at 
normal rates in the presence of interferon, and may be resistant to other 
actions of interferon (Gresser et al 1970, Tovey et al 1975). They may 
also differ in membrane properties and morphology from the parental line 
(Katz et al 1974). These experiments were all performed using aneuploid 
cell lines maintained in the presence of interferon for several passages.
The high frequency with which resistant cells are found resembles the 
development of colchicine resistance in Chinese hamster cells (Minor and 
Roscoe 1975) which has been attributed to changes in karyotype affecting 
membrane permeability. The limited data available on the interferon-resistant
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lines makes it unlikely that they are point mutations, which normally occur 
at very low frequency and are highly stable (Meiss and Basilico 1972).
When cells are treated with interferon their response to interferon 
inducers may be blocked or primed.
Blocking of interferon production was first recognised with viral 
inducers, where production of the inducing molecule may be prevented by 
the antiviral state (Friedman 1966), but it can also occur with dsRNA 
inducers (Youngner and Hallum 1969, Stewart et al 1971b). Blocking normally 
occurs with high doses of interferon (greater than 1000 times the antiviral 
dose, Barmak and Vi leek 1973), and may be a regulatory mechanism controlling 
interferon production or be due to impurities.
Priming of interferon production is normally found with low doses of 
interferon, and can even be found in cells which exhibit blocking at high 
interferon doses (Friedman 1966, Barmak and Vilcek 1973, Stewart et al 1971b). 
Depending on cell type and inducer, priming can put up the yield of interferon 
dramatically; for example, in L929 cells induced with MM virus the yield is 
increased 400 fold (Stewart et al 1971a) and with poly rl.rC, 30-100 fold
(Stewart et al 1973b).
•»
Interferon production by primed cells occurs more rapidly (Stewart et al 
1971b), and sooner becomes actinomycin D resistant (Stewart et al 1971a), than 
production by unprimed cells. After priming, a poor producer line of L929 
cells became equally productive as a high producer line (Stewart et al 1972c). 
These results suggest that priming may remove a block which normally limits 
interferon mRNA transcription.
Enhancement of toxicity of dsRNA
dsRNA may be toxic to normal cells (Cordell-Stewart and Taylor 1971, 
1973b), possibly because it inhibits DNA (Teng et al 1973) and protein 
(Cordell-Stewart and Taylor 1973a) synthesis. However, conditions can be 
found where low doses of dsRNA are not toxic, unless the cells have 
previously been treated with interferon (Stewart et al 1972a). The active
blocking of interferon production
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component in the interferon preparation has the characteristics of interferon 
(Stewart et al 1972a), and the toxic effect has even been suggested as a 
rapid interferon assay (Stewart et al 1972b).
Enhanced cytotoxicity is specific for dsRNA and is not due to a general 
increase in susceptibilityto all toxic compounds or all nucleic acids 
(Stewart et al 1973a). Apart from dsRNA only vaccinia virus also shows 
interferon-enhanced toxicity (Joklik and Merigan 1966), and this may involve 
intracellular production of dsRNA (Colby and Duesberg 1969, Stewart et al 
1973a). The molecular size requirements for a dsRNA to be toxic parallel 
those for induction (Stewart and de Clercq 1974), as do the metabolic and 
timing requirements for the development of the effect (de Clercq and 
de Somer 1974b). However, priming and enhanced toxicity can be separated, 
for example by treating with dsRNA before, as well as after, interferon 
treatment; a procedure which prevents primed interferon production but not 
the cytotoxic effect (de Clercq and de Somer 1974b).
The toxicity is rapid and extensive (Stewart et al 1972a), involving 
structural changes in many cellular organelles (Heremans et al 1976), but 
the metabolic changes caused by the dsRNA have not been identified. RNA 
and protein synthesis during the dsRNA treatment period are not required 
(de Clercq and de Somer 1974b) so that primed cells treated with dsRNA
i
and metabolic inhibitors will die, but not produce interferon.
Other effects
The other non-antiviral effects of interferons have been less well 
characterised. They fall into two main classes; altered toxicity of 
compounds, and alterations in the inducibility of various enzymes.
Thus, interferon treatment is said to protect chick cells against 
the cytotoxic action of streptomycin (A. Yabrov, personal communication 
1974) and to increase the toxicity of polycations (Katz et al 1974), 
concanavalin A (J. Suzuki and S. Kobayashi, personal communication 1974) 
and high concentrations of choline or urea (R. Ahl, personal communication 
1976). Lee and Rozee (1975) have reported lysis of interferon-treated cells
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in arginine-free medium, but not in media lacking other aminoacids. Addition 
of precursors to arginine, but not non-metabolisable analogues, prevented 
lysis. They suggested that this lytic effect and the antiviral effect could 
both result from changes in tRNA balance, although the involvement of 
arginine in other cell processes besides protein synthesis (for example, 
polyamine synthesis, Russell 1973), makes a variety of other theories possible.
Interferon can also modulate specific responses in specialised cells.
One of the many effects on lymphoid cells is to inhibit the action of mitogens 
on spleen cells (Lindahl-Magnusson et al 1972). This inhibition can be 
increased by prior treatment with "priming" doses of interferon (Rozes et al 
1973). Rossi et al (1975) showed that interferon can inhibit the DMSO induced 
differentiation of Friend leukemia cells, although Swetly and Ostertag (1974) 
disagree. Both of these effects may relate to the cell-growth inhibitory 
effect of interferon.
Rat hepatoma cells can be induced to synthesise tyrosine aminotransferase 
using dexamethasone. These cells are rather insensitive to rat interferon, 
making studies using partly purified, low titre, preparations difficult to 
interpret. The induced enzyme activity was decreased by prior interferon 
treatment, but 200-700 times the VSV yield reducing dose was required (Vassef 
et al 1974). Illinger et al (1976) met similar problems while studying the 
hydrocortisone induction of glycerol-6-phosphate dehydrogenase in rat glial 
cells. Again, impure preparations were used, at high titre. Glutamine 
synthetase induction by hydrocortisone in chick embryo neural retina cells 
is inhibited by 100-300 times the EMC inhibiting dose of chick interferon 
(Matsuno et al 1976). All these experiments involved interferon doses where 
growth inhibition may become important.
By contrast, increased activity of an induced enzyme has been reported 
(Nebert and Friedman 1973). Benzanthracene induction of aryl hydrocarbon 
hydroxylase activity in liver cells is increased by interferon pretreatment. 
Whether this is due to altered activity or rate of synthesis of the enzyme 
is unknown, but uptake of the inducer and degradation of the enzyme are 
unaltered (Nebert and Friedman 1973).
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Metabolic and genetic requirements for development of non-antiviral effects
The antiviral effects of interferon require a temperature and time 
dependant step which may require RNA and protein synthesis, and involve the 
nucleus - specifically, in human cells, chromosome 21 (Dianzani and Baron 
1975, Radke et al 1974, Revel et al 1976). Historically, this has been 
interpreted as the involvement of an "antiviral protein", although this 
concept is debatable (see discussion in section 1.3). The metabolic require­
ments for, and the chromosomes involved in, some of the non-antiviral 
activities of interferon have also been determined.
The requirements for developing the cell growth inhibitory effect 
cannot be determined directly using metobolic inhibitors, because the 
cells need to grow through several generations. However, O'Shaugnessy et al 
(1972) showed that S-phase was delayed by interferon treatment in synchronised 
cells, and this delay was prevented by puromycin. The suggestion that an
"antiviral protein" may be involved was corroborated by Tan (1976) who showed
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that chromosome 21 confined sensitivity to the cell growth inhibitory, as 
well as the antiviral (Tan 1975), action of human interferon. Cells resistant 
to cell-growth inhibition are commonly also resistant to the antiviral effect 
(Gresser et al 1970, Katz et al 1974) although this is not always true 
(V. Lackovic and L. Borecky, personal communication 1976).
Inhibitors are also difficult to use when investigating priming and 
blocking, because their effects must be fully reversed during the induction 
and production period, to avoid inhibition or superinduction phenonema 
(Tan et al 1971). However, it appears that blocking requires reasonably 
long exposure to interferon during which RNA and protein synthesis are 
permitted (Stewart et al 1971b, Barmak and Vilcek 1973). On the other hand, 
priming occurs rapidly, even in the presence of metabolic inhibitors (Stewart 
et al 1971b, Barmak and Vilcek 1973, Stewart et al 1971a). Not only does 
priming develop rapidly, it also decays rapidly (I. Rosztoczy .personal 
communication 1974). No increase in interferon yield can be detected when 
challenged 24 hours after priming, although the antiviral effect persists
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through several cell generations (Paucker and Cantell 1963).
Direct membrane involvement in priming is also suggested by the 
finding that insolubilised interferon can prime (Knight 1974a), although 
leakage from the support may occur (section 1.3).
The requirements for priming probably also apply to enhanced cytotoxicity, 
although the use of inhibitors is difficult because they may compound the 
cytopathic effect. A state which is "primed" for toxicity develops rapidly 
(Stewart et al 1971b), although perhaps not as rapidly as the state primed 
for interferon production (de Clercq and de Somer 1974b). There is unpublished 
evidence (quoted in Stewart 1975) that protein synthesis is not required.
Unlike the cell growth inhibitory and antiviral effects, neither 
priming nor toxicity enhancement are affected by the dosage of chromosome 21 
in human cells (de Clercq et al 1975a). It would be interesting to know 
whether any other chromosomes are required. Enucleation experiments could 
not be performed in connection with priming, but cells could be enucleated, 
exposed to interferon, challenged with dsRNA, and observed for cytopathic 
effects.
Molecular requirements for non-antiviral effects
Each of the non-antiviral effects is due to a protein which co-purifies 
with the antiviral activity. Thus, Stewart et al (1973b) followed three 
different sources of mouse interferon over a 100 fold range of specific 
activities, and found good correlation of antiviral, priming, and toxicity­
enhancing activities. Toxicity and priming correlate over a 1000 fold range 
of purity (Stewart et al 1972a), and very highly purified preparations show 
a cell growth inhibitory effect (Tovey et al 1975 for mouse interferon;
Knight 1976 for human fibroblast interferon).
The discovery that interferons may be heterogeneous led to the question 
of whether one component had all activities, or whether each activity was 
carried on a separate component.
Heterogeneity can be shown using antisera (Berg et al 1975, Havell 
et al 1975, Paucker et al 1975), affinity columns (Janowski et al 1975,
Davey et al 1976), isoelectric focussing (Dorner 1973), and denaturing
polyacrylamide gels (Stewart 1974). Some of the heterogeneity is present 
in the carbohydrate portion (Oorner 1973), but different polypeptides may 
also be found. L929 cell interferon contains between 2 (Stewart 1974) and 
11 (Knight 1975) distinct components, and human leukocyte interferon has 
two components (Stewart and Desmyter 1975).
The different components of human interferon may be responsible for 
cross-reactivity in rabbit (Paucker et al 1975, Stewart and Desmyter 1975) 
and cat cells (W.E. Stewart II, personal communication 1975). However, the 
components of L929 and leukocyte interferon, separated on denaturing gels, 
all show the same relative titres in antiviral, priming, and toxicity assays 
(Stewart et al 1976).
A report that the antiviral and cell growth inhibitory activities 
of mouse interferon could partially be separated on non-denaturing gels 
(Borecky et al 1972) needs some consideration. Cell growth inhibition was 
measured by inhibition of protein synthesis, and the fractions which were 
said to contain no growth inhibitory activity (yet still had antiviral 
activity) rely critically on the control value for protein synthesis - 
raising the control value by only 15-20% would give almost perfect correlation 
between protein synthesis inhibition and antiviral activity! Moreover, 
Sulkowski and colleagues (R.F. Buffet, personal communication 1976) using 
high activity mouse interferon, which inhibited 3T3 cell growth by 50% at 
only 10 u/ml, have shown that the two components separable on an affinity 
column are equally inhibitory.
Albumin agarose separates human leukocyte interferon into two components 
(Janowski et al 1975) which may differ in anticellular activity (H. Dahl and 
M. Degre, personal communication 1975). Confirmation of this would be 
interesting, in view of the failure to separate antiviral and anticellular 
activities on denaturing gels (Stewart et al 1976).
In conclusion, even though different molecular species of interferons 
may be produced by cells derived from different tissues (Berg et al 1975,
Janowski et al 1975, Stewart et al 1974), and possibly in response to 
different inducers (Janowski et al 1975), it seems that each component 
expresses all the different activities of interferon in a given species 
of cell. The only differences which can be detected are seen when the 
antiviral activity is compared in cells from different animal species 
(Steward and Desmyter 1975) and may reflect differences in recognition by 
cell-surface receptors. The results are consistent with individual 
molecules of interferon inducing the whole range of different effects in 
the recipient cells.
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! _6_ dsRNA IM THE CONTROL OF MACROMOLECULAR SYNTHESIS
dsRNA has many biological effects: in vivo it induces interferon and 
causes cytopathic effects in interferon-treated cells, and in vitro it may 
induce an inhibitor of translation and a mRNA-specific ribonuclease. This 
section will discuss evidence relating to the presence of dsRNA in normal 
and infected cells, and the possible involvement of dsRNA in the control of 
protein synthesis. 
dsRNA in uninfected cells
Small amounts of dsRNA can be detected in uninfected cells (Colby and 
Duesberg 1969, Harel and Montagnier 1971, Stern and Friedman 1970), and as 
a host background in studies on the production of viral dsRNA (Dubois 1974). 
Detection normally utilises ribonuclease to selectively digest contaminating 
ssRNA, after which dsRNA is isolated by gel filtration (Harel and 
Montagnier 1971). The physical studies have thus been performed on molecules 
from which any single-stranded regions have been removed.
The dsRNA is heterogeneous, sedimenting at about 8 S(Harel and 
Montagnier 1971), and is of high enough molecular weight to induce interferon 
when applied to cells (de Maeyer et al 1971). The high melting temperature 
and the base composition suggest high complementarity between the strands.
When melted and anneal!ed to cellular DNA, more than 20& of the labelled 
dsRNA enters hybrids, compared with less than 1% annealling in controls 
containing E. coli RNA or native dsRNA. This 20% was not reduced by 
competition with rRNA, and this evidence, coupled with the base composition 
and the stability of its RNA.DNA hybrid, suggested that its sequences were 
not related to rRNA (Harel and Montagnier 1971). Ribonuclease-resistant RNA 
is also synthesised in the presence of concentrations of actinomycin D 
adequate to fully inhibit rRNA synthesis (Stern and Friedman 1970). This 
would seem to exclude its production from hairpin loops in ribosomal precursor 
RNA, as occurs in bacteria (Dunn and Studier 1973). Instead the dsRNA may
42
be synthesised by an actinomycin D resistant route, either using a DNA or 
an RNA-directed polymerase.
Of the DNA-dependant activities present in the cell, nucleoplasmic 
RNA synthesis is relatively insensitive to actinomycin D, although the 
molecular basis for this is not well understood (Lindell 1976X- This 
activity could be responsible for dsRNA synthesis, either as hairpin loops 
or by as symmetric transcription of dsDNA. Random RNA sequences are highly 
likely to contain inverted repeat regions able to form hairpins (Gralla and 
De Lisi 1974), and hairpins do indeed occur in Hn RNA (Jelinek et al 1974) 
where they probably correspond to transcripts from hyper-repetitious DNA.
Pays (1976) has shown dsRNA in in vitro chromatin transcripts, presumably 
due to asymmetric transcription.
The high proportion of dsRNA which does not anneal to host cell DNA 
might represent sequences not found in the genome, although it could merely 
be due to inappropriate reaction conditions. Different sequences, or 
amplification of uncommon sequences, could arise if the cells contained an 
RNA-dependant RNA polymerase, such as the one found in reticulocytes (Downey 
et al 1973). This activity is fully dependant on added RNA, but not DNA, 
template, and is inhibited by rifamycin (which inhibits the QB RNA-dependant 
RNA polymerase) but not by rifampicin (which inhibits prokaryotic DNA-dependant 
RNA pol}fnerase, and oncornavirus reverse transcriptase). Such an enzyme could 
produce complementary RNA, which, when deproteinised, could anneal to from 
dsRNA. Reticulocytes are specialised cells and are enucleate but similar 
enzymes have been reported in rat brain microsomes (Mikoshiba et al 1974) 
and on the ribosomes of avian erythrocytes (Boyd and Fitschen 1975). It is 
possible that the RNA dependance of these enzymes represents elongation from 
a 3' terminal, rather than synthesis of a complementary strand (Mikoshiba 
et al 1974).
mm
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There is other evidence that the cell is able to process dsRNA.
Perez-Bercoff et al (1974a) have shown that mengovirus RF is infectious, 
and that actinomucin D and a-amanatin can inhibit the early stages of 
infection. This may mean that the input dsRNA acts as a template for a 
cellular polymerase, particularly as the a-amanatin sensitive cellular RNA 
polymerase binds to dsRNA (Perez-Bercoff et al 1974b) and the input dsRNA becomes 
associated with newly synthesised RNA (R. Perez-Bercoff, personal communication 
1976). However, recent evidence that initiation of protein synthesis can 
occur on viral dsRNA (Szekely et al 1976) makes it possible to interpret 
these results as showing the binding of ribosomes to dsRNA followed by viral 
polymerase synthesis and the normal course of infection. Nothing is yet 
known about the antibiotic sensitivity of dsRNA-dependant translation. 
dsRNA as an intermediate in virus replication
The replication of RNA viruses requires synthesis of both message 
sense (+) and complementary sense (-) RNA. Except in the case of the 
diploma viruses,where ( + ) RNA synthesis occur in the input virion cores 
and (-) RNA synthesis occursin minus-strand synthesising particles (Burke 
and Russell 1975), both strands are present in the cytoplasm. Therefore 
the presence of dsRNA in extracts of infected cells could mean that dsRNA 
exists as such in the cytoplasm, although it may arise by annealling of 
complementary strands during extraction.
Besides dsRNA (the replicative form, RF), extracts of infected cells 
usually contain a multistranded structure, the replicative intermediate (RI), 
thought to consist of a single RNA template strand with multiple nascent 
complementary strands (Levin and Friedman 1971, Bruton and Kennedy 1975).
In bacterial (Billeter et al 1966, Feix et al 1967) and animal virus systems 
(Martin and Burke 1974, Bruton and Kennedy 1975), the RI is the main intra­
cellular structure with the RF playing a minor role or being an artefact of 
phenol extraction.
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The RI may contain some double-stranded regions. Two different 
structures have been postulated; either the template and nascent strands 
could be held apart by proteins, with contact only at the growing point 
(31 end) of the nascent strand, or each nascent strand could be hybridised 
to the template until displaced by the next strand. The former structure 
contains much less dsRNA than the latter, and corresponds to QB RI formed 
in vitro (Feix et al 1967) and R17 RI in vivo (Thach and Thach 1973).
Similarly, with picorna viruses it seems that the former structure is 
present, as shown by electron microscopy of EMC virus RI (Thach et al 1974), 
or by carbethoxylating single-stranded regions of poliovirus RI before phenol 
extraction (Oberg and Philipson 1971, Ehrenfeld 1974). Studies with other 
RNA viruses have not been reported.
In conclusion, the finding that deproteinised RNA from RNA virus- 
infected cells contains dsRNA in RF and RI, and that the dsRNA sections 
of isolated RI are adequate to produce biological effects in vitro (f2 RI,
Hunter et al 1972; Sindbis viris RI, Shenk and Stollar 1972; rhinovirus RI, 
Macnaughton et al 1976), does not mean that dsRNA exists in the cell, nor 
that it mediates effects in vivo. However, the ability to show some activities 
of dsRNA in non-deproteinised extracts of infected cells (Hunt and Ehrenfeld 
1971) is strong evidence that dsRNA is produced in infection.
The situation with DNA viruses is rather different. Here there is no 
necessity for RNA of both senses to be transcribed, and replication complexes 
containing RNA.DNA hybrids to not have the same biological activities as 
dsRNA. However, there are some reports that small amounts of dsRNA are found 
in vaccinia virus infected cells (Colby and Duesberg 1969), although not in 
herpesvirus infected cells (Perez-Bercoff et al 1973). The vaccinia virus 
dsRNA is not only found in infected cell extracts, but is also found before 
deproteinisation, and in in vitro transcripts (Colby et al 1971); vaccinia cores
can synthesise an inhibitor of protein synthesis, probably dsRNA, when incubated
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in the reticulocyte lysate (H.R.B. Pelham, personal communication 1976).
Thus it is not an aretfact of phenol extraction.
dsRNA could arise by transcription of both strands of a given segment 
of dsDNA. Asymmetric transcription is known to occur in SV40, polyoma, and 
adenovirus infected cells (see Sambrook 1975), but the RNA sequences do- 
not overlap in these cases, so pox viruses seem to be unusual in making 
self-complementary RNA. It is interesting that an endonuclease able to 
degrade dsRNA is induced as a late function in frog virus 3 infected cells, 
and is integrated into the virus (Kang and McAuslan 1972), so dsRNA may 
play a role in the replication of iridoviruses. 
dsRNA as an inhibitor of in vitro translation
dsRNA is an efficient inhibitor of protein synthesis in reticulocyte 
lysates (reviewed by Hunt 1976) but is less active in other cell-free systems. 
Despite an initial report that E.coli cell-free translation was inhibited 
(Chao et al 1971), it now seems that prokaryotic systems are insensitive to 
(Jay et al 1974), and may even be stimulated (Bogaslawski et al 1976) by dsRNA. 
The wheat germ system (Reijnders et al 1975), ascites S-30 (Robertson and 
Mathews 1973), chick cell S-30 (Shenk and Stollar 1972), Hela S-30 (Celma and 
Ehrenfeld 1974), and L cell S-30 (Kerr et al 1974b) are all relatively 
insensitive to dsRNA, concentrations of about 1 pg/ml being required (Beuzard 
and London 1974)compared with 1 ng/ml in the reticulocyte lysate (Hunter et al 
1972).
The relative insensitivity of these systems may be explained by the 
presence of nucleases able to degrade dsRNA (Robertson and Mathews 1973); by 
the presence of a factor able to overcome the inhibition (Balkow et al 1973; 
Kaempfer and Kaufman 1973); or by a range of other theories based on artefacts 
arising from preparation of the systems. On the other hand, L cell extracts 
can be made highly sensitive to dsRNA (Kerr et al 1974b), so different 
responses to dsRNA in vitro could reflect real differences in control systems
operating in vivo. The high sensitivity of reticulocyte lysate to dsRNA
could be because the dsRNA control system is permanently switched "on", 
whereas in most other cells it is normally "off".
The mechanism of inhibition has been explored most deeply in 
reticulocyte lysates, and so far as is known, the same processes occur in 
the ascites S-30 (Robertson and Mathews 1973; Beuzard and London 1974). The 
chief characteristics of inhibition are: biphasic kinetics, with almost total 
shut off after a short lag (Hunter et al 1972); potentiation by preincubation 
(Hunter et al 1972; Robertson and Mathews 1973); and reversal by an initiation 
factor, IF-E2 (Balkow et al 1973, Kaempfer 1974; Beuzard and London 1974).
In agreement with this, the lesion is at initiation of new polypeptide 
chains, with dsRNA preventing the binding of met tRNAp to 40S subunits 
(Darnbrough et al 1972), a process thought to be involved in normal initiation 
(Darnbrough et al 1973; Schreier and Staehelin 1973a, Sundkvist and Staehelin 
1975). This binding is IF-E2 dependant (Schrier and Staehelin 1973a), so it 
was proposed that dsRNA was inactivating IF-E2.
Early work showed that a factor labelled IF-3 could bind strongly to 
dsRNA (Kaempfer and Kaufman 1973). That factor is now know to contain both 
IF-E2 and IF-E6 (equivalent to If -MP and If -M3, W. Merrick personal 
communication 1976) and both factors bind dsRNA although only IF-E2 overcomes 
the inhibition (Kaempfer 1974). An explanation of the inhibition based on 
inactivation of IF-E2 by dsRNA binding is thus unlikely, and the finding 
that bacterial IF-3 does not bind dsRNA (Jay et al 1974) is not an adequate 
explanation for the insensitivity of bacterial translation.
An alternative mechanism has been suggested (P. Farell, K. Balkow,
T. Hunt and R. Jackson, personal communication 1975) which embraces the 
inhibitory effects of dsRNA, hemin deficiency (Hunt et al 1972), and 
oxidised glutathione (Giloh and Mager 1975). Hemin control is mediated by 
an inhibitor (Gross 1974 a and b) which is formed in an ATP-dependant reaction 
(Balkow et al 1975) and inhibits formation of the met tRNA p-AOS.GTP initiation 
complex (Legon et al 1973). Moreover, the inhibition is reversed by IF-E2
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(Balkow et al 1973; Clemens et al 1974; Clemens et al 1975}. A similar 
inhibitor was generated by dsRNA (Legon et al 1974), thus making direct 
interaction of dsRNA with the initiation factor unlikely.
The probable mode of action of these inhibitors has now been 
elucidated (P. Farrell, K. Balkow, T. Hunt, and R. Jackson, personal 
communication 1975; Ernst et al 1976). All treatments cause prosphorylation 
of a 35000 dalton polypeptide which is identical to the small subunit of 
IF-E2. This phosphorylation is prevented by a variety of purine derivatives 
known to reverse the inhibition of protein synthesis (Legon et al 1974). 
Moreover, phosphorylated IF-E2 is probably unable to bind ret tRNAp (B.Hardesty, 
personal communication 1976). The observation that formation, as well as 
action, of the inhibitor requires ATP (Balkow et al 1975) suggests that a 
series of protein kinases may be activated sequentially (Traugh et al 1976) 
to amplify the response.
Some of the more important features of this mechanism have been confirmed 
in Hela S-30, which is partly hemin dependant (C. Baglioni, personal 
communication 1976). Moreover, the finding that inhibition due to dsRNA 
proceeds by a similar mechanism to hemin and oxidised glutathione control
argues for its physiological significance, for hemin control is important
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in intact reticulocytes (Hunter 1974; Hunter and Jackson 1975), and oxidising 
agents may be generated in energy-starved reticulocytes (Giloh and Mager 1975). 
However, a precise role for dsRNA in the reticulocyte is difficult to imagine, 
although some suggestions have been made (Downey et al 1976).
Inhibition of host ceil protein synthesis by viruses
There are two problems here - firstly, what is the chemical nature of 
the protein synthesis inhibitor, and secondly, how does it discriminate 
against cellular protein synthesis whilst allowing viral protein synthesis 
to proceed?
The chemical nature of the inhibitor will be examined for the 
particular case of poliovirus infection, for here there is a variety of 
evidence on a possible role of viral dsRNA.
Willems and Penman (1966) investigated polyribosome run off in the 
presence or absence of an elongation inhibitor. The results implied either 
a lesion at, or before, polypeptide chain initiation, or degradation of mRNA. 
Gross degradation of mRNA can be excluded because extracted mRNA had the 
same sedimentation characteristics as mRNA from control cells (Willems and 
Penman 1966). There was no effect on the transit in time of ribosomes, or 
on the availability of charged met tRNAp (Summers and Maizel 1967). Detailed 
evidence is now available confirming that the lesion is at initiation, and 
is due to an inhibitor located in the ribosomal saltwash fraction of infected 
Hela cells (Kaufmann et al 1976).
When Hunt and Ehrenfeld (1971) took cytoplasmic extracts of infected 
cells and assayed for inhibition of protein synthesis in the reticulocyte 
lyate system, they wereable to isolate a macromolecular, heat-stable inhibitor, 
which appeared in parallel with inhibition of host protein synthesis in the 
infected cells (Ehrenfeld and Hunt 1971). Although resistant to trypsin,
DNAse, and ribonuclease, it was sensitive to alkaline digestion or micrococcal 
nuclease and showed other characteristics expected for the RF. dsRNA purified 
from infected cells had the same sedimentation constant and enzyme sensitivity 
as the inhibitor (Ehrenfeld and Hunt 1971). Purified virions can also inhibit 
the lysate, but only at high concentration (Racevskis et al 1976).
The presence of dsRNA able to inhibit cell-free translation in 
reticulocyte lysates does not mean that the RF or RI is responsible for 
host-cell shut off in vivo. Celma and Ehrenfeld (1974) attempted to quantitate 
the RF in infected Hela cells in terms of its ability to inhibit protein 
synthesis in Hela cell S-30s. They found that the effect of RF on in vitro 
synthesis was not sufficient to account for the inhibition of in vivo synthesis. 
However, because they used F-met tRNAp incorporation as a measure of 
initiation rate, they may have by-passed the inhibited step (Kerr et al 1974a,b, 
Content et al 1975), accounting for the apparently low inhibition.
Less direct evidence comes from experiments using mutants or metabolic 
inhibition. Cooper et al (1973) have proposed a model for the control of
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poliovirus transcription and translation based on genetic studies. Basically, 
a precursor of the structural proteins acts as a regulator which binds to 
the 5' end of (+) sense RNA, preventing the completion of (-) sense strands, 
and allowing protein synthesis initiation on virus (+) RNA but not host mRNA. 
Processing of the precursor by cleavage to capsid proteins thus regulates (+) 
and (-) strand transcription, translation and maturation. Similar models, 
in which viral proteins regulate transcription, have been proposed for the 
(+) RNA coliphages (Weissmann 1974; Jay and Kaempfer 1975) and may explain 
the results with alphavirus t£ mutants (H. Brzeski and S.I.T. Kennedy, 
personal communication 1976).
The finding that host-cell shut off maps in the structural protein 
genes (Steiner-Pryor and Cooper 1973) is thus not surprising. There was 
no correlation between the level of dsRNA produced and shut off, but there 
is always the problem that the level of detectability and the amount of 
dsRNA to inhibit protein synthesis may not be the same. Garwes et al (1975), 
in a survey of the same collection of t£ mutants, concluded that the late 
cytopathic effect of poliovirus was due to RF formation, but it was unclear 
how protein synthesis inhibition was involved in this.
DI particules of poliovirus have a large deletion covering some of 
the structural gene precursor (Cole and Baltimore 1973). However, shut off 
of host synthesis occurs just as for the standard virus, suggesting that the 
structural gene product is not directly involved. Despite the deletion, 
viral RNA synthesis was normal, and could have caused the shut off.
The use of guanidine to inhibit viral RNA synthesis has also yielded 
confusing results. Guanidine prevents the bulk of viral RNA synthesis but 
shut off occurs normally (Bablanian et al 1965a,b). However, this does not 
exclude the RF as a candidate for protein synthesis inhibition because 
guanidine probably inhibits the release, not synthesis, of progeny RNA, 
and may thus increase the formation of RF (Baltimore 1967).
A final piece of evidence comes from the use of bovine enterovirus, 
which is related to poliovirus. BEV RF is not infectious, but is capable
of inhibiting host protein synthesis when added to uninfected cells (Cordell- 
Stewart and Taylor 1973a). It is not known whether exogenous dsRNA inhibits 
by the same mechanism as intracellular dsRNA, or whether the dose used 
reflected the quantity of RF normally formed during infection. These 
experiments show that dsRNA could mediate poliovirus-induced shut off, but 
cannot exclude other candidates.
Whatever the chemical nature of the inhibitor, the question of 
discrimination between host and viral synthesis remains. The finding that 
dsRNA inhibits in vitro translation of host and viral mRNAs equally 
(Robertson and Mathews 1973), is in keeping with a lesion prior to mRNA 
binding (Darnbrough et al 1972). How then, does dsRNA added to cells inhibit 
host, but not viral, mRNA translation (Cordell-Stewart and Taylor 1973a), and 
why does shut off by one virus not prevent translation of another virus 
(Kaluza et al 1976)?
It is important to realise that when different mRNAs are competing 
in the same system, their relative translation will be critically dependant 
on the overall initiation rate (Lodish 1974). Moreover, initiation seems 
to be normally rate-limiting in vivo (Lodish 1971, Lingrel and Woodland 1974), 
so the translation of mRNAs which have high-efficiency initiation sites is 
favoured. The relative translation of such mRNAs increases further when a 
non-specific block on initiation is applied (Lodish 1974). Thus, Lawrence 
and Thach (1974) have shown that in a competition situation in vitro, host- 
type (immunoglobulin) mRNA is less efficient than viral (EMC) mRMA. The 
same situation is found in infected cells, and the relative preference for 
viral rather than host mRNA is increased under conditions whence initiation 
is non-specifically inhibited by high salt (Nuss et al 1975). Viruses which 
produce highly efficient mRNA in large quantities could compete effectively 
without inhibiting total protein synthesis, but some viruses might benefit 
from producing a non-specific inhibitor of protein synthesis early in 
infection, when the quantity of virus mRNA is low (G. Koch, personal 
communication 1976).
This argument does not require mRNA-specific factors,just slightly 
different affinities of normal initiation factors for different mRNAs. It 
has been shown that the relative translation of different mRNAs competing 
in a fully-defined cell-free system can be varied at will by adjusting the 
conditions (McKeehan 1974), and those factors which had been identified 
as being mRNA specific (for globin mRNA, Lebleu et al 1972, Nudel et al 
1973; or for EMC mRNA, Wigle and Smith 1973) are now thought to represent 
non-specific initiation factors (Safer et al 1976), or factors required in 
different quantities by capped and uncapped mRNAs (M. Revel, personal 
communication 1976).
Viral cytopathic effects
It is possible that the cytopathic effects of some viruses are 
mediated by dsRNA. Cell killing is determined by an early virus function 
in Sindbis (Atkins and Lancashire 1976), VSV (Mar^s and S^kellick 1975), 
vaccinia (Bablanian 1968), polio (Bablanian et al 1975b), and reo (Subasinghe 
and Loh 1971) virus infection, as shown by the use of metabolic inhibitors 
and ts mutants. The virus functions required are still poorly characterised, 
but there is evidence that cytotoxicity is not simply a consequence of 
inhibition of host protein synthesis (Atkins 1976, Atkins and Lancashire 1976, 
Yamazaki and Wagner 1970, Collins and Roberts 1972, Garwes et al 1975). Some 
evidence concerning the cytopathic effects of picornaviruses will be given, 
to complement the preceeding discussion on inhibition of host protein synthesis.
In a survey of ts mutants of poliovirus, Garwes et al (1975) found a 
strong correlation between late cytopathic effects and the synthesis of (-) RNA 
on the input (+) RNA. This suggested that formation of RF could be important. 
Unfortunately, DI particles of poliovirus, which produce normal quantities of 
dsRNA (Cole and Baltimore 1973), have not been characterised for cytotoxicity.
Other workers added protein synthesis inhibitors at various times 
during mengovirus infection and found that a "late" protein was responsible 
for cytotoxicity (Gauntt and Lockart 1968, Amako and Dales 1967). The 
differential effects of puromycin (which causes premature termination of
nascent polypeptides) and aminoacid analogues (which allow synthesis of 
non-functional proteins) suggested that cytotoxicity may be caused by 
a polyprotein precursor (Collins and Roberts 1972). Guanidine (which 
inhibits releaseof progeny RNA from the replication complex, Baltimore 1967) 
does not prevent the cytopathic effect of poliovirus when added 3.5 hr after 
infection, whereas puromycin does (Bablaniqn et al 1965b).
These results can be reconciled if there are two types of cytopathic 
effect. One, detected by trypan blue exclusion, is due to an early event in 
virus replication, possibly RF formation Garwes et al 1975). The other, 
detected in mengovirus infection by morphology changes or neutral red uptake 
(Amako and Dales 1967, Collins and Roberts 1972), or in poliovirus infection 
by morphology changes (Bablanian et al 1965b), may be due to synthesis of 
a "late" protein, possibly a polyprotein precursor. It is not unreasonable 
that different procedures for measuring cytopathic effects should yield 
different results - the effects seen by Garwes et al (1975) did not involve 
lysosomal activation, whereas neutral red stain incorporation involves dye 
uptake by lysosomes (Allison 1967).
By adding RF to uninfected cells it was possible to show that dsRNA 
could cause cytopathic effects. Cordell-Stewart and Taylor (1971) showed 
that purified bovine enterovirus RF was toxic to cells, as well as inhibiting 
protein synthesis (Cordel1-Stewart and Taylor 1973a). No infectious virus 
was produced, although the primary sequence of the RNA was important, as 
shown by the low toxicity of double-stranded homopolymers (Cordell-Stewart 
and Taylor 1971). Treating the RF preparation with nucleases to remove 
traces of ssRNA resulted in RF totally lacking in infectivity which could 
still cause cytopathic effects, even in the presence of protein synthesis 
inhibitors (Cordell-Stewart and Taylor 1973b). Thus, dsRNA can directly 
cause a cytotoxic effect, but as the cells absorbed about 100 times the 
amount of RF normally produced in infection, the cause of cytopathic effects 
during infection remains unclear. Whether this cytotoxicity resulted from 
protein synthesis inhibition (Cordell-Stewart and Taylor 1973a) or DNA
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synthesis inhibition (observed by Teng et a! 1973 in synchronised cells), 
and how it relates to the interferon-enhanced toxicity of dsRNA (Stewart 
et al 1972a), are all questions which need to be answered.
Summary
The evidence presented here suggests that dsRNA exists in low levels 
in normal cells, and in higher amounts in cells infected with some RNA and 
DNA viruses. It is able to inhibit translation in cell-free extracts of 
reticulocytes and interferon-treated cells, and less well in extracts of 
other mammalian cells. The mechanism for this inhibition is being investigated, 
and may be the same in different cell types. Non-specific inhibition of 
initiation could allow preferential synthesis of viral proteins, and dsRNA 
could be the molecule which causes virus inhibition of host synthesis in 
poliovirus infected cells. Involvement of dsRNA in virus cytopathic effects 
is less certain.
An involvement of dsRNA in the control of cell functions, and even 
in the control of virus infection in whole organisms, has been discussed 
before (Carter and de Clercq 1974, Metz 1975a), with similar conclusions.
Other types of RNA, including the RNAs of endogenous oncornaviruses, small 
nuclear RNAs, and RNAs associated with mRNA, may also be important in the 
control of cell functions (Reanney 1975, Goldstein 1976, Reichman and Penman 
1973, Heywood et al 1975, Bogdanovsky et al 1973).
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1.7. AIM OF THE WORK
The preceeding sections have outlined the molecular basis for the 
actions of interferon and dsRNA, both in intact cells and in cell-free 
translation systems, and have related these effects to the possibility that 
virus-induced intracellular dsRNA is important in the control of macromolecular 
synthesis.
The observations that interferon treatment of L929 cells renders 
them susceptible to the toxic effects of dsRNA (Stewart et al 1972a) and to 
early cytopathic effects of vaccinia virus infection (Joklik and Merigan 1966, 
Stewart et al 1973a), as well as changing the protein synthesising machinery 
so that it is inhibited by dsRNA (Kerr et al 1974b), suggest that the control 
of protein synthesis is central to the effects of both vaccinia infection 
and dsRNA treatment. Thus when vaccinia virus infects an interferon-treated 
cell, the production of virus-specified dsRNA may trigger the activation of 
a protein synthesis inhibitor, which prevents the translation of viral mRNA. 
Inhibition of host-specified protein synthesis occurs by the normal mechanism, 
possibly mediated by dsRNA, and the cell rapidly dies as a result of early 
virus products or dsRNA. "Suicide" of the cell would preclude any virus 
production occurring through a leak in the interferon-induced block.
A similar mechanism could explain the toxicity of dsRNA for interferon- 
treated cells. Added dsRNA may be transported into the cell, there to trigger 
the formation of a translational inhibitor. Either as a result of this block, 
or because of the interaction of the dsRNA with some other structural or 
control system, the death of the cell follows.
This project set out to characterise the toxic effect in L929 cells and 
to find quantifiable biochemical changes occurring soon after dsRNA treatment, 
which might represent the initial events in the development of cytopathic 
effects. In particular, any changes which might occur in protein synthesis 
could be investigated both in vivo and in cell-free translation systems from 
parallel cultures. In vivo and in vitro changes could be correlated to test
whether exogenous dsRNA could produce the same changes as dsRNA added to
cell-free extracts, and whether the in vitro effects gave any clues to the 
mechanism of the in vivo toxicity.
During the course of these experiments other lines of research were 
pursued. The chemical properties of the dsRNA used were explored, and 
the effects of various synthetic homopolymers were tested for inhibition 
of protein synthesis in the reticulocyte lysate. Because of the requirement 
for investigating in vivo and in vitro aspects in the same cells, a novel 
procedure for preparing cell-free systems from monolayer grown cells was 
devised, and the characteristics of the system investigated. Finally, the 
cytotoxic effect was described and the effects of dsRNA on in vitro 
translation characterised.
SECTION 2
MATERIALS AND METHODS
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2.1. MATERIALS
All inorganic chemicals were of analytical grade. The sources and 
specifications of some of the other materials used are listed here.
Antibiotics and inhibitors
Edeine was from Calbiochem; actinomycin D from Merck, Sharpe and Dohme;
D(+) threo chloramphenicol and cycloheximide from Sigma.
Enzymes ,
Ribonucl eases/^Type IA) and T1, micrococcal nuclease, and pronase were from 
Sigma; deoxyribonuclease I (ribonuclease free) was from Worthington; creatine 
phosphokinase (Type I) was from Sigma.
Trypsin for cell passage and for biochemical experiments was Sigma Type III 
(from bovine pancreas). Soybean trypsin inhibitor (Type I-S, with an activity 
neutralising 1.4 mg trypsin/mg inhibitor) was also from Sigma.
Chemicals
ATP, GTP, CTP, all aminoacids, E. coli tRNA (Type XXI), spermine 
tetrahydrochloride, sucrose (Grade I, for density gradients), G-mercaptoethanol, 
DTT, tris (Trizma base and Trizma HC1), Triton type N101, Hepes (free acid), 
hemin (Type I), bovine serum albumin, most of the proteins for molecular 
weight markers, OEPC, heparin, acetyl phenyl hydrazine, phenyl hydrazine, EGTA 
(free acid), and 2-aminupurine were all from Sigma; most stains were from 
G.T. Gurr; KgEDTA was from Koch-Light; Creatine phosphate from Boehringer; 
scintillation chemicals from Nuclear Enterprises; Soluene 350 from Packard; 
acrylamide and N,N'methylenebis-acrylamide were from Kodak and were not 
normally recrystallised; ammonium sulphate was from Schwartz-Mann (ultrapure 
grade); ethanol from Franklin columns was Fisons "Spectrograde"
Chromatography supports
Oligo dT cellulose was from Collaborative Research; CF-11 cellulose from 
Whatman; Sepharose and DEAE dextran from Pharmacia.
Biological
Sera and media were from GIBCO Biocult or Flow Laboratories, some media were 
made in the laboratory. The anaesthetic used for the rabbits (2 Kg, male, NZW) 
was Intraval sodium.
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Polynucleotides
All homopolynucleotides were obtained from P-L Biochemicals and were madecV i'
up in physiological salt. Specifications!™ section 2.5.1. Reovirus dsRNA 
was the kind gift of L. Garcia.
P.chrysogenum dsRNA (BRL 5907) was the kind gift of C. Burbidge, Beecham 
Research Laboratories. EMC mRNA was the kind gift of A.E. Smith, ICRF. 
Radiochemicals
All radiochemicals were from Amersham. Some were diluted to lower specific 
activity before use.
L- [3® S] methionine: normally about 200 Ci/mmole, 3-6mCi/ml 
[32P ] orthophosphate: carrier free, lOmCi/ml
adenosine 5 ’ [Y-32P] triphosphate, ammonium salt: 10 Ci/mmole or greater 
[5-3H] uridine 25-30 Ci/mmole, 1 mCi/ml 
[methyl-3H] thymidine 5 Ci/mmole, 1 mCi/ml 
L- [4,5-3H] leucine 40-60 Ci/mmole, 1 mCi/ml 
^3CaCl2: 0.9 Ci/mmole, 1.15 mCi/ml 
86RbCl: 0.56 Ci/mmole, 3.86 mCi/ml 
Miscellaneous
The stock solution of Mg (00CCH3)2 used in most of the cell-free experiments 
was nominally 1.0 M and actually contained 1.05 M Mg(00CCH3)2 and 0.05 M 
k2 EDTA.
The stock solution of hemin was made and checked according to Hunt and 
Jackson (1974).
The stock solution of 2-aminopurine is described in the legend to Fig. 6. 
Initiation factors were prepared according to section 2.3.10 or were the 
gift of T. Staehelin, Basel Institute for Immunology.
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2.2. CELL CULTURE,VIRUSES AND INTERFERON
2.2.1. Media
Media were prepared according to the formulations given in the Flow 
Manual (Flow Laboratories Ltd. 1974), with the following modifications:
GMEM (Glasgow modification of Minimal Eagles Medium) was as 
specified with glutamine, non-essential aminoacids, and 
crystamycin added.
GMEM (Hepes) was GMEM without NaHCOg, Hepes added to 20 mM 
and pH adjusted with NaOH.
GMEM-P contained no NaH^O^ (normal concentration in GMEM:
1.5 mM) and buffered with 20 mM Hepes
GMEM-M contained no methionine (normal concentration in
GMEM: 100 pM) and buffered with 20 mM Hepes
GMEM/2% CS contained 2% newborn calf serum
GMEM/10% FBS contained 10% foetal bovine serum
PBS contained no CaCl2 or Mg SO^.
trypsin/versene was 80 yg/ml recrystallised trypsin, 80 yg/ml 
Na2EDTA in PBS.
All media were sterilised by passing through a 0.22 ym filter, and sera 
were mycoplasma and virus screened (Flow Laboratories Ltd).
2.2.2. Cell culture
NCTC 929 cells were obtained from GIBCO-Biocult at passage 566,
9 passages from American Type Culture Collection stock, and were passaged 
o
in 150 cm bottles (Corning) every 5-8 days at 1 to 4 or 1 to 6 split. 
Monolayers were washed with PBS, trypsinised in about 10 ml trypsin/versene 
at 37°C for 5 min, and clumps dispersed by vigorous pipetting after the 
addition of 10 ml GMEM/10% FBS. Cells were normally counted using an 
improved Neubauer hemocytometer. Where required, the cells were spun out 
of the trynsin, resuspended in GMEM/10% FBS containing 10% DMSO and frozen 
at about l°C/min, for storage in liquid nitrogen. Most of the experiments 
described were performed using cells 2 to 15 passages away from a frozen stock
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For experiments cells were seeded into plastic petri dishes, (Sterilin, 
tissue culture grade), or into thoroughly-washed glass scintillation vials 
arranged and sterilised in foil-covered metal rocks. The numbersof cells 
seeded per culture so as to achieve confluence in 2 days were as follows:
140 mm petri dish; 10 x 106 cells in 50 ml GMEM/10% FBS
50 mm petri dish; 1 x 106 cells in 5 ml GMEM/10% FBS
25 mm glass vial; 0.5 x 106 cells in 3 ml GMEM/10% FBS
10 mm glass vial; 0.2 x 106 cells in 1 ml GMEM/10% FBS
Cultures were used shortly after reaching confluence at about 0.3 x 106 
cells/cm^.
The cells were screened periodically for mycoplasma contamination, 
using the fluorescent staining procedure (Russell et al 1975) or the uridine 
phosphorylase assay (Levine 1972).
2.2.3. Viruses
NDV (strain F) was grown according to Moore and Burke (1974). About 
10 HAU of seed virus (kindly provided by N. Moore) was injected into 11 day 
old embryonated eggs, and the allantoic fluid was harvested after 60 hr.
The stock contained about 6000 HAU/ml.
SFV was grown up from a mouse brain stock (kindly provided by 
C.J. Bruton and S.I.T. Kennedy) in chick-embryo cell suspension as described 
(Kennedy and Burke 1972).
2.2.4. Interferon preparation
The interferon stocks used for treating cultures were induced by 
NDV (strain F) in monolayer cultures of L929 cells, and were purified by the 
first step of the procedure described by Knight (1975).
O
About 10 L929 cells were treated with a mixture of 10 ml of 
GMEM/10% FBS and 10 ml of clarified allantoic fluid. Uninfected allantoic 
fluid was used for "mock" induction, or NDV (strain F) infected allantoic 
fluid was used for interferon induction. After 1 hr at 37°C for virus 
adsorption, the fluids were replaced with 50 ml of GMEM (containing no 
serum) and incubated overnight.
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After 17-18 hr some cytopathic effects were evident in the infected 
cultures. The fluids were collected, clarified at 10000 g for 15 min, made 
to pH2 with HC1, and left 24 hr at 4°C. While still at 4°C and pH2, 
crystalline ammonium sulphate was added slowly to 24.1 g/100 ml, and the 
precipitate removed at 20000 g for 10 min. A further 15.1 g of ammonium 
sulphate was added to each 100 ml of supernatant, and the precipitate 
collected at 20000 g for 10 min. The pellet was dissolved in a small volume 
of PBS and dialysed against several changes of 200 volumes of PBS. The 
preparations were clarified at 40000 g for 15 min before diluting to 5 ml
O Q
per 10 cells, and storing at -20 C in small aliquots.
The interferon preparations were titrated on several occasions using
a laboratory internal standard and the NIH standard (G—002-904—511). Titres
5 3 5 9ranged from 10 ' to 10 ‘ u/ml (international units/ml) according to the 
preparation used and time of storage. The specific activity was about 
106 u/mg protein, and mock preparations contained 50-1007» as much protein 
as interferon preparations.
Occasionally, "crude" interferon was used. This was the laboratory
internal standard, and was induced as described above but was not purified
3 5 4 5
beyond pH2 treatment and clarification. It titred at 10 * to 10 ' u/ml 
according to the preparation used.
2.2.5. Interferon assay
Interferon was assayed in L929 cells using SFV challenge and the 
nucleic acid synthesis inhibition procedure described (Atkins et al 1974). 
Assays were normally performed using cell cultures grown in 25 mm scintillation 
vials, and the monolayers were solubilised, and scintillant added, to the 
vials. Some assays were performed using cell cultures grown in 10 mm vials, 
when the volume of interferon used was reduced to 0.5 ml, and volumes of 
virus, isotope, solubiliser, and scintillator were all reduced by half.
The NIH standard mouse interferon (G-002-904-511) routinely titred 
at 104-25 (18000) INASggU/ml compared with its defined titre of 12000 u/ml, 
so INASggU and u (international units) are equivalent to within a factor of 2. 
All titres are expressed in international units.
2.2.6. Interferon induction by polynucleotides
Confluent monolayers in 50 mm petri dishes were treated for 16-18 hr
? n o c
with GMEM/2% CS containing interferon at 10 ' - 10 u/ml, or an equivalent
concentration of "mock interferon". After removing serum and interferon with 
three 2 ml washes of GMEM, 1.0 ml of GMEM containing 50 yg/ml of annealled 
poly rl.rC was added. After 50 min at 37°C this was removed, the cultures 
were washed once with 2 ml of GMEM, and fed with 2 ml of GMEM/2% CS. The 
fluids were harvested at 24 hr after induction or as required, and dialysed 
for 2 days at 4°C against 87 mM KC1, 13 mM HC1 (pH2.0). The samples were 
neutralised by dialysis against PBS. Cell debris was removed at 2000 g for 
5 min. If a lx dilution was included in the assay, the final dialysis was 
against GMEM, and calf serum was added to the sample to 2% before making 
serial dilutions in GMEM/2% CS as usual.
The monolayers used for induction were normally fixed with 4% (v/v) 
formaldehyde in saline and stained with 1% gentian violet in 20% (v/v) ethanol 
for visual inspection of cytopathic effects.
2.2.7. Estimation of cytopathic effect
Cultures were grown to confluence in 25 mm glass vials and treated 
for 16-18 hr with 1.0 ml of GMEM/2% CS containing 102-0 - 102*5 u/ml of 
interferon or an equivalent concentration of "mock interferon". The cultures 
were then transferred to a circulating waterbath maintained at 37°C. After 
washing three times with 2 ml of warm GMEM, annealled poly rl.rC was added 
at 50 yg/ml in GMEM (Hepes). After 50 min the fluids were removed, the 
cultures washed with GMEM and fed with 2 ml of GMEM(Hepes). After a further 
2.5 hr at 37°C the cultures were removed from the bath, washed three times 
with 2 ml PBS and fixed with 2 ml 10% TCA. The cultures were later washed 
with ethanol, dried, and solubilised in 0.50 ml lM NaOH at 37°C for 1 hr.
50 yl was taken for protein determination.
Twelve cultures were used for each experiment, triplicate cultures 
being treated with both interferon and dsRNA (IFIC), interferon only (IF0), 
mock and dsRNA (MIC), and mock only (M0). The cytopathic effect was defined
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as the average protein lost by the IFIC cultures:-
i.e. 100 x (1
3 x IFIC 
IFO + MIC + MO
2.2.8. Radioactive labelling
• . • .35
25 mm vial cultures of cells were labelled with 0.5 ml ofr S
32 3methionine in GMEM-M, P orthophosphate in GMEM-P, and with H uridine,
®®RbCl, ^CaClp, or thymidine in complete GMEM. The quantity of
radioactivity used varied from experiment to experiment, but for routine
35
estimation of acid soluble and insoluble incorporation 10 pCi/ml S
3
methionine or 10 pCi/ml H uridine was used. When cell DNA was labelled
3
to estimate the number of cells present, H thymidine was added at 5 pCi/ml 
during the 24 hr preceeding interferon treatment.
Pulses were normally stopped by removing the medium, transferring 
the vial to ice cold water, and washing rapidly three times with 2 ml of 
cold PBS. 1.0 ml of cold 10% TCA was added and acid soluble material 
extracted for at least 1 hr at 4°C. A sample of the TCA was taken for 
scintillation counting and the monolayer was washed a further two times 
with TCA, and then with ethanol, before drying and solubilising. If a 
sample was required for protein estimation, the monolayer was solubilised 
in 0.5 ml 1M NaOH and a sample counted in gel scintillator. Otherwise the 
monolayer was dissolved in 200 ul of soluene 350 and counted in acidified 
toluene scintillator.
2.2.9. Other procedures
Trypan blue excluding cells were counted in a hemocytometer after 
trypsinising 25 mm vial cultures of cells with 1.0 ml trypsin/versene, and 
adding 1.0 ml of GMEM/10% FBS and 0.5 ml 0.1% trypan blue in PBS.
Electronic cell counting made use of a Coulter counter (Coulter 
Electronics Ltd) set up with a 100 pm orifice, amplification of $, current
-12
of I, and thresholds 10-100. This counted all material from 0.3 to 3.7 x 10 1
-1 2
in volume; the average cell volume was 1.4 to 1.6 x 10 1. The cells were
prepared by trypsinising with 1.0 ml trypsin/versene, adding 1.0 ml GMEM/10% FBS,
breaking up clumps, and diluting to 20.0 ml with saline. The cells in a 
500yl aliquot of the resulting suspension were counted.
Mitotic index was estimated from cultures which had been fixed in 
industrial methylated spirits, dried, and stained with Giemsa (freshly 
diluted 5 fold with H20 and centrifuged to remove particles). After 10 min 
staining the cultures were washed well and random fields of about 100 cells 
were photographed. The photographs were later used to estimate the number 
of cells in late telophase.
Photomicrography used on inverted microscope (Leitz Diavert) with 
phase ring, yellow filter, and 20 or 32x objectives. Panatomic X was rated 
at 50 ASA and developed in Acutol.
2.3. CELL-FREE SYSTEMS
2.3.1. Reticulocyte lysate
Rabbit reticulocyte lysate was prepared essentially according to 
Hunt and Jackson (1974).
2 Kg male rabbits were made anaemic by one of two methods. Either 
5 daily injections with 0.5 ml of 2.5% v/v phenyl hydrazine were followed by 
one day's rest and bleeding on day 7, or 4 daily injections with 2.5 ml of 
1.25% w/v acetyl phenyl hydrazine was followed by bleeding on day 9. Bleeding 
was by cardiac puncture, yielding 100 ml of blood per rabbit. Samples were 
routinely sent to Mr. Raven, Pathology Laboratory, Warwick Hospital, for 
hematological analysis, and contained 90-100% reticulocytes with a hematocrit 
of 17-23%. There seemed to be no difference between the two injection 
schedules.
The heparinised blood was centrifuged at 2500 g for 15 min at 4°C.
The red cells were washed three times in 130 mMNaCl, 5 mM KC1, 7.5 mM MgC^, 
and the final pellet lysed with 1.5 packed-cell volumes of sterile distilled 
water. Debris was removed at 20000 g for 15 min at 4°C, and the supernatant 
dispensed and stored in liquid nitrogen.
2.3.2. Reticulocyte lysate high-speed supernatant
Reticulocyte lysate can be centrifuged so as to pellet most of the 
polyribosomes and globin mRNA, yet leave sufficient ribosomal subunits and 
initiation factors in the supernatant to give a mRNA dependant system (C. Preston, 
personal communication, 1975). This system was used in characterisation of 
mRNAs (section 2.4.4).
Lysate was made 25 pM in hemin and centrifuged at 100000 g for 2 hr 
at 4°C. The supernatant was assayed as described below for total reticulocyte 
lysate, except that spermine was added to 80 pM (Atkins et al 1975), and 
mRNA as required. This system showed about 3% of the endogenous activity of 
complete lysate, and was stimulated to about 32% of the activity of complete 
lysate by SFV 26S mRNA.
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2.3.3. Micrococcal nuclease treated lysate2+By using a Ca dependant nuclease to degrade globin mRNA, the 
reticulocyte lysate can be made fully message-dependant (Pelham and Jackson 
1976). This system was used for the assay of mRNA activity extracted from 
L929 cell-free systems, and was made as described (Pelham and Jackson 1976).
It was assayed in the absence of polyamines.
2.3.4. Reticulocyte lysate assays
Total lysate, supernatant, or nuclease-treated lysate were all 
assayed by basically the same procedure. Hemin (see section 2.1) and 
creatine kinase (section 2.3.6) were added to the lysate to 25 pM and 50 pg/ml 
respectively. Preincubations with dsRNA were performed before adding the 
other components of the incubation .
Incubations were made up in 500 pi plastic vials kept in ice-water. 
Additions were made to the lysate using a micropipette (Finpipette, Jencons 
Scientific Ltd) or microsyringe (Terumo, Shandon Southern Instruments Ltd, 
or Hamilton, Micromesure B.V) to give the following final concentrations of 
components. 10 mM creatine phosphate,100 mM KC1, 0.5 mM Mg (OCOCH..^,
aminoacids and 70 pi of lysate per 100 pi incubation. Aminoacids were
35
normally added at 50 pM, with S methionine at 0.1 - 0.2 pM and 30-60 pCi/ml.
3
Alternatively, with H leucine present at 25 or 80 pM and 16 or 50 pCi/ml, 
the remaining aminoacids were added according to their frequency in rabbit 
globin (Hunt and Jackson 1974).
Incubations were performed at 30°C in a pumped waterbath. When 
required,2pl - 10 pi samples were removed with a microsyringe and either 
diluted into 1 ml H20 or deposited onto numbered squares of Whatman No. 1 
filter paper.
Samples in HgO were treated with 0.5 ml of lMNaOH, 0.15M H202,
1 mg/ml leucine or methionine (according to isotope used) at 37°C for 
15 min, before precipitating with 1 ml 257, TCA and filtering on GF/C filters. 
Filters were washed with a total of 30 ml per filter of 8% TCA and dried at 
37°C before counting in toluene scintillator.
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Samples deposited onto filter paper squares were allowed to dry 
for 30s before dropping into 10% TCA containing 1 mg/ml leucine or 
metnionine. When all the samples were ready, H^O^ was added to 0.015 M and 
the filters heated at 90-100°C for 20 min. The hot TCA was decanted and 
replaced with fresh 10% TCA 1 mg/ml leucine or methionine. -After standing 
for 1 hr at room temperature the TCA was removed, and filters washed briefly 
with&hanol and ether before drying and counting.
For separation of labelled products by polyacrylamide gel electrophoresis, 
incubation mixtures were treated at 30°C for 15 min with 100 yg/ml RNAse A 
and 10 mM Na„EDTA, before making 1% in SDS and 2% in 3 mercaptoethanol 
and immersing in boiling water for 3 min. The precipitate of protein 
and potassium dedecylsulphate was redissolved by dialysis against a large 
excess of NURB (see section 2.6.2) before loading onto the gel.
2.3.5. Detergent extracts from L929 cells
140 mm petri dish cultures of L929 cells were used when confluent.
If required, the cells were treated with interferon or mock-interferon in 
5 ml or 10 ml of GMEM/2% CS for 16-18 hr,and 5 ml of 50 pg/ml poly rl.rC in 
GMEM added after 3 x 10 ml washes with warm GMEM.
Lysis was performed as follows. Plates were removed individually from 
the incubator and immediately drained and rapidly cooled,by floating on ice-cold 
water and adding about 50 ml of ice-cold PBS. After a further two washes with 
PBS and one wash with cold KHMD (90 mM KC1, 30 mM Hepes K0H, 4 mM MgfOOCCH^,
1 mM DTT, pH 7.4), the plates were drained for 30s and sucked dry. While the 
plate was floated horizontally on ice-cold water, five 100 yl aliquots of 
KHMD containing 0.1% v/v Triton N101 were added, distributed over the area 
of the plate. After 3 min, during which the detergent spread over most of 
the cells, the plate was tipped. Over the next 2 min the fluid was collected 
and transferred to a cold plastic vial (for liquid nitrogen storage, Sterilin). 
The extract was either assayed within 30 min or stored in liquid nitrogen.
2.3.6. Assay of detergent extracts
Incubations were performed in plastic vials (Sarstedt test tubes,
500 pi capacity), using the following stock mixtures:
E containing 10 mM ATP, 1 mM GTP, 6 mM CTP, 100 mM creatine phosphate,
17 mM tris base, final pH 7.0-7.5.
-M containing nineteen aminoacids (no methionine) at 1 mM and 10 mM DTT.
CK containing 5 mg/ml creatine kinase in 50% v/v glycerol, 50% v/v 50 mM tris 
HC1 pH 7.4.
Incubations were made up using 70 yl extract, 10 yl E, 5 yl - M, 1 yl CK,
OC
and S methionine, mRNA, and H20 to a total of 100 yl. Smaller volumes 
were used if required.
Final concentrations were thus:
63 mM KC1, 24 mM Hepes K0H, 2.8 mM Mg(0C0CH3)2, 0.07% v/v Triton N101,
1 mM ATP, 0.1 mM GTP, 0.6 mM CTP, 10 mM creatine phosphate, 50 yg/ml creatine 
kinase, 50 yM each nineteen aminoacids, 1.2 mM DTT, and 2.2 mM tris, final pH 
about 7.4.
The ionic conditions are very approximate, being determined by the 
proportion of KHMD in the cell extract. The concentration of free Mg2+, 
allowing for chelation by the nucleoside triphosphates, was about 1 mM. The 
total concentration of K+ , added i^ as KC1 and Hepes K0H, was about 75 mM.
Incubations were performed at 30°C in a circulating waterbath.
Samples (2 yl - 10 yl) were taken and processed, as described in section 
2.3.4 except that no H ^  was present-
2.3.7. Assay of protein phosphorylation in detergent extracts
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Incubations contained, in every 100 yl, 10 yl of ATPy P (20-90 yCi), 
70 yl of detergent extract, and 20 yl of 50 mM KC1 containing 0.5 yg/ml dsRNA 
(BRL 5907) when required. The final concentration of added ATP was about 
20-50 yM. Incubation was at 30°C or 37°C for 15 min. Samples for acid 
precipitation were taken to 1 ml H20 or to filter paper squares as described 
in section 2.3.4, except that the TCA contained 0.1 M Na2P20? and filtration
was on nitrocellulose filters (HAWP 45 y, Millipore S.A., France) instead 
of GF/C , and no alkali was used.
Samples for polyacrylamide gel analysis were not ribonuclease treated 
but were made 1% in SDS and 2% in B mercaptoethanol and immersed in boiling 
water for 3 min. Free P orthophosphate was removed by exhaustive dialysis 
against NURB (section 2.6.2).
2.3.8. Preparation and assay of S-10 from suspension L929 cells
A cell-free extract was prepared from suspension grown L929 cells 
essentially as described by Clegg and Kennedy (1974). It was used,after 
preincubation and gel-filtration,for characterisation of mRNA (section 2.4.4). 
The assay system was as described (Clegg and Kennedy 1974) except that 
phosphoenolpyruvate was replaced by creatine phosphate and the pyruvate 
kinase by creatine kinase. KC1 was added to 70 mM and MgiOCOCH^),, to 4 mM 
total concentration.
2.3.9. Assay for inhibitor in detergent extracts
Inhibitors were formed in interferon-treated detergent extracts by 
preincubation with an energy supply and dsRNA, and were assayed in complete 
reticulocyte lysate containing 10 yg/ml dsRNA.
Preincubations contained, per 100 yl: 70 yl of detergent extract or 
0 . U  v/v Triton N101 in KHMD, 1 yl of CK, 10 yl of E, and 20 yl of 50 mM KC1 
containing 0.5 yg/ml dsRNA (BRL 5907) as required.
After 30 min at 30°C, aliquots were removed to vials containing, 
per 100 yl : 70 yl of reticulocyte lysate (containing hemin and CK), 1 yl
of 1 mg/ml dsRNA (BRL 5907), 5 yl of preincubation, and 24 yl of a mixture
35of creatine phosphate, aminoacids, salts, and S methionine to give the 
final concentrations listed in section 2.3.4.
Incubation was at 30°C for 30 min. Samples were removed for acid 
precipitation as required.
2.3.10. Reticulocyte initiation factors
Rabbit reticulocyte polysomes were prepared from reticulocytes lysed 
as described by Schreierand Staehelin (1973b). Polysomes were pelleted from
the 12000 g supernatant at 100000g for 4 hr at 4°C. The pellets were 
resuspended and salt washed, and the supernatant from a 34 hr, 160000 g spin 
collected. This was fractionated as described (Schreier and Staehelin 1973b) 
to yield fractions A and Bl. The preparations were dialysed against Schreier 
and Staehelin's Buffer D containing 120 mM KC1 and protein quantitated by 
extinction at 260 and 280 nm before storage in liquid nitrogen. Reticulocytes 
from 6 rabbits yielded 5 mg of fraction A and 20 mg of fraction Bl.
The purified IF-E2 used by P. Farrell (section 7.5) was the kind
gift of T. Staehelin.
IV
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2.4. mRNA PREPARATION AND CHARACTERISATION
mRNAs for cell-free translation were obtained from rabbit reticulocytes 
and SFV-infected BHK21 cells, and were characterised before use by translation 
in two different mRNA dependant cell-free systems.
2.4.1. Buffers
All solutions were treated with DEPC or autoclaved before use. Normal 
precautions against nucleases were taken.
TNE: 100 mM NaCl, 50 inM tris HC1, 1 mM Na2EDTA, pH 7 .4 .
TLES: 100 mM LiCl, 50 mM tris, HC1, 1 mM Na2 EDTA, 0.1% SDS pH 7.4.
2.4.2. Globin mRNA
Red cells were prepared ^rom one anaemic rabbit as described (section
2.3.1), and lysed with 2 packed-cell volumes of 4 mM Mg(0C0CH2)2, 6 mM
8 mercaptoethanol, 1.7 yM DEPC (freshly-opened bottle). This was followed
by hemin to 30 yM and one volume of 1.5 M sucrose, 40 mM tris HC1 pH 7.4.
-for o
Debris was removed at 20000 g 10 min at 4 C. Polyribosomes were pelleted 
at 100000 g for 4 hr at 4°C. The pellets were rinsed with 6 mM B-mercaptoethanol 
and resuspended in about 8 ml of ice cold 100 mM LiCl, 50 mM tris HC1, ImM Na2 
EDTA, 2% SDS, 1% NDS, pH 7.4 using a loose-fitting dounce homogeniser.
The ribosomes were then extracted with 10 ml of TNE saturated phenol 
by shaking for 10 min at room temperature, and the phases separated at 3750 g 
for 10 min. The phenol layer was extracted with 10 ml TNE and the aqueous 
layers combined and extracted twice more with phenol and once with 95% v/v 
chloroform 5% v/v octan-l-ol.
Traces of phenol and chloroform were removed by three extractions 
with TNE-saturated ether, and residual ether blown off with dry nitrogen.
The RNA was precipitated with 2.5 volumes of ethanol at -20°C, and pelleted 
at 3780 g for 20 min at 4°C.
PolyA(+) RNA was bound to oligo dT cellulose. A 2.5 ml bed-volume 
of oligo dT cellulose, which had been washed with 0.1 M NaOH and then with 
10 mM tris HC1 0.1% SDS pH 7.4 at 37°C, was equilibrated with TLES at 0°C.
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About 400 0D2gQ units of RNA in 5 ml TLES were loaded and polyA(-) RNA 
washed off with TLES at 0°C, and then with TLES at 20°C. PolyA(+) RNA was 
eluted 37°C with 10 mM tris HC1 0.1% SDS pH 7.4. One quarter volume of 
5 times concentrated TLES was added and the polyA(+) RNA purified by a 
further cycle through oligo dT cellulose.
The final yield of polyA(+) RNA was 4 OD^gg units. It was precipitated 
from the 10 mM tris HC1 0.1% SDS pH 7.4 by adding NaCl to 100 mM, ethanol to 
70% v/v, and placing at -20°C. It was washed by pelleting, dissolving in 
H.,0, reprecipitating in the presence of 100 mM NaCl and 70% ethanol, and 
then washing with a mixture of 30% 100 mM KC1, 70% ethanol at -20°C.
Finally the RNA was dissolved in H20 and adjusted to an extinction 
of 20 at 260 nm. It was dispensed and stored at -70°C.
2.4.3. SFV intracellular RNA
Total polyA(+) RNA from SFV infected BHK21 cells (referred to as 
'SFVmRNA') and a 26S fraction of this (referred to as 126S mRNA') were 
prepared from cells infected, harvested, and lysed as described by Clegg 
and Kennedy (1974). (Virus and cells were kindly provided by C.J. Bruton).
The cytoplasmic extract was deproteinised by three extractions with 
TNE-saturated phenol, one with 95% v/v chloroform 5% v/v octan-l-ol, and 
two extractions with TNE-saturated ether. Ether was blown off with dry 
nitrogen and the RNA precipitated in 70% ethanol at -20°C.
A portion of the RNA was purified by one cycle of oligo dT cellulose 
chromatography as described in section 2.4.2. The polyA(+) RNA CSFV rnRNA') 
was dhanol precipitated and washed as before, dissolved in H20 to an optical 
density of 15 (260 nm) and stored in aliquots at -70°C.
The remainder of the RNA was loaded onto a 5-20% w/v sucrose gradient 
in TLES in the B XIV zonal rotor as described (Clegg and Kennedy 1974). The 
fractions containing 26S RNA were pooled and precipitated with 2.5 volumes 
of ethanol at -20°C. It was purified by one cycle of oligo dT cellulose
chromatography, precipitated, and washed as described (section 2.4.2). The 
25S mRNA was dissolved in H20 to an optical density of 18 (260 nm) and 
stored in aliquots at -70°C.
2.4.4. Characterisation of mRNA
The mRNA preparations were characterised by translation in a 
preincubated L cell S-10 (Fig.la) and a reticulocyte high speed supernatant 
(Fig.lb). Both sets of densitometer tracings show a high background at 
the top of the resolving gel, which appeared on the autoradiographs as a 
diffuse area of radioactivity and is probably due to free isotope. Apart 
from this, the 26S and SFV mRNAs coded for a product migrating with SFV 
capsid protein, and globin mRNA gave rise to a product migrating with rabbit 
globin. No other products were evident.
2.4.5. Other RNA extractions
RNA was extracted from cell-free incubations (experiment described 
in Fig.37) using the method of Perry et al (1972).
50 pi aliquots of incubation mixture (section 2.3.6), containing
3
detergent extract from H uridine labelled cells and SFV mRNA, were taken 
to 1 ml of ice-cold TLES. 1 ml of a TNE-saturated mixture of 50% v/v 
phenol 50% v/v chloroform was added and shaken for 5 min at room temperature.
The phases were separated at 3000 g for 10 min and the organic layer removed, 
leaving the interphase with the aqueous layer. After a further two extractions, 
the upper layer was extracted twice with TNE-saturated ether and precipitated 
with ethanol at -20°C in the presence of 50 pg E.coli tRNA. The precipitated 
RNA was dissolved in 100 mM KC1 and reprecipitated before dissolving in
q
50 pi H20 and assaying for recovery of H radioactivity and ability to
stimulate protein synthesis. This extraction removed all but 0.01% of the 
35S radioactivity present in the initial incubations and allowed recovery of 
60-80% of the radioactivity.
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Translation of giobin mRNA (B) and 26S mRNA (C.) in L ceil 
0, compared with endogenous (A). Incubations were performed 
¡ction 2.3.8) for 120 min before analysis on a 15% polyacrylamide 
I (section 2.6.2). The gel was dried without fixation or staining.and 
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FIG. 1. Characterisation of mRNA preparations.
a) Translation of globin mRNA (B) and 26S mRNA (C.) in L cell 
S-10, compared with endogenous (A). Incubations were performed 
(section 2.3.8) for 120 min before analysis on a 15% polyacrylamide
gel (section 2.6.2). The gel was dried without fixation or staining,and 
autoradiographed for 36 hr. Approximate loadings: A, 33000 cpm;
B, 32000 cpm; C, 44000 cpm.
b) Translation of 26S mRNA (B) and SFV raRNA (C) in reticulocyte 
S-100, compared with endogenous (A). Incubations were performed 
(section 2.3.4) for 90 min before analysis on a 12.5%
polyacrylamide gel. The gel was dried without fixation or staining, and 
autoradiographed for 72 hr. Approximate loadings: A, 26000 cpm;
B, 45000 cpm; C, 48000 cpm.
The arrows show the top of the resolving gel (single arrow), 
and the positions of authentic SFV capsid protein (double arrow), 
and of authentic rabbit globin (triple arrow), run on parallel
tracks.
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2.5. POLYNUCLEOTIDES AND NUCLEASE DIGESTION
2.5.1. Specification of polynucleotides
Table 1 gives the manufacturer's specifications of the "size-kit" 
poly rl and poly rC, and the chain lengths calculated from sedimentation 
constants using two independant formulae (Hull et al 1969, Tyrell et al 
1970). The two formulae disagree over the precise sizes of the low 
molecular weight polynucleotides, but the hybrids range from 30-50 up to 
1000 base pairs. An indication of heterogeneity is provided by the limits 
between which more than 80% of the optical density sediments.
Other polynucleotides were specified as having molecular weights 
in excess of 10^ daltons, apart from poly dl.dC which was greater than 
0.6 x 105 daltons. All contained negligible acid soluble material.
The molarities of polynucleotide solutions were calculated from 
published data (Chamberlin and Patterson 1965). The molarities given 
are the molarities of nucleotides, unless otherwise stated.
The molar extinction coefficient of poly rC at 300 nm was less than
3
0.4 x 10 , confirming the absence of double-stranded structures (Chamberlin 
and Patterson 1965).
2.5.2. Anneal! ing
Polynucleotides were dissolved in solutions containing 150 mM 
monovalent cations (either 150 mM NaCl, 50 mM tris HCl, 0.2 mM N 2 EDTA 
pH 7.4, or PBS) and were anneal led together at equimolar concentrations 
at 45 C for 1 hour. Duplexes were stored for short periods at 4°C, or 
for longer periods at -20°C. Frozen solutions were always annealled, 
either at 45°C for 30-60 min or briefly at 60-70°C, and left to cool 
before dilution or use. Solutions of poly rl also required heating before 
use.
2.5.3. Melting curves and spectra
Melting profiles and spectra of polynucleotides were obtained using 
a Unicam SP800 spectrophotometer fitted with a water-jacketted cuvette block.
Water temperature was maintained at temperatures up to 90°C by a waterbath 
(Haake, Berlin).
The temperature in a cuvette next to the sample cuvette was measured 
using an electronic thermometer (Comark Instruments Ltd) to within 0.5°C.
The sample and reference solutions were contained in 3 ml or 1.5 ml silica 
cuvettes fitted with polypropylene stoppers, and at the end of each run the 
temperature was returned to 25°C to check that the concentration of 
polynucleotide had not been altered by evaporation.
2.5.4. Nuclease digestion
Digestion of poly rl and poly rC by various concentrations of 
ribonucleases T1 and A were performed at 25°C in 50 mM tris HC1 pH 7.4 
solutions containing NaCl at concentrations from 150 mM to 800 mM. Samples 
were taken as required and precipitated with 0.5M HCIO^ in the presence of 
500 yg BSA. After 1 hr at 4°C the acid insoluble material was removed at 
4000 g at 4°C for 20 min and the acid soluble optical density read, relative 
to a blank containing no polynucleotides, in the Unicam SP600. The digestion 
products of poly rC were quantitated at 280 nm, and those of poly rl at 
250 nm.
The standard conditions chosen for selective degradation of poly rl 
and poly rC but not poly rl.rC were lO'^g/ml RNAse A, 300 u/ml RNAse T1,
150 mM NaCl, 50 mM tris HC1 pH 7.4 at 30°C for 1 hour, followed by acid 
precipitation as above. The digestion products of poly rl.rC were read 
at 263 nm, so that oligonucleotides from both strands should contribute 
equally to the acid soluble optical density.
Ribonuclease sensitivity was always expressed relative to complete 
digestion effected by either 1M K0H at 37°C for-2 hours, or by 50 pg/ml 
RNAse A, 5000 u/ml RNAse T1, 10 mM NaCl, 3 mM tris HC1 pH 7.4 at 30°C for 
1 hour.
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2.6. FRACTIONATION PROCEDURES
2.6.1. Cellulose column chromatography of polynucleotides
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Poly rl, poly rC and poly rl.rC where chromatographed on Whatman 
CF-11 cellulose in buffers containing ethanol according to the procedure 
of Franklin (1966).
Cellulose was defined and washed in 100 mM NaCl, 50 mM tris HC1,
10 mM Na^EDTA, 1% 6 mercaptoethanol pH 7.4 before equilibrating with 
100 mM NaCl, 50 mM tris HC1, ImM Na£ EDTA pH 7.4 (TNE) containing 35% v/v 
ethanol (Spectrograde reagent, section 2.1). About 10 ml of cellulose was 
loaded into a 9 mn internal diameter column connected to a flow cell 
(UVicord II, LKB Produkter AB, Sweden) set to monitor the column output 
at 256 nm.
A sample containing about 10 0D2gQ units of polynucleotide in 
0.15 M salt was made 35% v/v with ethanol and loaded onto the column. The 
sample was washed in with three small aliquots of 35% v/v ethanol in TNE, and 
then with a large volume of the same buffer, until the optical density 
of the effluent fell to background. The column was then eluted with 15% v/v 
ethanol in TNE, and finally with TNE.
The fractions corresponding to each peak in the elution profile were 
pooled, the volume found, and the optical density at 260 nm measured using 
the relevant buffer as reference. The proportion of optical density in each 
fraction was thus calculated. Recovery of input optical density was 
(100 ± 15)%.
2.6.2. SDS-polyacrylamide gels
Samples of cell-free incubations were prepared for gel electrophoresis 
as described in section 2.3.4, l>y exhaustive dialysis against NURB (40 mM tris 
base, 40 mM boric acid, 0.1% SDS, pH 8.6). Occasionally, the SDS treated 
incubations were made to pH 8 with NaOH and alkylated as described (Kennedy 
1974) before dialysis against NURB.
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Slab gels (200 x 170 x 1 .8 mm or 160 x 140 x 1 ,8 mm) were made using 
the discontinuous system described by Laemmli (1970). Basically, this uses 
a tris glycine (pH 8.4) electrophoresis buffer, a 4.5% polyacrylamide stacking 
gel containing 125 mM tris HC1 at pH 6.8, and a resolving gel containing 
275 mM tris HC1 at pH 8.8.
The concentration of acrylamide was varied according to the separation 
required. The normal proportion of bis-acrylamide was 2.66% (w/w relative to 
acrylamide), which was reduced to 0.5% in high percentage gels to minimise 
cracking during drying down. Gradient gels were made using 20 ml of high 
concentration mixture (30% acrylamide containing 0.5% bis) in a constant 
volume mixing chamber, into which was pumped 60 ml of low concentration 
mixture (7.5% acrylamide containing 2.66% bis). The gradient was thus 
concave exponential, running from 7.5% at the top to 30% at the bottom.
A variety of different slot-formers were used, of which one with 
Teflon teeth was found to be best. Samples were loaded after the addition 
of sucrose to about 10% w/v and bromophenol blue to about 0.02% w/v. 
Electrophoresis was at 50V constant voltage or 14 mA, constant current, 
for 16-18 hours.
2.6.3. Analysis of gels
Gels were stained, when required, by soaking for 2 hours in 0.05% w/v 
coomassie blue, 10% v/v acetic acid, 25% v/v methanol, and destained for the 
first 2 hours in 0.0025% w/v coomasic blue 10% v/v acetic acid 10% v/v 
methanol and then in 10% v/v acetic acid 10% v/v methanol, until fully 
destained. Alternatively, gels were fixed by overnight soaking in 10% v/v 
glacial acetic acid, 40% v/v methanol. Fixed or stained gels were washed 
in H£0 for 2-4 hours to removed volatile components before drying down onto 
Whatman 3 MM using a metal hot plate at about 80°C and a vacuum line.
Autoradiography was against Kodirex Medical X-Ray Film, developed 
in five times diluted Kodak DX80 and fixed in five times diluted Kodak FX40.
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Fluorography of gels containing low amounts of S radioactivity 
was by the technique of Laskey and Mills (1975), in which the gel is 
impregnated with PPO before drying down and then exposed to 'pre-flashed'
Kodak RPR40 film at -70°C. 'Pre-flashing' was performed using a photographic 
enlarger rather than an electronic flash gun, to a background absorbance 
increment of 0.2.
32
Fluorography of gels containing low amounts of P radioactivity used 
a procedure suggested by R. Laskey (personal communication 1976). The gel 
was dried down without PPO treatment, and 'pre-flashed' Kodak RPR40 film was 
sandwiched between the gel and an intensifying screen (Kodak X-Omat, Regular) 
for exposure at -70°C.
Autoradiographs and fluorographs were scanned using a Joyce-Loebl 
microdensitometer.
2.7. QUANTITATIVE METHODS
2.7.1. Protein estimation
Protein concentration was determined by the method of Lowry et al 
(1951). Samples containing 20-50 yg of protein were diluted to 0.50 ml 
with water and mixed with 2.5 ml of a mixture of 100 parts 2% w/v Na2C03 in 
0.1 M NaOH with 1 part 1% vi/m sodium potassium tartarate and 1 part 2% w/v 
copper sulphate. After 10 min at room temperature 0.25 ml of a mixture of 
1 part Folin and Ciocalteau's phenol reagent and 1.4 parts of water were 
added and immediately mixed. Optical density was read at 750 nm relative 
to a water blank. BSA in the relevant buffer was used as a standard.
Solutions containing Triton N101 formed a precipitate with the 
phenol reagent. This was avoided if the initial dilution to 0.50 ml 
used 0.1% SDS rather than I^O. 0.1% SOS was also included in the BSA 
standards.
2.7.2. Liquid scintillation counting
Four scintillants were used according to the nature of the sample: 
Triton-toluene scintillator (0.4% w/v PPO, 0.005% P0P0P, 33.3% v/v Triton 
X-100 in toluene) was used for aqueous samples.
Toluene scintillator (0.4% w/v PPO in toluene) was used for samples dried 
on glassfibre, nitrocellulose, or cellulose filters.
Acidified toluene scintillator (0.5% PPO, 0.01% POPOP, and 0.1% v/v glacial 
acetic acid in toluene) was used for sample which had been solubilised in 
soluene 350
Gel scintillator (0.7% PPO, 0.015% POPOP, 5% w/v naphthalene, 3.5% w/v 
silica gel, homogenised together in a mixture of 7 parts dioxan, 2 parts 
toluene, 0.3 parts ethanol) was used for samples which had been solubilised 
in alkali.
Samples were counted in a Packard Tri-Carb Scintillation Spectrometer.
oc o oo o
Double-labelling with S and H or P and JH was used in some experiments.
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Labelling conditions were chosen to give high H counts compared with 
35S or 32P to minimise the effects of spillover. Samples labelled with 
one isotope only were included in each experiment for the calculation of 
spillover, and double-labelled samples were corrected assuming that this 
proportion was constant'. When the efficiehcy of counting was required, a 
standard prepared in exactly the same way as the samples was included.
* '
SECTION 3
CHEMICAL PROPERTIES OF POLY rl.rC
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3.1. CHEMICAL PROPERTIES OF POLY rl.rC: INTRODUCTION
The double-stranded complex between the homopolymers polyriboinosinic 
acid (poly rl) and polyribocytidylic acid (poly rC) is a good interferon 
inducer (de Clercq 1974). Both homopolymers are readily synthesised using 
polynucleotide phosphorylase (Michelson et al 1967), and Can be radioactiyely 
labelled. Being a synthetic polynucleotide it is not infectious, and chemical 
analogues can readily be made. It has thus become the dsRNA of choice for 
most interferon induction investigations and for studies on cell-surface 
binding of dsRNA. For these reasons, polyri.rC was selected as a model dsRNA 
for use in the in vivo and in vitro experiments reported in the rest of this 
thesis.
There were two problems with the poly rl.rC preparations in use in 
the laboratory. Firstly, it was highly sensitive to nuclease degradation. 
Thus, when treated with 50 yg/ml RNAseA and 500 u/ml RNAseTl in 0.15 M salt 
at 37°C for 30 min, conditions where SFV virion RNA is fully degraded but 
SFV RF is fully resistant, poly rl.rC was completely degraded. Secondly, 
radioiodinated poly rl.rC behaved anomalously on cellulose chromatography 
(M.D. Johnston, personal communication 1973). It was thus necessary to 
characterise the preparation to ensure it was double stranded, and not 
contaminated with unhybridised single strands of either poly rl or poly rC. 
These preparations were purchased aa "double-atranded HNA".
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3.2. RIBONUCLEASE DIGESTION
An assay for ribonuclease sensitivity (see section 2.5.4) was 
developed based on the measurement of acid soluble optical density.
As a criterion for distinguishing poly rl.rC from free single strands, 
digestion conditions were found where poly rl.rC was fully resistant but 
poly rl and poly rC were fully degraded. This required the definition 
of the concentrations of two ribonucleases - RNAseA will degrade poly rC 
and RNAse T1 will degrade poly rl - ionic strength, temperature, and time 
of digestion.
Initial experiments were performed following the kinetics of 
digestion at different RNAse concentrations. The curves were expected to 
plateau at complete digestion. Lowering the nuclease concentration, or 
raising the salt concentration, should lower the rate, and any tendancy 
to reach a plateau before complete digestion would imply the presence of 
two populations of RNA with different sensitivity.
Fig. 2 shows the digestion of poly rl.rC at different concentrations 
of RNAseA and T1, and two different ionic strengths. Under all conditions, 
poly rC was more sensitive than poly rl.rC, and there was no indication of 
contamination of the poly rl.rC with poly rC. Similar results were obtained 
when poly rl was compared to poly rl.rC (not shown).
Table 2 shows the extents of digestion of poly rl, poly rC and 
poly rl.rC using different ribonuclease concentrations but fixed ionic 
strength, time, and temperature. Using this data, the conditions finally 
chosen for selective ribonuclease digestion were 0.1 pg/ml RNAse A, 300 u/ml 
RNAseTl, 150 mM NaCl, 50 mM tris HC1 pH 7.4 at 30°C for 1 hr, followed by 
perchloric acid precipitation and measurement of acid soluble optical 
density at 263 nm. Under these conditions poly rl.rC was fully resistant, 
but poly rC and poly rl were fully degraded. This assay was used for the 
experiments in section 4.7.
10
FIG.2. Kinetics of ribonuclease digestion of poly rC and 
poly rl.rC.
Poly rC (a,b), or poly rl.rC (c,d), was mixed with various 
concentrations of RNAse A and RNAse T1 in 150mM (a,c) or 
800mM (b,d) NaCl, 50mM tris HC1 pH7.4. After various times 
at 25°C, aliquots were removed and precipitated (section 
2.5.4). Acid soluble 0D at 260 nm was expressed relative 
to complete digestion by alkali.
A control
□ 0.1 yg/ml RNAse A, 300 u/ml RNAse T1
a 0.3 yg/ml RNAse A.1000 u/ml RNAse T1
o 1.0 yg/ml RNAse A,3000 u/ml RNAse T1
• 3.0 yg/ml RNAse A,10000u/ml RNAse T1
ac
id 
so
lub
le 
0D
 
(%
)

TABLE 2 : Comparison of sensitivities of poly rl,
poly rC and poly rl.rC to different 
concentrations of RNAse.
Concentration of % acid so1uble OD
RNAse
A
(yg/ml)
T1
(u/ml)
poly rl 
(250nm)
poly rC 
(280nm)
poly rl.rC 
(263nm)
3.0 10000 115 100 48
1.0 3000 112 100 28
0.3 1000 n o 94 14
0.1 300 108 91 4
Digestion was carried out at 25°C in the presence of the 
indicated concentrations of RNAse A and RNAse T1 and 
150 mM NaCl, 50 mM tris HC1 pH 7.4, for 2 hr. Results 
are means of triplicates related to complete digestion 
by alkali. RNAse T1 had no effect on poly rC and RNAse A 
had no effect on poly rl.
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3.3. CHROMATOGRAPHY OF POLY rl.rC ON CELLULOSE
dsRNA can be separated from DMA and ssRNA by chromatography 
on cellulose with buffers containing different proporations of ethanol 
(Franklin 1966). The sample is applied in buffer containing 35% v/v 
ethanol and all the RNAs, but not DNA or oligoribonucleotides, bind. 
ssRMA is eluted when the ethanol concentration is reduced to 15% v/v, 
and dsRNA is eluted in buffer containing rio dbhanol. Multistranded RNA 
may also elute in this fraction. (Macnaughton et al 1976).
Poly rl.rC chromatographs anomalously in this system. Fig.3a 
shows a comparison of poly rl.rC and reovirus dsRNA extracted from 
3H uridine labelled virus. The poly rl.rC was annealled before mixing with 
the 3H reovirus dsRNA and applying to the column in 35% v/v ethanol. Although 
82% of the recovered H eluted as dsRNA in the 0% ethanol fraction, the 
bulk of the optical density eluted as ssRNA (82% of recovered optical density 
in 15% v/v ethanol fraction). When the material eluted by 15% v/v ethanol 
was made 35% v/v in ethanol and rechromatographed, the profile was unchanged 
(Fig. 3b,c).
It was possible that the secondary structure of poly rl.rC was 
destroyed by 35% v/v ethanol. However, when the sample was applied in 
15% v/v ethanol, only 2% of the optical density was eluted in the 0% ethanol 
fraction (results not shown). Moreover, when poly rl.rC in 15% v/v ethanol, 
and the 15% v/v ethanol fraction from the Franklin column, were compared 
with poly rl.rC in buffer alone, all showed the same melting profiles (with 
a melting temperature of 63.5 - 65.5°C and hyperchromicity of 68-76%) and 
the same spectra at 25°C and 72°C. All showed 100% resistance to nuclease 
digestion (conditions of section 3.2). When sedimented on sucrose gradients 
containing 150 mM NaCl and 50 mM tris HC1 pH 7.4, but no ethanol, all 
sedimented at about 13S (data not shown).
These results show that poly rl.rC elutes from cellulose columns 
with the characteristics of ssRNA, yet this is not due to degradation or loss 
of secondary structure. This procedure clearly cannot be used to isolate 
poly rl.rC.
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When phage f2 RNA is chromatographed at low temperature, the profile 
differs from that at room temperature (Engelhardt 1972), with a greater 
proportion running in the 0% ethanol fraction. It was possible that 
altering the temperature would alter the characteristics of poly rl.rC on 
the column.
When poly rl.rC was loaded onto a Franklin column at 4°C, 40-60% 
of the optical density routinely eluted in the 15% v/v ethanol fraction, 
and the remainder in 0% ethanol (Fig. 3d). No more material was eluted 
when the temperature was raised. Each of the fractions rechromatographed 
true (Fig. 3e,f). Under these conditions poly rC eluted in the 15% v/v 
ethanol fraction (Fig. 3g) but poly rl bound strongly even in 0% ethanol, 
and was only eluted at higher temperature (Fig. 3h).
Running the column at 4°C thus alters the elution profile of poly rl.rC. 
A greater proportion elutes as "dsRNA". About half of the material elutes 
as "ssRNA", and this would seem to be structurally different from the "dsRNA" 
because it chromatographs true. Both fractions could be contaminated with 
ssRNA, the 15% v/v ethanol fraction with poly rC, and the 0% ethanol fraction 
with poly rl.
The elution profile of poly rl.rC is thus dependant on both the 
proportion of ethanol and temperature. When poly rl.rC was adsorbed to the 
column in 35% v/v ethanol at 4°C, and the buffer changed to 15% v/v ethanol, 
about half of the material eluted (as in Fig. 3d). The temperature was 
then raised in steps of about 5°C, keeping the proportion of ethanol constant, 
and a second peak of absorbance eluted at 15-20°C. No further material 
eluted when the buffer was changed to 0% ethanol. Under these conditions 
poly rl eluted as a single peak at 35-40°C in the 15% v/v ethanol buffer.
FIG.3. Franklin column profiles
3
(a) Comparison of H reovirus dsRNA (broken line) and poly rl.rC 
(solid line) at 20°C. The column was loaded with 8.5 0D26g units
3
of poly rl.rC and 1700 cpm (0.04 0D2gg units) H reovirus dsRNA.
(b,c) Re-chromatography of 15% V/V ethanol fraction. 8.4 OD^gg 
units of poly rl.rC were chromatographed at 20°C (b). Peak B 
was taken, made 35% V/V in ethanol, 2.0 0D2gQ units loaded onto 
a second column, and chromatographed as before (c).
(d,e,f) Chromatography of poly rl.rC at 4°C. 18.8 0D2gg units
of poly rl.rC were chromatographed at 4°C (d). 5.5 0D2gQ units 
of peak B was made 35% V/V ethanol and rechromotographed (e).
7.2 002gg units of peak C was made 35% V/V in ethanol and 
chromotographed on another column (f).
(g) Chromotography of poly rC at 4°C. The column was loaded 
with 8.9 0D2gg units.
(h) Chromotography of poly rl at 4°C. The column was loaded 
with 3.8 0D2gg units and chromotographed as before. At the end 
of the run, tightly bound optical density was eluted by raising 
temperature to 25°C (broken line).
In each case chromotography was by the procedure described 
in (section 2.6.1) and the total 0D2gQ eluting in the 35% V/V 
ethanol (A), 15% V/V ethanol (B) and 0% ethanol (C) fractions 
is expressed as a percentage of the total recovered 0D2gQ. In 
(a), samples were also taken for liquid scintillation counting.
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3.4. DISCUSSION
Poly rl.rC is double-stranded as shown by its resistance to 
ribonuclease under conditions where poly rl and poly rC are fully degraded.
It inhibits protein synthesis in the reticulocyte lysate (section 4.3) and 
induces interferon and causes a cytotoxic effect in interferon-treated cells 
(section 5). However, it is more sensitive to RNm .v A and RNAse T1 than 
most viral dsRNAs and shows unusual elution characteristics on cellulose 
chromatography.
These findings might be common to all homopolymer duplexes or 
peculiar to poly rl.rC, and could result from base sequence or from size 
heterogeneity. For example, the high nuclease sensitivity could be due 
to partial endonuclease action with the nuclease following one strand of 
the duplex, or could be due to the fact that random cleavage of a short 
polynucleotide is more likely to produce acid soluble fragments than 
random cleavage of a long polynucleotide. The second explanation is 
unlikely with the size of polymer used here, although it may be important 
with short duplexes (section 4.7).
The reason for the unusual elution off cellulose columns is also 
unknown. At 4°C there seem to be two populations of poly rl.rC - one which 
elutes at 15% v/v ethanol, and one which binds more strongly and can either 
be eluted by raising the temperature or by lowering the ethanol concentration. 
Both populations elute together in the 15% v/v ethanol fraction when the 
experiment is performed at room temperature. The basis of this separation 
was not investigated, but may result if single-stranded tails of poly rl 
or poly rC were free to bind to the cellulose (De Larco and Guroff 1973).
The tight binding of poly rl to cellulose is not surprising.
Poly rl is known to form multistranded complexes, particularly at low 
temperature (Thiele and Guschlbauer 1973; Zimmerman et al 1974). These 
complexes should be unstable under the ionic conditions used, but the 
presence of ethanol and polar groups on the cellulose could be important.
PolyrC only forms double-stranded structures at low pH and low ionic strength 
(Klump 1975). On the other hand, the tight binding of poly rl may represent 
a preferance of the cellulose for polypurines (De Larco and Guroff 1973).
What is clear from these results is that the Franklin column cannot 
be used to purify poly rl.rC away from any free poly rl or poly rC. ssRNA 
contamination is high at both room temperature and in the cold. There are 
a number of alternative fractionation procedures available. Sepharose 4B 
has been used to separate dsRNA from ssRNA (Erikson 1969). However, no 
significant separation between poly rl.rC and poly rC or poly rl was 
achieved (data not shown). Methods which were not tried but may give good 
separation include precipitation with lithium chloride (Baltimore 1966) 
and fractionation on BD-cellulose (Stern and Friedman 1969).
SECTION 4
THE EFFECTS OF POLYNUCLEOTIDES ON 
PROTEIN SYNTHESIS IN RETICULOCYTE 
LYSATES
4. EFFECTS OF POLYNUCLEOTIDES ON PROTEIN SYNTHESIS IN RETICULOCYTE LYSATES
4.1. INTRODUCTION
It has been shown that dsRNA, but not ssRNA, inhibits protein 
synthesis in reticulocyte lysates (Ehrenfeld ^nd Hunt 1971). dsRNA has 
other biological activities, including interferon induction (Tytell et al 
1967) and toxicity for interferon-treated cells (Stewart et al 1972a), which 
show a requirement for stable secondary structure, high molecular weight, 
and 2‘ hydroxyl groups (de Clercq 1974).
Work on the inhibition of the reticulocyte lysate has been primarily 
from the point of view of mechanism, rather than the molecular requirements 
in the dsRNA structure, so it has involved a range of unrelated dsRNAs as 
inhibitors (for example poliovirus RF, Ehrenfeld and Hunt 1971; phage f2 
RF Hunter et al 1972; and reovirion dsRNA, Darnbrough et al 1972). It was 
thus of interest to investigate the synthetic homopolymers commonly used in 
interferon research in terms of their ability to inhibit the reticulocyte 
lysate.
FIG.4 . Effect of reovirus, dsRNA and hemin on protein synthesis 
by the reticulocyte lysate.
Incubations were performed as described (section 2.3.4) with
3
H leucine at 80 yM and 16 yCi/ml, in the presence of various 
concentrations of reovirus dsRNA (a and b) or, using a different 
lysate, in the absence of hemin (c). 5 yl aliquotis were taken
at various times for acid precipitation and counting.
(a) Protein synthesis kinetics in the presence of 25 yM hemin 
and ^  0; Si 0.5; A 5; Y  50; or + 500 ng/ml reovirus dsRNA.
(b) The 30 min values from part (a) plotted against the 
concentration of dsRNA. The open circle is the control value.
(c) Protein synthesis kinetics in the absence of dsRNA in 
a lysate supplemented with #  25 yM or ■  no hemin.
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4.2. CHARACTERISTICS OF THE LYSATE
The charecteristies of inhibition of the lysate have been described 
(Hunter et al 1972). Like the inhibition resulting from the absence of 
hemin or the presence of oxidised glutathione, the inhibition due to dsRNA 
is characterised by biphasic kinetics, in which linear synthesis proceeds 
for a defined period, after which protein synthesis is almost totally shut 
off. The length of the lag period is reduced by increasing the concentration 
of dsRNA; but there is a limit above which the inhibition is reduced. The 
inhibition can be increased by preincubating the lysate with dsRNA before 
adding the other components required for protein synthesis (Hunter et al 
1972).
The lysates used in this study were checked for these characteristics 
using various viral dsRNAs. Fig. 4 shows the kinetics (Fig.4a) and 
concentration dependance (Fig.4b) of protein synthesis in the presence of 
dsRNA extracted from reovirions. Maximal inhibition occurred at about 
100 ng/ml, when the lag was about 5 min. For comparison, the effect of 
omitting hemin from the incubation is shown (Fig. 4c).
The effect of preincubation with dsRNA was studied (Fig.5), and the 
sensitivity of the assay was increased (Fig.5b) as previously reported 
(Hunter et al 1972).
Other virus RNAs have been assayed. For example, total RNA from 
Sindbis virus infected chick embryo cells inhibits with the characteristics 
of dsRNA, showing typical kinetics (Fig.6a), potentiation by preincubation 
(Fig.6b), and relief by 2-aminopurine (Fig.6a, Legon et al 1974). Total RNA 
from uninfected cells was not inhibitory at this concentration. We have 
also shown inhibition by rhinovirus RF and RI purified by Franklin column 
fractionation and lithium chloride precipitation from infected Hela cells 
(Macnaughton et al 1976).
FIG.5. Effect of preincubation on protein synthesis inhibition
by reovirus dsRNA.
(a) 100 pi incubations were made up containing reticulocyte 
lysate, 25 pM heroin and reovirus dsRNA at various concentrations. 
At 0, 15, 40, or 60 min after the start of incubation at 30°C,
20 pi samples were removed to tubes containing 5 +il of a mixture
of all the components required for protein synthesis, to give a
3final concentration of 80 pM and 16 pCi/ml H leucine. After 
a further 30 min at 30°C, acid insoluble radioactivity was 
determined. The concentrations of dsRNA were: O  0; □  0.05;
▲  0.5; T 1.0; ■  5.0; and •  50 ng/ml.
(b) Using the same lysate as in part (a), 20 pi preincubations 
were performed at 0 or 30°C for 30 min before adding 3H leucine 
and other components and continuing incubation for 30 min. The 
results are expressed as a percentage of the incorporation in 
the absence of dsRNA, plotted against the concentration of 
dsRNA.
•  preincubation at 0°C 
■  preincubation at 30°C.

FIG.6. Inhibition of protein synthesis by RNA from Sindbis
virus infected cells.
Chick embryo cells were infected with Sindbis virus and grown 
for 4 hr in the presence of 1 pg/ml actinomycin D. The RNA 
was extracted, treated with DNAse, and dissolved in 100 mM KC1, 
using 50 pi for every 106 cells. This RNA was assayed for 
inhibition of the reticulocyte lysate at 10 or 100-fold dilution. 
RNA from mock-infected cells was not inhibitory unless preincubated 
with the lysate, when a 10-fold dilution inhibited 18%. The 
assays contained H leucine at 25 pM and 50 pCi/ml, and 3 pi 
aliquots were taken for acid precipitation.
(a) RNA from infected cells assayed without preincubation in 
the presence or absence of 2-aminopurine. 2-aminopurine was 
dissolved in water to about 140 mM and neutralisedwith K0H 
(final 0D306 = 810). It was diluted 20-fold in the assay, to 
about 7 mM.
•  control
■  + 10-fold diluted RNA 
V  + 2-aminopurine
^  + RNA + 2-aminopurine
(b) RNA from infected cells diluted 100-fold into the lysate 
was preincubated at 30°C for 30 min before the addition of the 
other components for protein synthesis.
•  control
■  + 100-fold diluted RNA.
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4.3. INHIBITION BY POLY rl.rC
Poly rl.rC has been reported to inhibit the reticulocyte lysate 
(Ehrenfeld and Hunt 1971). However, with a number of lysates I found the 
inhibition at low concentrations to be irregular and difficult to reproduce.
At concentrations in-the range of 10 ® to'10 4M (3.10 • to 3.10 ® g/ml) ~ 
inhibition after 30 min incubation was never more than 30%. "Activating" 
the dsRNA, by incubating in a buffer containing magnesium ions (de Clercq 
et al 1971; de Clercq and Merigan 1971), before adding to the lysate did 
not increase the inhibition.
However, when the poly rl.rC was preincubated with the lysate, 
inhibitions of up to 95% were observed, representing inhibition within 2 min 
of the addition of components for protein synthesis (Fig.7). 80% inhibition
was observed with only 1 ng/ml dsRNA (compare Fig.5b and 6c).
Poly rl.rC thus behaves like a classical dsRNA inhibitor in preincubated 
systems, but no conclusions could be drawn about non-preincubated systems.
The following experiments ware performed after preincubation, unless otherwise 
stated.
FIG.7. Inhibition of protein synthesis by poly rl.rC
Poly rl.rC was diluted as required and added to the reticulocyte 
lysate. After 30 min at 30°C the other components for protein 
synthesis were added, including leucine at 80 pM and 50 pCi/ml, 
and incubation continued. 5 pi aliquots were taken as required 
and acid insoluble radioactivity determined.
(a,b) Kinetics of protein synthesis. The ordinate scale has 
been expanded 10-fold in part (b) to show the inhibition caused 
by high concentrations of poly rl.rC, and the control line from 
part (a) is shown.
9 co n tro l
□ 0 .2  nM p o ly  r l . r C
A 1.0  nM
V 5 .0  nM
»V■K» 27 nM
O  135 nM
Results using 675 nM or 3380 nM could not be distinguished from 
those shown for 135 nM.
(c) The 30 min time points from parts (a) and (b) plotted as 
percentage of control incorporation against concentration of
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4.4. COMPARISON OF DIFFERENT HOMOPOLYMERS
To verify a requirement for a double-stranded structure with 2' 
nydroxyl groups on both strands, a comparison of poly rI.rC,poly dl.dC.poly rl.dC 
poly rl and poly rC was made. Poly dl.rC has a melting temperature in 
100 mM NaCl of only 35°C (Chamberlin and Patterson 1965) and would only be 
marginally stable in the lysate. Although poly rl and poly rC can each 
form multistranded complexes under certain conditions (Thiele and 
Guschlbauer 1973, Klump 1975) this should not occur in the lysate.
Fig. 8 shows that dsRNA is more inhibitory than dsDNA, DNA.RNA, or 
ssRNAs, and is the only polynucleotide showing biphasic kinetics.
In view of the failure of tsRNA to induce interferon in primary 
rabbit kidney cells, even though it competes with dsRNA for the interferon- 
inducing receptor (de Clercq et al 1974), it was of interest to see whether 
tsRNA could inhibit the lysate. Triple-stranded complexes of poly rl with 
poly rC are not stable under the conditions of interferon induction or in 
the lysate (Thiele and Guschlbauer 1969), so a non-homologous tsRNA was 
used.
Poly rA.rll.rU has been characterised (Michelson et al 1967) and no 
disproportionation to dsRNA occurs in 150 mM NaCl at 37°C (de Clercq et al 
1975b). When assayed at 11 pM (in the same experiment as Fig.8) poly rA.rU.rU 
inhibited 54%, compared with 81% for 1 pM poly rl.rC. The inhibition was 
comparable with that due to poly rl. However, when assayed in another lysate 
after 60 min preincubation, it was found that 11 pM poly rA.rU.rU could 
inhibit with biphasic kinetics (Fig. 9a,b). This effect depended on 
preincubation (Fig.9c). Knowing the dose-response curve for poly rl.rC, 
and assuming it is the same for poly rA.rU, the inhibition can be explained 
by contamination of the 11 pM poly rA.rU.rU with about 0.1 pM poly rA.rU.
It has been reported (de Clercq et al 1974) that tsRNA can prevent 
induction by dsRNA. As poly rA.rU.rU and poly rl.rC do not exchange strands 
under physiological conditions (de Clercq et al 1975b), and poly rA.rU.rU
is less inhibitory than poly rl.rC, it was possible to perform an analogous
FIG.8 . Inhibition of protein synthesis by single and double- 
stranded homopolynucleotides.
Polynucleotides were added to the lysate to a final concentration 
of 1 yM (in nucleotides). After 30 min at 30°C components for
3
protein synthesis were added, including H leucine at 25 yM and 
50 yCi/ml. 5 yl aliquots were taken as required for acid 
precipitation. Parts (a) and (b) represent data from the same 
experiment.
(a) O control; □  + poly rl.dC; A + poly dl.dC; V + poly rl.rC
(b) A + poly rC; V + poly rl.


FIG.9. Inhibition of protein synthesis by poly rA.rU.rl)
Polynucleotides were added to the reticulocyte lysate at 1 pM 
(poly rl.rC, poly rl, or poly rC) or at 11 pM (poly rA.rU.rll) 
final concentration. After various times of preincubation at 
30°C, aliquots were removed and other components for protein
3
synthesis were added, including H leucine to 25 pM and 
50 pCi/ml. 5 pi aliquots were taken as required for acid 
precipitation.
(a) Kinetics of protein synthesis with no preincubation
(b) Kinetics of protein synthesis after 60 min preincubation
(c) 30 min incorporations after various times of preincubation, 
expressed as percentages of the relevant control.
O  control
A  11 pM poly rA.rU.rU
□  1 pM poly rl.rC
+ 1 pM poly rl
X  1 pM poly rC.
incubation 
time ( min ) 
preincubation
time 
( min )
SH cpm ( x10 4 )
O  -T" CD
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experiment in the lysate, adding poly rA.rU.rU in an 11-fold molar excess 
(7-fold excess of base triples over base pairs) before the poly rl.rC.
Whatever the time of addition of the poly rA.rU.rU relative to the 
poly rl.rC, there was no reduction in the poly rl.rC inhibition (Fig.10). 
If the binding of tsRiNA to the lysate receptor were as strong as to the 
induction specific cell surface receptor, this protocol might have been 
expected to reduce the dsRNA inhibition.
FIG.10. Effect of poly rA.rU.rll on the inhibition due to
poly rl.rC.
Reticulocyte lysate, with hemin added, was incubated alone or 
with poly rA.rU.rU at 11 pM final concentration. If required, 
poly rl.rC was added to 1 pM at 30 min, or poly rA.rU.rU to 
11 pM at 40 min. All incubations were continued to 60 min 
when other components for protein synthesis were added, 
including leucine to 25 pM and 50 pCi/ml. 5 pi aliquots
were taken as required for acid precipitation. The control was 
approximately linear up to 2 0 min, and then reached a plateau 
at 23000 cpm.
time(min) 0 30 40
addition none none none ■
none rl .rC none □
none none rA.rU.rU ▲
none rl.rC rA.rU.rU A
rA.rU.rU none none T
r A . rU. rU rl.rC none V
Addition of poly rA.rU.rU at 10, 2 0 , or 30 min also made no
difference to the inhibition by poly rl.rC added at 30 min 
(data not shown).

4 .5 . RELATIONSHIP BETWEEN INHIBITION AND MOLECULAR WEIGHT OF POLY rl.rC
A commercial "size kit" of poly rl and poly rC of different average 
lengths has been used extensively in interferon research. When anneal led 
togetner to form short (2.5 S poly rl with 3.IS poly rC), intermediate, or 
long (12.5 S poly rl with 13.2 S poly rC) duplexes, interferon induction 
was reduced as molecular size was decreased (Stewart and de Clercq 1974).
Tne effect of these duplexes on the lysate was determined.
Fig. 11 shows the kinetics of inhibition and dose-response curves
for short, intermediate and long duplexes. Clearly, the difference in
-3 *7
inhibitory effect depends on the concentration used. Above 10 to 10 M,
all duplexes inhibit. Three independent experiments were performed to 
estimate the 50% inhibitory concentrations of the shortest and longest 
duplexes (Taole 3). Somewhere between 5 and 50 times as much short dsRNA 
as long dsRNA is required for a given inhibitory effect.
Table 4 shows the results of an experiment using all six different 
size duplexes each added at 1 nM. Apart from the low inhibition due to
the hybrid of 10.5 S poly rl with 10.5 S poly rC, which could be due to
degradation of one of the strands, there is a general decrease in inhibition 
as size is reduced.
dsRNA molecules can also be constructed by annealling high molecular 
weight poly rl with low molecular weight poly rC, and vice versa. When 
annealled in equimolar concentrations of bases, the expected structures 
consist of duplexes in which one strand has occassional breaks. In the 
lysate, it appears that the integrity of the poly rl strand is more important 
than the integrity of the poly rC strand (Fig. 12).
Two questions arise from this work. Firstly, is the inhibitory effect 
of low molecular weight dsRNA due to contamination with high molecular 
weight material? Secondly, does the loss of biological activity as the 
size of both strands, and particularly the poly rl strand, is reduced, 
correlate with changes in stability?
FIG.11. Kinetics of inhibition of protein synthesis by different
sizes of poly rl.rC.
Hybrids were made from different size classes of poly rl and poly rC. 
Dilutions were made as required, and preincubated in the reticulocyte 
lysate at 30°C for 30 min. Other components for protein synthesis
O
were added, including H leucine at 80 yM and 50 yCi/ml, and 
incubation continued. 5 yl aliquots were removed as required for 
acid precipitation.
O  control 
X 0.1 nM poly rl .rC
□  1 nM
A 1 0 nM
V  100 nM
(a) The poly rl.rC was made from 2.5S poly rl and 3.08S poly rC
(b) The poly rl.rC was made from 6.13S poly rl and 5.94S poly rC
(c) The poly rl.rC was made from 12.5S poly rl and 13.2S poly rC
The control line from part (a) is also shown in parts (b) and (c), 
which are plotted with the ordinate expanded 2 -fold.

TABLE 3. Dependance of 50% inhibitory concentration
on size of dsRNA.
poly rl.rC size 50% inhibitory concentration
poly r.I S value poly rC S value (log molarity)
expt.no. I II H I
"short" 2.5 3.08 -8.4 -8.3 -8.4
"long" 12.5 13.2 -9.6 -9.0 -10.1
ratio "short" 
"long"
1.2 0.7 1.7
Each experiment was performed as described in the legend to Fig. 11, except
3
that two 5 pi aliquots were taken after 30 min incubation with H leucine. 
Incorporation into acid insoluble material was plotted against the log 
concentration of dsRNA, and the 50% inhibitory concentration found by 
interpolation.
FIG.12. Relative importance of the poly rl strand for inhibition
of protein synthesis by poly rl.rC.
Hybrids were formed by anneal ling together poly rl and poly rC of 
different size classes, at equimolar concentrations of nucleotides. 
Serial 5-fold dilutions were made and incubated with the reticulocyte
lysate at 30°C for 30 min before adding the other components for protein
3
synthesis, including H leucine at 80 pM and 50 pCi/ml After a further 
30 min, two 5 pi aliquots were taken for acid precipitation. 
Incorporations are expressed relative to a control of 19400 cpm.
size of poly rl.rC 
poly rl S value poly rC S value
symbol 50% inhibitory 
concentration 
(log molarity)
2.5 3.08 O -8.4
2.5 13.2 3 -9.1
12.5 3.08 € -9.6
12.5 13.2 • -9.6
a) 50% inhibitory concentration interpolated from the curves shown 
in the figure. These are not intended to be absolute figures, but 
give an indication of the relative importance of the poly rl and poly rC
strands.

TABLE 4. Inhibition by different sizes of poly rl.rC
assayed at 1 nM.
poly rl .rC size
% inhibition relative 
to control at 30 min
poly rl S value poly rC S value
2.5 3.08 4
4.39 3.88 6
6.13 5.94 18
7.94 8 . 2 0 63
1 0 . 6 10.5 34
12.5 13.2 65
Hybrids were prepared from different size classes of poly rl and poly rC,
and added to the lysate at 1 nM. After 30 min at 30°C, other components
3
for protein synthesis were added, including H leucine at 80 pM and 
50 pCi/ml. After a further 30 min, 5 pi aliquots were taken for acid 
precipitation. Control incorporation was 12100 cpm.
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4.6. SIZE HETEROGENEITY OF POLYNUCLEOTIDES
In view of the broad size range quoted by the manufacturers for the 
"size kit" polynucleotides (see section 2.5.1), the sedimentation 
characteristics of the poly rl preparations were determined (Fig. 13).
These gradients were run under non-denaturing conditions, so reliable 
S values cannot be found. However, it is clear that only very small amounts 
(maybe 1-2%) of the "2.5 S" pieces sediment at 8 S or more, that is, are 
large enough to inhibit the lysate at 1 nM (Table 4). As diffusion could 
be significant and the gradients were heavily overloaded, this estimate 
is likely to be an upper limit. It thus seems probable that the inhibition 
caused by the short dsRNA molecules at high concentration (Table 3) is 
not caused by contamination with long molecules. However, it was desirable 
to repeat the inhibition experiments with less polydisperse preparations.
Sucrose gradients were found to be unsuitable for further fractionation 
of the poly rl preparations, because of the long times of centrifugation 
required. When poly rC was radioiodinated and fractionated on 3% or 7.5% 
polyacrylamide gels, good separation of low molecular weight pieces was 
obtained, but attempts to electrophorese the RNA from the gel slices and 
onto DEAE paper, followed by elution and concentration, were unsuccessful, 
and introduced problems of degradation and yield. These attempts were not 
pursued further. It might have been more profitable to fractionate the 
poly rl.rC than its constituent single strands, because dsRNAs show good 
resolution on gel electrophoresis (Shatkin et al 1968). However, the
proolem of recovery from the gel slices would have remained.
FIG.13 Sedimentation of poly rl on sucrose gradients.
Poly rl pieces of different nominal lengths (Table 1) were centrifuged 
through 12 ml 5-30% W/W sucrose gradients in the MSE 6 x 14 ml rotor 
at 40000 rpm for 24 hr, maintained at 2°C. The gradients were made 
from 5% W/W and 30% W/W sucrose dissolved in TNE (section 2.4.1), and 
were convex, but not isokinetic. After centrifugation the gradients 
were unloaded from the top and pumped through the Uvicord. Percent 
transmission was converted to optical density and the optical density 
of some of the fractions checked in the SP500.
Three of the six profiles are shown:-
(a) "2.5S" poly rl, 17 OD0 5 4 units
(b) "4.39S" poly rl,14 0D2 5 4 units
(c) "12.5S" poly rl,16 OD^g^ units
and the markers are the peak fractions of these, and other gradients:-
A, "2.5S"; B, "4.39S"; C, "6.13S"; D, "7.94S"; E, "10.6S";
F, "12.5S".

4.7. VARIATION OF CHEMICAL PROPERTIES WITH SIZE OF dsRNA
Low activity of short dsRNA molecules in the lysate assay could be 
due to a reduction in stability of the double-stranded structure. Stability 
was assessed by two methods - by following the optical melting curve, and 
Dy determining resistance to nuclease digestion.
When spectra of solutions of the duplexes, at either 25 or 85°C, were 
scanned from 210 to 310 nm, no differences were detected. However, when the 
optical density at 250 nm was monitored over this temperature range, 
significant differences were evident (Fig. 14a). The shorter duplexes showed 
a lower melting temperature (TM ), lower hypochromicity and broader melting 
transition, than the longer duplexes. The breadth of the melting transition 
implies the presence of a population of molecules of different T^s, that is, 
of different stabilities.
A similar analysis was performed on the hybrids made by annealling 
long strands with short (Fig. 14b). The poly rl strand length was found 
to be more important than the poly rC strand length for structural stability 
in agreement with their relative importance for inhibiting protein synthesis 
(Fig. 12).
Selected duplexes were also compared in terms of their resistance to 
ribonuclease digestion. The conditions were chosen to degrade poly rl and 
poly rC but not high molecular weight poly rl.rC (see section 3.2). The 
assay does not distinguish degradation of the poly rl strand from degradation 
of the poly rC strand, because digestion products of both strands contribute 
equally to the acid soluble optical density.
Table 5 shows that the shorter duplex is more sensitive to nuclease 
degradation than longer ones, which implies the existence of free single 
strands. These could either be present free in solution, or as local 
regions of instability within the double helix (Teitelbaum and Englander 
1975). The results do not distinguish these mechanisms, but either explanatio 
implies that the short duplexes are less stable. An alternative interpretatio
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FIG.14. Dependance of melting profile of poly rl.rC on 
molecular weight
Hybrids were formed using poly rl and poly rC of various sizes, 
and diluted in PBS (0.15 M monovalent cations) to an 00250 of 
0.4 to 0.5. Melting curves were followed at 250 n m  as described 
(section 2.5.3), and increases in O D ^ g  converted to percentages 
of the starting 0D2gQ. Each curve is displaced relative to the 
others by 15%, for clarity.
(a) Hybrids made from poly rl and poly rC of similar sizes
a 2.5S poly rl and 3.08S
3 4.39S 3.38S
A 6.13S 5.94S
7 12.5S 13.2S
63.5°C 
64.5°C 
66.0°C
(o) Hybrids made from poly rl and poly rC of different sizes.
2.5S poly rl and 13.2S poly rC(melting temperature 55.5°C) 
13.2S 
3. OSS
O
• 12.5S
C 12.5S
64.5°C
64.5°C
% 
inc
re
as
e 
in 
OD
is tnat a few breaks in a short strand may produce more acid-soluble 
fragments than a proportional number of breaks in a long strand. However, 
this effect should be negligible, provided that the smallest strand 
length considered is many times the maximum size for acid solubility, as 
is the case in these experiments.
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4.8. DISCUSSION
For a polynucleotide to be capable of inducing interferon in normal 
or primed cells, and to cause cytopathic effects in interferon-treated cells, 
it must have a stable secondary structure, high molecular weight, and 2 ‘ 
hydroxyl groups on both strands (de Clercq 1974; Stewart et al 1973a;
Stewart and de Clercq 1974). These requirements have now been shown to 
apply for another biological activity - the inhibition of protein synthesis 
in a cell-free system from rabbit reticulocytes. This conclusion has since 
been confirmed by Hunter et al (1975), who studied a variety of 
bacteriophage mycophage and viral RNAs as well as some homopolymers.
The use of a homologous series of homopolymers (formed from poly rl, 
poly rC, poly dl and poly dC) has enabled the analysis of each parameter 
independantly of base composition. ssRNAs, dsDNA and RNA.DNA all inhibit 
poorly and with different kinetics from dsRNA (Fig. 8). The tsRNA poly rA.rU.rU 
(Michelson et al 1967; de Clercq et al 1974; de Clercq et al 1975b), is not 
inhibitory, and does not prevent the inhibition by dsRNA (Fig. 9,10). It 
is not impossible, however, that conditions could be found where tsRNA could 
prevent the effects of dsRNA, so this result should not be taken as evidence 
that the induction specific, receptor and the lysate receptor recognise 
different characteristics of the polynucleotide structure.
The results using different length duplexes show that short duplexes 
are less effective than long ones, but even the shortest duplex tested is 
inhibitory at high concentrations (Table 3, Fig. 12). The question of the 
minimum size for inhibition, discussed by Hunter et al (1975), may not be 
meaningful if it depends on the concentration at which the dsRNA is added. 
Moreover, the increase of inhibition with size of dsRNA can be rationalised 
on the basis of the requirements for a stable secondary structure and for 
resistance to nucleases. As the molecular weight of the poly rl strand, 
and to a certain extent the poly rC strand, is reduced, so is the melting 
temperature and ribonuclease resistance of the hybrid (Table 5). This 
correlates with a reduction in all the biological activities studied (data
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presented in Table 5 from Stewart and de Clercq 1974; de Clercq 1974), and 
suggests that the absolute size of the hybrid is immaterial, and that what 
is important is structural stability. Indeed, any receptor capable of 
interacting with, say, 100 base pairs of dsRNA would probably need to be 
an aggregate of proteins, because individual proteins are only capable of 
binding to short stretches of double-stranded polynucleotides (Gilbert and 
Maxam 1973; Nathans and Smith 1975; Kornberg 1974). Such aggregates could 
exist on the cell surface (Edelman et al 1973), and could be important 
in mitogenesis (Dean et al 1972), but are difficult to envisage in a 
membrane-free lysate.
The degree of stability in question is not the difference between 
double strands and single strands, because ail the duplexes used are 
stable at the assay temperature (Fig. 14). Rather it is a question of 
local perturbations in structure (de Clercq and Merigan 1971; Teitelbaum 
and Englander 1975), which could be significant in a situation where cellular 
proteins might selectively stabilise and destabilise different polynucleotides 
(Travers 1976; de Clercq et al 1975b).
On the basis of the limited survey presented here it appears that the 
lysate receptor recognises the same characteristics as the induction and 
toxicity - specific cell surface receptor. It would be interesting to 
extend this work further to establish fine-structure requirements. In 
particular, the poly c^A.rll analogues which are inactive in induction 
(A.M. Bobst, personal communication 1976), and those batches of poly rl 
which have been reported to Tnduce interferon without complexing to poly rC 
(E. de Clercq, personal communication 1975).
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presented in Table 5 from Stewart and de Clercq 1974; de Clercq 1974), and 
suggests that the absolute size of the hybrid is immaterial, and that what 
is important is structural stability. Indeed, any receptor capable of 
interacting with, say, 100 base pairs of dsRNA would probably need to be 
an aggregate of proteins, because individual proteins are only capable of 
binding to short stretches of double-stranded polynucleotides (Gilbert and 
Maxam 1973; Nathans and Smith 1975; Kornberg 1974). Such aggregates could 
exist on the cell surface (Edelman et al 1973), and could be important 
in mitogenesis (Dean et al 1972), but are difficult to envisage in a 
membrane-free lysate.
The degree of stability in question is not the difference between 
double strands and single strands, because ail the duplexes used are 
stable at the assay temperature (Fig. 14). Rather it is a question of 
local perturbations in structure (de Clerr.q and Merigan 1971; Teitelbaum 
and Englander 1975), which could be significant in a situation where cellular 
proteins might selectively stabilise and destabilise different polynucleotides 
(Travers 1976; de Clercq et al 1975b).
On the basis of the limited survey presented here it appears that the 
lysate receptor recognises the same characteristics as the induction and 
toxicity - specific cell surface receptor. It would be interesting to 
extend this work further to establish fine-structure requirements. In 
particular, the poly c^A.rU analogues which are inactive in induction 
(A.M. Bobst, personal communication 1976), and those batches of poly rl 
which have been reported to induce interferon without complexing to poly rC 
(E. de Clercq, personal communication 1975).
SECTION 5
CHANGES IN CELLS EXPOSED TO
INTERFERON AND dsRNA
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5. CHANGES IN CELLS EXPOSED TO INTERFERON AND dsRNA 
5.1. INTRODUCTION
When interferon-treated cells are exposed to dsRNA, the titre of 
interferon produced may be altered - either being primed (Stewart et al 
1971a) or blocked (Stewart et al 1971b; Friedman 1966) relative to the 
levels produced by control cells treated with dsRNA. In L929 cells, in 
the absence of DEAE dextran and with low interferon doses, only priming 
is important. Additionally, the cells may show a pronounced cytotoxic 
effect, not evident when control cultures are treated with dsRNA (Stewart 
et al 1972a). Such interferon-enhanced cytotoxicity is only exhibited by 
dsRNA (Stewart et al 1972a) and by vaccinia virus (Joklik and Merigan 1966). 
Other compounds tested are equally toxic for interferon-treated and control 
cells (Stewart et al 1973a). The toxicity of vaccinia virus may involve the 
dsRNA which is produced during virus multiplication (Stewart et al 1973a).
Toxicity and primed interferon production thus requires both interferon 
and dsRNA. The active component in the interferon preparation is probably 
the same as that which causes the antiviral effect (Stewart et al 1972a; 
Stewart et al 1973b), and the structural features recognized in the dsRNA 
molecule are the same for induction, primed induction, and toxicity (Stewart
l
and de Clercq 1974). Indeed, the cytotoxic and priming effects are closely 
linked in temporal development, dose response, and time of exposure to dsRNA 
(de Clercq and de Somer 1974b) and complex manipulations are required to 
dissociate them (de Clercq and de Somer 1974b).
It is not clear what metabolic changes occur in cells as a result of 
exposure to interferon. The antiviral state (Dianzani and Baron 1975), the 
primed state (Stewart et al 1971b), and perhaps the increased sensitivity 
to the toxicity of dsRNA (de Clercq and de Somer 1974b; Stewart 1975), 
all develop rapidly. Although it seems that protein synthesis is required 
for the antiviral state (Levine 1964) but not for tne primed state (Stewart 
et al 19/la), these results are complicated by the need to remove the
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inhibitors during the challenge or interferon production period, and by 
the possibility of superinduction (Chany et al 1971). The metabolic 
requirements for the enhanced toxicity of dsRNA are unclear, presumably 
because of problems in interpreting a cytotoxic effect when inhibitors 
are present, but there is unpublished evidence (quoted by Stewart 1975) 
that protein synthesis is not required. In human cells enucleation prevents 
the antiviral state developing (Radke et al 1974), but both priming and 
toxicity are independent of the dosage of chromosome 21 (de Clercq et al 
1975a), which is important for the antiviral state (Revel et al 1976).
In view of the pronounced changes seen after dsRNA treatment 
(Heremans et al 1976) it seemed profitable to investigate events occurring 
during this period, rather than during the interferon treatment period.
This also had the advantage of built-in controls for non-specific effects 
of interferon or dsRNA treatment, because whereas any changes which were 
apparently interferon specific could be due to contaminants in the interferon 
preparation, and any change which were dsRNA dependant could be due to 
binding or ionic effects, only those changes requiring both interferon and 
dsRNA wou’d be implicated (either causally or coincidentally) in the 
cytotoxic and priming effects.
During preliminary characterisation of the toxic effect it became 
apparent that the treatment did not affect all cells equally, but a significant 
proportion of the cells remained viable. The biological basis for this 
phenomenon was investigated.
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5.2. CHARACTERISTICS OF THE CYTOTOXIC EFFECT
Cultures of L929 cells grown as monolayers in plastic dishes or 
in glass vials showed a cytopathic effect when treated with 100-300 u/ml 
of interferon overnight, followed by poly rl.rC at 50yg/ml. Under these 
conditions about 50u of interferon were produced per 10^ cells. Cytopathic effects 
and interferon could not be detected (less than 0.3u interferon/10^ cells) 
when control cultures were treated with poly rl.rC or in cultures which had 
been treated with interferon but not with poly rl.rC.
The cytotoxic effect was routinely quantitated as follows. Cultures 
were grown to confluence in glass vials and treated with interferon for 
15-17 hr. The cells were washed free of serum, incubated with poly rl.rC 
for 1 hr, and then washed and incubated for a further 2.5 hr, still in the 
absence of serum • Total protein remaining attached to the glass was then 
measured after washing to remove dead cells. In all experiments, triplicate 
interferon and poly rl.rC treated cultures were compared to three sets of 
controls: interferon but no poly rl.rC, and mock-treated cultures with or 
without poly rl.rC.
A typical assay is shown (Fig. 15a). The quantities of protein in 
the three sets of controls are similar, but the quantity in the treated 
cultures is reduced. The cytotoxic effect is defined as the proportional 
loss of protein when the treated cultures are compared with the average 
of the three sets of controls.
This assay method was compared with the conventional dye uptake 
procedure (Finter 1969), and counts of trypan blue excluding cells (Fig.l5a,b,c) 
The results of the dye uptake and cell counting procedures are comparable 
with the results reported by Stewart et al (1972a). Parallel cultures were 
used to assay interferon production (Fig. 15d), before staining with gentian 
violet to demonstrate tf^visible effects of interferon and poly rl.rC 
treatment (Fig. 15e).
The photomicrographs (Fig. 15f,g) show petri dish cultures from a 
separate batch of L929 cells. The interferon and poly rl.rC treated culture
(-16. 15. Changes in L929 cells exposed to interferon and poly rl.rC
(a,b and c) Cultures of cells in glass vials were treated with 
interferon and poly rl.rC as described (section 2.2.7). After 3.5 hr, 
the cultures were washed 3 times with PBS and
(a) the protein remaining on the monolayer quantitated (sections 
2.2.7 and 2.7.1); or
(b) the monolayers were incubated with 0.2 mg/ml neutral red,
20 mM tris HC1 pH 7.4, 2mW MgCl^in Earles salts for 1 hr 
before washing twice with PBS and eluting the stain with 
12 ml of 50% v/v ethanol, 110 mM acetic acid, 50 mM NaOH; 
or
(c) the cells were trypsinised and trypan blue excluding cells 
counted (section 2.2.9).
In each case the results shown are means of triplicate cultures treated 
with A, interferon and poly rl.rC; B, interferon alone; C, "mock-interferon" 
and poly rl.rC; and D, "mock-interferon" alone.
(a) shows the total protein content per culture, (b) the relative neutral 
red stain incorporation measured by 0D,.^ q , and (c) the total number of
trypan blue excluding cells per culture.
>
(d and e) Cells seeded in 50 mm dishes were treated with interferon and
poly rl.rC as required. The interferon produced between 1 and 24 hr
after poly rl.rC was collected in 2 ml GMEM/2% CS, and titrated after
pH2 treatment (sections 2.2.5 and 2.2.6). The interferon titre (d)
and appearance of the gentian violet stained monolayers (e; section 2.2.6)
are shown for A, interferon and poly rl.rC; B, interferon; C, "mock-interferon
and poly rl.rC; and D, "mock-interferon" treated cultures.
(f and g) Cells were treated with interferon and dsRNA (f) or "mock-interferon 
and dsRNA (g) and photographed 3.5 hr after treatment (section 2.2.9). The 
medium was left on the cells for photography; if it had been removed and 
the cells washed, most of the rounded cells in (f) would have be^n lost.
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shows the pronounced cytopathic effect evident 3.5 hr after poly rl.rC 
treatment, most of the rounded cells being readily removed by washing 
(Fig. 15f). On the other hand, the culture treated with poly rl.rC alone 
shows no cytopathic effects (Fig. 15g), and was identical with the other 
control cultures (not shown).
FIG. 16 Parallel loss of DMA and protein during cytotoxic effect.
3
Cells were seeded in glass vials and labelled with H thymidine at 
5 pCi/ml for 24 hr before treating with interferon and poly rl.rC 
as usual (section 2.2.7). At various times after poly rl.rC addition 
the cultures were washed three times with PBS, fixed with TCA, dried, 
and solubilised in 0.5 ml 1M NaOH and 50 pi aliquots used for 
scintillation counting and for protein estimation.
3
□  DMA content, TCA insoluble H cpm per culture 
O  protein content, mg protein per culture.
( a ) Cells treated with
( b ) Cells treated with
( c ) Cells treated with
( d ) Cells treated with
interferon and poly rl.rC 
interferon.
"mock-interferon" and poly rl.rC 
"mock-interferon".
1 2 3 4 5 6 1 2 3 4 5 6
time ( hr )
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5.3. HETEROGENEITY IN THE RESPONSE OF CELLS TO THE TOXIC EFFECT
Experiments were performed to test whether the protein remaining on 
the monolayer represented intact cells or debris. If the remaining protein 
was in intact cells, and was not reduced at higher doses of interferon or 
dsRNA or after longer exposure, then the data would suggest that a
significant proportion of the cells resisted the toxic effect.
3
The loss of DNA (labelled with H thymidine) and protein were compared 
over a period of 6 hr after dsRNA treatment (Fig. 16). Even though 35% of 
cellular protein was lost in the treated cultures, the DNA to protein ratio 
remained approximately constant.
When DNA loss was measured at different interferon concentrations (in 
the range 2-20000 u/ml) the results paralleled loss of protein synthesis 
capacity and ami noacid precursor pool (Fig. 17). All three parameters 
increased as the interferon was diluted, to reach the values of the untreated 
controls.
Thus it is clear that the loss of protein represents the loss of all 
components and functions of complete cells, and the controls for experiments 
presented below confirm this. Moreover, the proportion of protein left after 
treatment was related to the proportion of intact cells left, when they were 
counted after removal by trypsin (Fig. 15, Table 6, and data not shown).
Cell loss was progressive over the period from 1 to 3 hr after dsRNA treatment, 
and was complete by 3.5 hr, the time chosen for routine assessment of the 
cytopathic effect. Less than 10% of the cells destined to die in the first 
3 hr were removed with the poly rl.rC at 1 hr, so essentially all cell death 
occurred in a two hour interval. No further cell loss occurred between 
3.5 hr and 24 hr.
The extent of cell loss varied between experiments; the mean loss of 
protein after 300 u/ml interferon and 50yg/ml poly rl.rC was 43.6 - 10.2%
(mean and standard deviation of 22 experiments, range 24% to 60%). Within
FIG.17. Loss of DNA and protein synthesis capacity.
Cells were seeded in glass vials in the presence of 1 pCi/ml JH
thymidine and treated with different concentrations of interferon
for 16 hr before washing and treating with poly rl.rC at 50 pg/ml.
At 3 hr the fluid were replaced with GMEM-M containing 10 uCi/ml
35S methionine. After a further 30 min at 37°C the cultures were
washed, fixed with TCA, and processed for TCA soluble and insoluble
35 3radioactivity (section 2.2.8). S to H spillover was negligible.
3
□  DNA content, H cpm per culture
35V methionine pool size, TCA soluble S cpm 
per culture
35A protein synthesis, TCA insoluble S cpm 
per culture
2 3
In each case the controls are: [3 , 10 ' u/ml interferon but no 
poly rl.rC; ■  , "mock-interferon" and 50 yg/ml poly rl.rC;
II , "mock-interferon" and no poly rl.rC.
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each experiment, however, the range of triplicates was usually of the order 
of 10% of the mean. The variation from experiment to experiment was not 
accounted for.
There is thus a significant proportion of cells (50-70% of cell 
protein) which resists the toxic effects of 300u/ml interferon and 50pg/ml 
poly rl.rC. This could be due to insufficient interferon or poly rl.rC
fc
being present to interact with every cell, or to a real difference in the 
response of individual cells to interferon and dsRNA. It was necessary to 
exclude the former explanation.
The dose of interferon was adequate to protect all the cells against
virus infection. Fig. 18a shows the results obtained when the interferon
used for the toxicity experiments was titrated with SFV as challenge virus.
There was no detectable viral RNA synthesis at 300 u/ml, indeed only 0.7 u/ml
were needed for the 50% end point. Immunofluorescence shows that infection 
tttu Mp**-
at-trrrs multi pi icityiis total (K.B. Logan and J.A.C., results not shown), 
so, to prevent viral RNA synthesis, treatment with 300 u/ml of interferon 
must be protecting every cell.
Increasing the interferon dose further did not increase the toxicity 
of dsHNA (Fig.19b; Fig.17)* although the effect was dose dependent. Even 
20000 u/ml did not lead to complete toxicity, so it is clear that interferon
was not limiting.
The dose of poly rl.rC was shown to be adequate by two experiments. 
Firstly, the dose could be increased to 200 pg/J4+ without increasing toxicity - 
indeed, as little as 12.5 pg/ml was needed for the full effect (Fig. 19). 
Secondly, exposure of the resistant cells to a second treatment with 50 pg/ml 
poly rl.rC did not increase the toxic effect (Table 6). Additionally, limited 
toxicity is not due to the choice of poly rl.rC as the dsRNA, because 
Penicillium chrysogenum dsRNA (50 pg/ml) caused 44% loss of protein in an 
experiment in which poly rl.rC (50 pg/ml) caused 51% loss.
These results show that the resistant population is probably resistant 
because of a physiological difference between these cells and the sensitive
FIG.18. Effect of interferon concentration on antiviral effect
and cytotoxic effect.
Cultures of L929 cells were treated with different dilutions of 
the same interferon stock. After 18 hr the cells were treated 
with 50 pg/ml poly rl.rC as usual or challenged with SFV (section 
2.2.5).
(a) Viral RNA synthesis as a percentage of controls treated with 
"nock-interferon". Comparison of this assay, and similar ones, 
with the antiviral effect of the NIH mouse standard interferon 
enabled calculation of the interferon concentration used, as 
given in the abscissa.
(b) Resistance to the cytotoxic effect, expressed as the protein 
remaining 3.5 hr after poly rl.rC treatment, relative to controls 
using 10^*3 u/ml interferon but no poly rl.rC, "mock-interferon" 
and poly rl.rC, or "mock-interferon" alone.
% 
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FIG.19. Effect of poly rl.rC concentration on cytotoxic etfect
Cells were treated with 102*3 u/ml interferon or "mock-interferon" 
for 18 hr and then with poly rl.rC at various concentrations. At 
3.5 hr the cultures were washed and protein estimated as usual. 
The error bars show the range of duplicate cultures.
O interferon treated 
"mock-interferon" treated

TABLE 6. Effect of second exposure to poly rl .rC on cell numbers.
treatment of culture
cell number 
culture 
(x IQ-6)
per
interferon
poly rl.rC concentration(pg/ml )
at 7.0 hrovernight 0-1 hr 3.5-4.5 hr at 3.5 hr
2 3
1(T# u/ml 0 0 1.70 1.86
50 0 0.322 0.312
50 50 - 0.294
100 0 0.256 NDa
"mock" 0 0 1.84 1.93
50 0 1.82 1.99
50 50 - 1.87
100 0 1.77 ND
Cell cultures were treated with interferon or "mock-interferon" for 
14 hr before washing and challenging with poly rl.rC at 0.50 or 
100 ug/ml for 1 hr. • After a further 2.5 hr in serum-free medium 
the cultures were washed and either trypsinised for counting or 
treated again with 0 or 50 pg/ml poly rl.rC for 1 hr. Cultures 
trypsinised at 3.5 hr or 7 hr were counted with an electronic 
cell counter (section 2.2.9). Each result is the mean of triplicate 
cultures.
a) ND = not determined.
5.4. CHARACTERISTICS OF THE RESISTANT POPULATION
The population of cells resistant to the toxic effect is active in 
RNA and protein synthesis, provided that the results are normalised with 
respect to the total protein present.
In the same experiment that monitored DNA and protein loss (Fig. 16), 
RNA and protein synthesis rates and precursor pool sizes were measured 
(Fig. 20). There were some changes in the rate of protein synthesis in 
control cultures after 4 hr which were countered by corresponding changes 
in the pool size; with increased synthesis depleting the pool. This is 
consistent with the finding that methionine transport is passive (not 
inhibited by iodoacetic acid and sodium cyanide) and that inhibition of 
protein synthesis allows pool expansion (data not shown). These long term 
changes are thus probably actual changes in protein synthesis rates, and 
may represent recovery from the removal of serum. On the other hand, the 
parallel loss of acid soluble and insoluble radioactivity at early times 
in the treated cultures, does not represent the inhibition of protein and 
RNA synthesis, but the loss of cells (Fig. 16). The resistant cells are 
clearly still synthesising protein and RNA (see also Fig. 17).
The culture can be fractionated at 3.5 hr into resistant cells (present 
on the monolayer), sensitive cells (present in the washes) or total cells
3
(complete culture, harvested without washing). When labelled with H uridine 
from 3 to 3.5 hr, the radioactivity in the total culture was due entirely 
to the resistant cells, and no radioactivity was found in the sensitive cells 
(Table 7). When the specific activity of the resistant cells is compared to 
that of the control cultures, the resistant cells are found to have been 
synthesTsing RNA at the control rate.
In any of the metabolic parameters studied, there were no significant 
differences between the resistant cells and control cells. Experiments were 
performed to guage viability over longer times.
FIG.20. Changes in RNA and protein synthesis after poly rl.rC
treatment.
Parallel cultures to those used before (Fig. 16) were treated with
interferon and poly rl.rC as required. At various times after
treatment the medium was removed and replaced with GMEM-M containing
5 pCi/ml 35S methionine and 10 pCi/ml 3H uridine for 30 min at 37°C,
before washing with PBS and fixing in TCA. Samples of TCA soluble
and insoluble material were prepared for scintillation counting
3 35(sections 2.2.8 and 2.7.2) and H counts corrected for S spillover.
35 35Each graph shows:O, acid soluble S cpm; •  , acid insoluble S cpm;
3 3
□  , acid soluble H cpm; and ■  , acid insoluble H cpm, corrected
for sample size to cpm per culture. Each point is the mean of
duplicate cultures, and is plotted against the time of the start of
the 30 min pulse.
(a) interferon and poly rl.rC treated
(b) interferon treated >
(c) “mock-interferon" and poly rl.rC treated
(d) "mock-interferon" treated.

TABLE 7. RNA synthesis by resistant and control cells.
Treatment 
of cells
Fraction of 
culture
Acid insoluble 
cpm per 
culture 
(x IO'3)
pg protein 
per
cui ture
cpm/pg
protein
interferon 
and polyrl.rC total a 85.5 305 280
monolayer b 100.6 202 501
c
washes 4.5 NDd ND
interferon total 209.7 305 687
monolayer 241.1 353 684
washes 8.8 ND ND
"mock- total 264.9 316 840
interferon" monolayer 318.4 380 838
and polyrl.rC washes 3.4 ND ND
"mock- total 217.6 340 647
interferon" monolayer 255.1 370 694
washes 7.2 ND ND
Cells were treated with interferon and poly rl.rC as required. At 3.0 hr, 
the medium was supplemented with H uridine to a final concentration of 
10 pCi/ml. At 3.5 hr the cultures were either solubilised with SDS .added 
to a final concentration of 1%, or were washed to separate the dead cells 
and debris (in the’ washes) from the resistant cells (on the monolayer) .Each 
fraction was TCA precipitated and washed three times with 10% TCA. The 
monolayer cells were washed in the glass vial; the wash fraction and SDS- 
treated total culture were washed by centrifugation. After one ethanol 
wash, the fractions were dried and solubilised in alkali for protein 
estimation and scintillation counting.
Results given are means of triplicate determinations.
a) "Total" culture solubilised with SDS before acid precipitation
b) "Monolayer": cells remaining attached to the glass after 3 PBS 
washes. Notice that the recovery of protein and. cpm in the "total" 
fraction is 81-84% of that recovered in the "monolayer" and "wash" 
fractions, presumably because SDS interferes with the precipitation. 
This does not alter the specific activity.
c) "Washes" : cells and debris removed by the 3 PBS washes.
d) ND * not determined.
When the protein content or cell number of treated cultures 24 hr 
after dsRNA treatment were compared with those 3.5 hr after treatment, 
the values were the same or slightly higher. These results were found 
in several experiments, whether or not serum was added at 3.5 hr (data 
not shown).
When the resistant cells were trypsinised at 3.5 hr and seeded in 
fresh medium, two different results were found, according to the seeding 
density.
In the experiment described in Table 8, the cells were seeded at 
4 2high density (5-10 x 10 cells/cm ) in tissue culture flasks. The resistant
5 2
cells took 3 days to reach confluence (about 3.3 x 10 cells/cm ) whereas 
the control cultures took 2 days. This suggests that the resistant and 
control cells were equally viable, because about 30» fewer cells were seeded 
for the resistant cultures. In the next passage, resistant and control 
cultures took equal times to reach confluence and the numbers of cells 
harvested from each flask were similar.
On the other hand, when resistant and control cells were seeded at
2
low density (about 50 cells/cm ), differences in their ability to form 
colonies were detected (Fig. 21). However, the inhibition of plating was 
interferon specific, and not dependent on both interferon and dsRNA, so 
might result from a growth inhibitory effect of interferon (Paucker et al 
1962) or from a toxic contaminant in the interferon preparation. There was 
no more than a two-fold difference between interferon-treated cultures 
exposed to dsRNA and interferon-treated controls, as expected from the 
relative amounts of protein in the cultures (Fig. 21).
It thus seems that the cells surviving interferon and dsRNA treatment 
are capable of growth and division. By contrast, it is clear that by 
3.5 hr after treatment the sensitive cells have lysed. When the washes 
(containing the remains of the sensitive cells) were centrifuged at low 
speed, only 5051 of the protein sedimented, whereas more than 90% of the small
FIG.21. Plating efficiency of cells exposed to interferon and
dsRNA.
Cultures of cells were treated with interferon and then with poly rl.rC,
or under control conditions, as usual. After 3.5 hr, the cultures were
washed three times with PBS and either fixed with TCA or trypsinised.
Fixed cultures were used to determine the protein content. Trypsinised
cells were diluted in GMEM/10% FBS and seeded into duplicate 50 mm petri
-3 -4dishes so that each dish contained 1.6 x 10 or 1.6 x 10 of the cells
from one 25 mm vial culture. After 7 days at 37°C the dishes were 
drained, fixed with 4% v/v formaldehyde in 0.9% w/v saline, and 
stained with 1% w/v gentian violet in 20% v/v ethanol. All the colonies 
were about the same size. About 100 colonies were counted on the dish 
of suitable dilution, and the colony number corrected for the dilution 
to "colony forming units per culture".
(a) Protein content in mg protein per culture. Means of duplicates.
(b) Colony forming units per culture. Results shown are means and 
standard deviations of 5 petri dishes per treatment (duplicate 
dishes from each of 3 initial cultures). In each case the 
treatment conditions were: A, interferon and dsRNA; B, interferon; 
C, "mock-interferon" and dsRNA; and D, "mock-interferon".
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amount of protein released from control cultures was sedimented. When the 
washes were screened for large particles in an electronic cell counter, 
only 3% of the number of cells lost from the monolayer were countable 
(data not shown).
The time course of interferon production was determined in several 
experiments (Fig. 22). The maximum yield is equivalent to about 50u/10^ 
cells. Slightly more interferon is produced if the medium is replaced at 
hourly intervals, and the production is not affected by the presence or 
absence of serum (J. Morser and J.A.C., results not shown). Very little 
interferon was produced after the period of cell death (Fig. 22), suggesting 
that the cells respond to dsRNA either by dying (sensitive cells) or by 
producing interferon (resistant cells), or alternatively, that interferon 
is produced by the sensitive cells before they die. These alternatives 
were not distinguished by these experiments.
iiH M H U m l
FIG.22. Kinetics of interferon induction.
Petri dish cultures of L929 cells were treated with 200 u/ml 
interferon and 50 yg/ml poly rl.rC as described (section 2.2.6). 
Interferon was collected in 2 ml medium and treated at pH2 
before assay (section 2.2.5). Cumulative interferon production 
has been converted to international units per ml (u/ml) and 
is plotted on a log scale. "Undetectable" interferon production 
means that no antiviral effect was detected at 10° dilution, 
implying a titre of less than -1 log(u/ml). The maximum titre 
2
of 10 u/ml corresponds 200 u per petri dish culture, or about 
50 u/106 cells.
O  primed cells 
□  unprimed cells

5.5. BIOLOGICAL BASIS FOR THE TWO POPULATIONS
Attempts were made to determine the difference between the cells 
resistant to, and the cells sensitive to, treatment with interferon and 
poly rl.rC.
Firstly, the observation was repeated in another type of mouse 
L cells. LA9 is a mutant cell line isolated in 1964 (Littlefield 1964) 
which is widely used in cell fusion and genetic studies. Its genotype 
is probably very different from L929, LA9 having a mean chromosome count 
of 52-56 compared with 65-66 for L929 (the diploid number for mouse cells 
is 40). This batch of LA9 cells was only 2-fold less sensitive to the 
antiviral effects of interferon than L929 (H. Graves and A. Meager, personal 
communication 1976). When the two stains were compared in the toxicity assay, 
both were equally sensitive to dsRNA, suggesting that a resistant population 
is also present in LA9.
The effect is also constant during passage of L929. Cultures were 
started from the same frozen stock at different times, and one batch eleven 
passages from stock was compared with another batch two passages from stock, 
in the same experiment. They showed 38* and 45% toxicity respectively.
These results do not discriminate between a genetic and a phenotypic 
basis for resistance, because resistance to interferon and dsRNA would 
presumably be selectively neutral under normal culture conditions. Table 8 
shows an experiment in which the cells surviving interferon and dsRNA treatment 
were cultured for 9 days and then tested for resistance to the toxic effect. 
There are no clear differences in toxicity dependent on both interferon and 
dsRNA, as would be expected if resistance was inherited as a simple genetic 
marker with a normal reversion rate (Meiss and Basilico 1972). There may 
be, however, some differences which are interferon dependent, perhaps because 
of a residual effect of interferon treatment (although the antiviral effect 
fully decays over the time interval involved, Paucker and Cantell 1963).
TABLE 8. Test for inheritance of resistance to the cytotoxic 
effect.
selection procedure resistance of "selected" < 
to cytotoxic effect (%)
interferon and poly rl.rC 72
interferon 70
"mock-interferon" and poly rl.rC 56
"mock-interferon" 56
Vial cultures were set up and treated as usual, with interferon and 
poly rl.rC or under control conditions. Parallel cultures showed 
about 30% loss of protein (i.e. 70% resistance), 3.5 hr after 
poly rl.rC treatment. At 3.5 hr the cultures were washed to remove 
debris and trypsinised. The cells from the duplicate vials
corresponding to each treatment were pooled and transferred to a
2
25 cm tissue culture flask. After 3 days the cells from each flask
2
were passed to a 150 cm flask, and after a further 4 days about 
50 x 10^ cells were recovered from each and used to set up 25 mm 
vial cultures. These "selected" cells were used for assaying resistance 
to interferon and poly rl.rC. Treated cultures were compared with controls, 
3.5 hr after treatment.
The Table shows the % resistance to interferon and poly rl.rC related 
to the past history of the cells.
Cells in culture show phenotypic variation due to the cell cycle.
In an unsynchronised culture, some cells will be at each stage of the 
cycle, but in confluent, resting, fibroblasts, most cells enter a stage 
called GO (Holley 1975). As L929 cells are transformed it is possible 
that they lack this degree of growth control, and heterogeneity may exist 
even in confluent cultures.
The cytotoxic effect was observed in cultures synchronised by the 
double thymidine block procedure (Lee and Rozee 1970). Interferon was 
present at all times until the cultures were treated with dsRNA, thus 
ensuring that all cells had been exposed to interferon at all stages of 
the cycle. The only variable was the stage of the cycle at which dsRNA 
was added.
These cells have a doubling time of 17-18 hr and reach confluence 
at about 1.5 x 10° cells/vial culture (3.3 x 10 cells/cm ) when they 
grow only slowly (results not shown). A preliminary experiment suggested 
that synchronising confluent cells would be unsuccessful, only a part of 
the cycle being completed. The experiment was thus performed using non­
confluent cells, and required two controls - that the time of interferon 
treatment was not important, and that the toxic effect did not vary with 
cell density. Firstly, interferon treatment for 4 hr was just as effective 
as treatment for 24 hr (39% and 42% toxicity respectively). Secondly, 
there was only slight variation of toxicity with cell density (Fig. 23), 
ranging from 51% toxicity in sparse cultures to 36% in confluent cultures.
Any variation found in synchronised cells could thus be attributed 
to the cell cycle and not to the length of interferon treatment or to the 
cell density. The cell cycle was monitored by DNA synthesis rate (Fig.24a) 
and mitotic index. The first S-phase peaked at about 2 hr, and the second 
sometime between 12 and 18 hr. Mitosis occurred between 6 and 8 hr.
Throughout the cycle the cytotoxic effect lay within 10% of the unsynchronised
FIG.23. Cytotoxic effect measured at different ceil densities.
Cells were seeded into 25 mm glass vials at 2, 4, 6 or 8 x 10 
cells/culture. After 2 days the cultures were treated with 
interferon for 16 hr and then with poly rl.rC.and the protein 
content measured 3.5 hr after treatment as usual.
(a) seeded at 8 * 105 cells/culture, confluent when treated 
with poly rl.rC.
(b) seeded at 6 * 105 cells/culture, not confluent
(c) seeded at 4 x 105 cells/culture, not confluent
(d) seeded at 2 * 105 cells/culture, not confluent
In each case the protein content after four different treatments is 
shown. A, interferon and poly rl.rC; B, interferon; C, “mock-interferon" 
and poly rl.rC; and D, "mock-interferon". Note the different scales.

value, whether calculated relative to all the controls (Fig. 24b), or just 
the "interferon only" cultures.
It is clear that there is no all-or-none dépendance of cytotoxicity 
on the stage of the cell cycle at which dsRNA is added.
These experiments would seem to eliminate the most straightforward 
explanations for resistance, but cannot rule out a dépendance on some 
combination of genotype and phenotype.
¿¿lliiWl**!!
FIG.24. Cytotoxic effect in synchronised ceils
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25 mm vials were seeded with 1 x 10 cells/culture and left to grow 
for 24 hr. The medium was then replaced with GMEM/10% FBS containing
2.5 mM thymidine (Lee and Rozee 1970) for 20 hr. The fluids were 
removed and the cultures washed with GMEM before adding GMEM/10% FBS 
containing interferon or "mock-interferon". After 10 hr, the second 
thymidine block was applied, with interferon or "mock-interferon" 
again present in the medium.
After 18 hr the fluids were removed, the cultures washed, and fed 
with GMEM/10% FBS containing interferon or "mock-interferon". As 
required, cultures were drained, and either used to determine DNA 
synthesis, or washed free of serum and treated with poly rl.rC for
3.5 hr before washing and estimating protein content. Cultures were 
also stained to estimate mitotic index (section 2.2.9).
3
(a) TCA insoluble H cpm per culture after 15 min with 5 pCi/ml 
3H thymidine. No samples were taken between 12 and 18 hr.
O  interferon treated
>
□  "mock-interferon" treated
(b) % resistance to interferon and poly rl.rC, expressed as the 
ratio of mean protein content of duplicate treated cultures, 
and the mean protein content of duplicate cultures treated 
with interferon alone, "mock-interferon" and poly rl.rC, or 
"mock-interferon" alone. Each point shows % resistance 
plotted against time of addition of poly rl.rC.
u = unsynchronised cells seeded at the same time as the 
synchronised cells.

5.6. SEARCH FOR SPECIFIC CHANGES EARLY IN THE CYTOTOXIC EFFECT
The problem of detecting early biochemical changes in interferon and 
dsRNA treated cells is complicated by the observation that about 60'S of 
the cells resist the toxic effect. Any changes detected could not be 
assigned unambiguously to one population rather than the other. However, 
it was possible that all the cells would initially respond in the same 
way, with the resistant population then "recovering" from the change.
It was possible that changes in ion transport might be important, 
particularly as interferon treatment alters the level of cAMP in the cell 
(Weber and Stewart 1975), which is known to modulate membrane functions 
(Korinek et al 1973). Transport changes have been implicated as inhibitors 
of protein synthesis in virus infected cells (L. Carrasco, personal coirmuni cation 
1976), and in the pleiotypic response of fibroblasts to serum concentration 
and contact inhibition (Foster and Pardee 1969; Rubin 1975; Cunningham and 
Pardee 1976). Accordingly the rapid transport of rubidium, calcium, and
orthophosphate were studied using radioactive tracers.
86Rb influx and efflux were linear over the time period studied (Fig.25).
No differences were found in the 30 min period following dsRNA treatment or
the period following dsRNA removal (efflux only, results not shown). The
86equilibrium levels of intracellular Rb remained constant during dsRNA 
treatment.
45It was not possible to measure the rate of Ca influx, because it
rapidly reached equilibrium levels. However, when the cells ware loaued with
45Ca during the interferon treatment period, and transport out measured during
the first 30 min of dsRNA treatment, the results of Fig. 26 were obtained.
Again, no differences between treated and. control cultures were found, with
45
about 70-75% of the intracellular Ca released by 30 min, with a half-time 
of 2 to 5 min. Only 15-25% of the label was released at 0°C. At all times
*
Experiments performed in collaboration with J. Mörser.
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FIG.25. Rubidium transport kinetics
(a) Rubidium uptake. Vial cultures were treated with interferon
or "mock-interferon" as usual. After washing to remove serum, GMEM(Hepes)
86
containing 0 or 50 yg/ml poly rl.rC and 43 pCi/ml RbCl was added. As 
required, the cultures were transferred to melting ice and rapidly 
washed three times with cold PBS, before extracting with cold 10% TCA.
An aliquot of the acid soluble material was counted and the cpm 
corrected to cpm per culture (about 1.6 x 106 cells). The intracellular 
Rb content was calculated from the specific activity of the isotope.
Each point is the mean of duplicate cultures.
•  interferon and poly rl.rC 
O  interferon
■  "mock-interferon" and poly rl.rC 
□  "mock-interferon"
(b) Rubidium efflux. Vial cultures were treated with interferon or 
"mock-interferon" in GMEM/2% CS containing 10.8 yCi/ml ®^RbCl for 18 hr 
and then transferred to ice. The vials were washed free of serum and 
isotope, warmed rapidly to 37°C and treated with 0.5 ml of GMEM(Hepes) 
containing 0 or 50 yg/ml poly rl.rC. At various times the fluids were 
removed and later sampled for scintillation counting. The cpm have been 
corrected for sample size to cpm per culture (about 1.6 x 106 cells),
or as a percentage of the TCA soluble cpm initially present in the 
cultures (equivalent to about 2.9 nmoles Rb/culture).
Each point is the mean of duplicate cultures 
•  interferon and poly rl.rC 
O interferon alone
"Mock-interferon" treated cultures gave similar results.
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FIG.26. Calcium transport kinetics.
Calcium efflux was measured as described for rubidium (legend to Fig.25b) 
except that the medium contained 5.5 pCi/ml 45CaCl2- The cpm in the 
extracellular fluids have been converted to cpm per culture (about 
1.6 x 10® cells), or as a percentage of the total cpm initially present 
in the cultures (equivalent to about 5 nmoles Ca per culture).
Each point is the mean of duplicate cultures.
•  interferon and poly rl.rC 
O interferon
B  "mock-interferon" and poly rl.rC 
□  "mock-interferon"
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Vabout 15-20* of the intracellular label was acid insoluble, presumably 
bound either to the glass or to macromolecules, but this fraction freely 
exchanged with acid soluble label. None of these parameters altered with 
the treatment of the cultures.
A C  O C
Whereas the Ca and Rb experiments were performed in complete
medium, phosphate influx was measured in medium containing about 450 pM
phosphate. Under these conditions the toxic effect was not reduced (59%
in low phosphate, 60% in complete medium). There were no significant 
32differences between P influx in interferon and dsRNA treated, and in 
control cultures (Fig. 27).
Any attempts to extend these observations to longer times would be
complicated by cell loss from the treated cultures.
When macromolecular synthesis rates and precursor transport were
studied, the most conspicuous effects were due to cell loss (Fig. 17, 20).
3
If the cultures were labelled from 3 to 3.5 hr with H uridine, and the 
3.5 hr washes pooled and acid precipitated, the released cell debris could 
be shown to have no RNA synthetic ability (Table 7). The fractionation 
into monolayer and washes could thus be used to study macromolecular 
synthesis in the sensitive cells, without interference from the resistant 
cells.
Cultures were labelled for various periods of time, starting at
different times after dsRNA treatment, but all pulses were stopped at 3.5 hr,
when the cultures were separated into monolayer and wash fractions, and
acid insoluble incorporation determined. Using this protocol, any disturbance
of the cells between 1 and 3.5 hr was avoided, so all the sensitive cells
should be present, as debris, in the wash fraction. _
3 “
Fig. 28 shows the results when H uridine was used. The cellular
35protein was previously labelled with S methionine so that the protein 
content of the wash fraction could be determined. In this experiment, 37% 
of the protein was recovered in the 3.5 hr washes, and less than one-tenth
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FIG.27. Orthophosphate transport kinetics
Phosphate uptake was measured as described for rubidium (legend to 
Fig.25a) except that GMEM-P was used so the medium contained 
30 yCi/ml "^P orthophosphate and 450 pM total orthophosphate. At 
various times TCA soluble and insoluble cpm per culture were 
determined, and converted to moles orthophosphate per culture 
(about 1.6 x 106 cells).
Results are means of duplicate cultures.
#  interferon and poly rl.rC 
O interferon
9  "mock-interferon" and poly rl.rC 
□  "mock-interferon"
The broken line shows the incorporation into acid insoluble material, 
which was approximately the same for each of the four treatments.
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of this was removed with the dsRNA at 1 hr. The results (Fig. 28a) show 
that RNA synthesis was approximately linear in the control cultures, and 
also in the monolayer fraction of the interferon and dsRNA treated cultures 
(i.e. the resistant population). The rates expressed relative to the amount 
of protein present are all similar. However, incorporation into the wash 
fraction of the interferon and dsRNA treated cultures (i.e. the sensitive 
population) is not linear, but the rate decreases markedly over the 3.5 hr 
period (Fig. 28b). If this change were due to increased degradation, rather 
than decreased synthesis, of RNA, the curve should be convex, rather than 
concave.
When the rates for cwo such RNA synthesis experiments and two protein 
synthesis experiments were compared (data not shown), it was clear that the 
sensitive cells were 50-100% as active as control and resistant cells, at 
least for the first hour of treatment. It was only in the second and 
third hours that a marked reduction in rate occurred (10-50% and 2-15% of 
controls, respectively), and this is the time when cell loss commences. It 
seems highly unlikely, therefore, that inhibition of RNA or protein synthesis 
precedes cell death, and more likely results from the disintegration of the 
cell structure.
It was possible that transient changes in protein synthesis would 
correlate with toxicity, in view of the results of Kerr et al (1974b). When
OC
cultures were labelled with S methionine for 5 min periods during the 
first hour of dsRNA treatment, there were no differences between interferon- 
treated and control cultures (data not shown).
Attempts were also made to detect qualitative changes in macromolecular 
synthesis. When cultures, labelled with uridine 0 to 0.75 hr or 3 to 
3.75 hr after dsRNA treatment, were extracted with phenol and chloroform 
and the RNA sedimented on sucrose gradients, profiles showing peaks of 
4-5S, 18S and 28S material superimposed on a background of heterogeneous, 
unprocessed, material were obtained. The profiles were identical for 
treated and control cultures (data not shown).
FIG.28. RNA synthesis during the cytotoxic effect.
Vial cultures were treated with interferon and poly rl.rC as usual.
3
At various times, H uridine was added to the medium to a final 
concentration of 10 yCi/ml, and was left on the cells until 3.5 hr, 
when all the cultures were washed three times with PBS. The washes 
were pooled, and the washes and the monolayer were washed three times 
with TCA and once with ethanol. The dried precipitates were solubilised 
and counted.
35Parallel cultures, which had been labelled beforehand with S methionine 
(2.5 pCi/ml in GMEM-M for 30 min at 37°C), were also treated with
3
poly rl.rC but not with H uridine. The resulting monolayers were 
solubilised in alkali and used for Lowry protein estimation. The
OC
S radioactivity, which was precipitated with TCA from the wash 
fractions, was used to estimate the protein content of the wash 
fractions relative to the monolayer fractions.
3
In the Figure, acid insoluble H cpm per culture is plotted against the
o
time of the start of the H uridine labelling period for • ,  interferon 
and poly rl.rC; O , interferon; B  ,"mock-interferon" and poly rl.rC; 
and □  , "mock-interferon" treated cultures. Each point is the mean 
of triplicate cultures.
(a) Monolayer fractions. Protein contents (Lowry) were 253, 339, 410, 
and 443 pg/culture respectively.
35(b) Wash fractions. Protein contents (from S cpm) were 145, 51, 52, 
and 34 pg/culture respectively.

interferon is produced (Fig. 22). To see whether this resulted from gross
changes in the pattern of proteins synthesised, cultures were labelled with
35high specific activity S methionine between 0.5 and 1 hr (to label both 
sensitive and resistant cells), or from 3 to 3.5 hr (to label the resistant 
cells). The cultures were acid precipitated, solubilised, treated with 
nucleases, and the proteins separated by isoelectric focussing and SOS 
polyacrylamide gels (O'Farrell 1975). Fig. 29 shows autoradiographs of 
the dried gels. Although a distinctive pattern of spots is visible, there 
were no changes induced by the different treatments of the cells. The 3.5 hr
i
wash samples (containing debris from the sensitive cells and interferon) 
were also analysed, but no spots could be seen on the autoradiographs.
One specific change is known to occur during the cytotoxic effect -
; i g .29. Tne pattern of proteins synthesised early in the cytotoxic effect.
26 mm vial cultures of cells were treated with 200 u/ml interferon and 
50 pg/ml poly rl.rC, as usual. 30 min after poly rl.rC treatment the 
cultures were washed with GMEM-M, drained, and 0.5 ml GMEM-M, containing 
¿50 pCi 3aS methionine, added. After a further 30 min at 37°C the cultures 
'were wasned three times each with PBS, 10% TCA, ethanol, and ether, and 
allowed to dry.
Analysis of labelled proteins was basically according to O'Farrell (1975).
Each mpnolayer was scraped into 100 pi of solution B, sonicated, treated 
with DNAse (buffer C), and then with solution A and solid urecl. The main 
differences from O'Farrell's procedure were that SDS was also added to 
0.1% before applying to the isoelectric focussing gels, and these were 
run with the acid in the top reservoir (to minimise interference from 
oligonucleotides). The isoelectric focussing gels were equilibrated with 
SDS before laying across a 7.5-30% gradient polyacrylamide slab with a 
stacker (section 2.5.2). After electropnoresisthe slabs were stained 
and dried down (section 2.6.3) for autoradiography.
5 day autoradiographs for A, interferon and poly rl.rC; B, interferon;
C, "mock-interferon" and poly rl.rC; and D, "mock-interferon" treated 
cultures are shown. The pH gradient was from a parallel isoelectric 
focussing gel. The molecular weight markers were; 165 K daltons, thyroglobulin 
L‘b K, phosphorylase A; 77 K, transferrin; 68 K, BSA; 45 K, ovalbumin; 34 K, 
carbonic anhydrase; 15.5 K, myoglobin. The antiviral effect of L929 cell 
interferon ran as 3 peaks on isoelectric focussing gels with isoelectric 
points of 5.60, 6.45, and 7.1, and as 2 peaks on SDS gradient gels with 
apparent molecular weights of 32. K and 25 K daltons (data not shown).
Experiments performed by J. Morser.
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5.7. DISCUSSION
When either LA9 or L929 cells are treated with interferon and dsRNA 
there is rapid and extensive cell death. However, in both cell types, a 
significant proportion (50-70%) of the cells remain attached to the 
substratum and continue macromolecular synthesis. These cells remain 
viable for at least 24 hr, whereas the sensitive cells are released into 
the medium as subcellular debris. The proportion of sensitive cells cannot 
be increased by increasing the dose of interferon or dsRNA, or by repeated 
administration of dsRNA, and is independent of the length of interferon 
treatment.
Stewart et al (1972a) have described the cytotoxic effect as involving 
total destruction of the cell monolayer. However, this corresponds to 8% 
trypan blue excluding cells and 29% residual neutral red stain incorporation. 
In Fig. 15 I compare neutral red stain incorporation with protein estimations 
and find a similar proportion (37%) of residual stain incorporation. It 
would seem, therefore, that there may be a resistant population in all 
L cell stocks. The precise proportion depends upon the assay used, and 
may be minimised by counting trypan blue excluding cells after trypsinisation, 
and maximised by^  the protein assay described here.
Recognising that cells may be sensitive or resistant to the toxic 
effect raises several interesting questions.
Firstly, what decides whether a particular cell is sensitive or 
resistant? The results presented here rule out simple explanations based 
on stable inheritance of resistance, cell density, or on stage of the cell 
cycle (Table 8, Figs. 23,24). However, the effect is not sufficiently 
reproducible to exclude small variations with any of these parameters, and 
a combination of phenotypic and genotypic factors could be important.
It is not known whether the resistant/sensitive decision is made 
before interferon treatment, during interferon treatment, or during dsRNA 
treatment. An interferon-treated cell could adopt one of two states; one
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in which it will be sensitive to dsRNA, or one in which it will be resistant.
On the other hand, the decision may only be made after dsRNA treatment.
These alternatives cannot be distinguished until some method of separating 
the two populations before cell death can be found.
Secondly, do the sensitive or the resistant cells produce interferon?
A variety of different methods for superinducing the interferon response 
(Tan et al 1970) involve procedures which cause extensive cytopathic effects. 
The data in Fig. 22 do not discriminate between production by the sensitive 
or by the resistant cells, because the bulk of synthesis occur during the 
period of cell death. Unfortunately, without a way of separating the two 
populations before dsRNA treatment, it is not possible to distinguish the 
alternatives.
Thirdly, the question of what triggers the toxic effect remains 
unanswered. Stewart and his colleagues have described the ultra-structural 
changes as involving alterations in nuclei, mitochondria and microfilaments 
(Heremans et al 1976). However, at this time, signs of lysosomal activation 
are evident (W. E. Stewart II., personal communication 1975), and the 
changes are probably the result, rather than the cause, of toxicity. The 
initial interaction with dsRNA must be at the membrane, and a membrane 
trigger for toxicity cannot be excluded, particularly in view of the changes 
in cAMP levels during interferon treatment (Weber and Stewart 1975). We 
were unable to show any changes in ion or precursor transport (Figs. 25,
26, 27, 17, 20) as might have been expected if action was directly at the 
membrane. No significant differences in macromolecular synthesis, quantitative 
or qualitative, were seen (Figs. 17, 20, 28, 29). However, as long as the 
toxic effect is only partial the sensitivity of the experiments is limited, 
and even if changes could be detected, their relevance in a causative chain 
of events would need to be established.
SECTION 6
PREPARATION AND CHARACTERISATION OF A 
CELL-FREE PROTEIN SYNTHESISING SYSTEM 
FROM MONOLAYER GROWN L929 CELLS
6. PREPARATION AND CHARACTERISATION OF A CELL-FREE PROTEIN SYNTHESISING 
SYSTEM FROM MONOLAYER GROWN L929 CELLS.
6.1. INTRODUCTION
L929 cells can be selected to grow either in monolayers or in suspension. 
Whereas the suspension cells are convenient for experiments where large 
numbers of cells are required, and for making cell-free protein synthesising 
systems, the monolayer grown cells are convenient for experiments involving 
repeated media changes, such as investigating virus growth or interferon 
action. It was desirable to obtain a cell-free protein synthesising system 
from monolayer cells, so that biochemical changes could be studied in parallel 
in vivo and in vitro. The most important characteristic of the system was 
that it should reflect the metabolic state of the cells, rather than for it 
to translate added mRNAs with high efficiency.
Standard methods for preparing cell-free systems have been described 
(Eggen and Shatkin 1972). Basically, the cells are collected, washed 
homogenised in a small volume of hypotonic buffer, made to contain suitable 
concentrations of potassium and magnesium ions, and a supernatant fraction 
prepared at 10000 or 30000 g. This procedure was not applicable to the 
monolayer L929 cells in use in our laboratory. Firstly, the rapid cooling 
essential for an active system (Kerr et al 1966) is technically difficult 
for monolayers of cells on glass bottles, particularly when large numbers 
of cells are required. Secondly, and most important, these cells were very 
resistant to most mechanical breakage methods tried. Even after swelling 
the cells in hypotonic buffer, dounce and Potter homogenisers only produced 
low percentage breakage, especially at the high cell densities required. It 
was necessary to use sonication to produce an effective elongating system, 
but this system was defective in initiation (results not shown).
However, non-ionic detergents have been used successfully to rupture 
cells. Austin and Kay (1975) lysed Hela cells using the non-ionic detergent 
Nonidet P-40, and Ball and White (1976) have described a long-lived coupled
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transcription and translation system in which the non-ionic detergent 
Triton N101 is present. It was thus possible that the presence of non-ionic 
detergents would not inhibit protein synthesis.
In addition, the advantages of breaking the cells in isotonic conditions 
have been pointed out (Villa-Komaroff et al 1975). Hela cell S-30s made by 
douncing in isotonic buffer were at least 10 times more active in elongation 
and initiation than extracts made after swelling in hypotonic buffer.
Finally, the description of an active nuclear RNA synthesising system, 
prepared using detergent to lyse cells whilst still attached to the petri dish 
(Tsai and Green 1973), led me to develop the system described below, in which 
cells are rapidly cooled on the dish, lysed in isotonic buffer using a 
non-ionic detergent, and the cytoplasmic fraction is collected and assayed 
without centrifugation.
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6.2. PROCEDURE FOR PREPARING THE CELL-FREE SYSTEM
Phase-contrast microscopy suggested that 0.1% V/V Triton N101 
(polyoxyethyleneglycol (9-10) nonylphenol) in isotonic buffer was adequate 
for lysing L929 cells. It was observed that 50yl of detergent would spread 
to cover most of a 50mm plastic petri dish in about 2 min, lysis being 
virtually instantaneous. Higher concentrations of detergent spread more 
rapidly but were thought to be more likely to inhibit protein synthesis, 
whereas low concentrations spread slowly and did not cause complete lysis.
The nuclei remained intact and attached to thedish even when 1% v/v Triton N101 
was used. Triton X-100 and Nonidet P40 produced slower lysis and were not 
investigated further.
The procedure adopted (see section 2.3.5) was to grow the cells to 
confluence in 140 mm dishes, cool rapidly by transferring to melting ice, 
and then to wash three times, rapidly, with cold PBS before draining and 
washing with the extraction buffer. This was removed, and the dish floated 
horizontally on ice-cold water and five lOOpl aliquots of 0.1% v/v Triton N101 
in extraction buffer applied. After 3 min for the cells to lyse, the dish 
was tipped and the cytoplasmic fraction collected over the next 2 min. This 
was either assayed directly or stored in liquid nitrogen.
The average volume of cytoplasm collected was 650-700pl per dish, with 
a protein concentration of 2.39 - 0.79 mg/ml (mean and standard deviation,
29 extracts). The yield of protein depended on the cell density, but within 
a series of dishes seeded at the same density, the concentration of protein 
was relatively constant. The yield of protein (about 30-40yg/10^ cells) was 
only about 10% of the total cellular protein, so presumably most of the 
cellular protein remained associated with the nucleus or cytoskeleton. The 
protein concentration is probably equivalent to conventional lysis proceedures 
using homogenisation in 10 packed-cell volumes of buffer.
FIG.30. Characteristics of endogenous protein synthesis by
detergent extracts.
Extracts of L929 cells were prepared (section 2.3.5) and assayed 
immediately (section 2.3.6).
(a) Kinetics of protein synthesis. 100 pi incubations contained
O  , 4 pCi of methionine, or □  , 25 yCi of H leucine, 
and unlabelled amino acids,energy supply, and 127 yg extract 
protein. 10 pi aliquots were taken as required for acid 
precipi tation.
(b) Dependance on concentration of extracts. 50 yl incubations
OC
contained 10 yCi of S methionine, unlabelled amino acids 
and energy supply, and various concentrations of extract 
protein, diluted with 0.1* V/V Triton N101 in extraction 
buffer. After 30 min at 30°C, two 10 yl aliquots were 
taken for acid precipitation, and the mean incorporation
found.

TABLE 9. Effects of inhibitors and energy supply on endogenous 
and SFV mRNA stimulated protein synthesis.
Experiment
No.
Additions cpm/5yl % control
endogenous +40yg/ml 
SFV mRNA
endogenous +40yg/ml 
SFV mRNA
1 none 4360 5766 (100) (100)
100 yg/ml 
cycloheximide 477 392 11 7
100 yg/ml 
chloramphenicol 3867 5769 87 100
2 none 2097 3453 (100) (100)
10 mM NaF 730 1114 35 32
no ATP,GTP,CTP 659 ND 31 ND
Incubations contained all the usual requirements for protein synthesis, 
except that nucleoside triphosphates were omitted from one tube in 
experiment 2. Incubations were for 30 min at 30°C, and the average acid 
insoluble incorporation in two 5 pi aliquots is shown.
Experiments 1 and 2 used two different extracts such that experiment 1 
had 59 yg protein/50 yl assay, and experiment 2 had 65 yg protein/ 50 yl
assay.
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6.3 CHARACTERISTICS OF PROTEIN SYNTHESIS
When these cytoplasmic extracts were incubated under conditions
35 3allowing protein synthesis, incorporation of S methionine or H leucine 
into hot acid insoluble material took place with the kinetics illustrated 
(Fig. 30a). After a short lag of 1-2 min, synthesis proceeded more or less 
linearly until 20-30 min when a plateau was reached. Occassionally a small 
reduction in incorporation occurred after continued incubation.
Table 9 shows the effects of some inhibitors on protein synthesis.
There was only slight inhibition when mitochondrial protein synthesis was 
prevented by chloramphenicol, whereas cycloheximide was fully inhibitory.
This suggests that synthesis is occurring on cytoplasmic ribosomes. Synthesis 
was increased by added mRNA and was dependant on an energy supply.
The rate of endogenous protein synthesis is proportional to the amount 
of extract protein used (Fig. 3(^ ). This experiment was performed keeping 
the ionic conditions and the concentration of detergent constant, and the 
magnesium dependance curve was shown to be similar at two different protein 
concentrations (data not shown). Because of the large endogenous pool of 
32S methionine in the extracts (Fig. 32), the dependance of the absolute rate 
of protein synthesis on protein concentration is not linear (Fig. 30), but a 
concave curve.
Both endogenous and SFV mRNA-stimulated protein synthesis rates were
shown to be insensitive to the addition of extra detergent, up to an extra
0.1% final concentration (data not shown).
Fig. 31 shows an experiment in which the optimal ionic conditions for
making the extracts were investigated. A series of dishes of cells were
lysed in buffers of different ionic composition, and assayed for protein
35concentration, and for incorporation of S methionine in the absence and 
presence of added mRNA. The graphs show several features. Firstly, the 
relative rate of protein synthesis is highly reproducible from one dish of 
cells to the next. Secondly, these curves are similar to ones obtained by
Fîg.31. Effect of ionic conditions on activity of detergent extract
Duplicate 140 mm petri dish cultures of L929 cells were lysed in buffers 
of different ionic composition and assayed directly in 50 pi incubations 
containing 9 yCi 35S methionine, 0 or 2 yg SFV mRNA, 35 yl of extract, 
and other components for protein synthesis. After 30 min at 30 C 
duplicate 10 yl aliquots were acid precipitated. Each pair of points 
shows the 35S incorporation per yg extract protein for extracts from 
two separate petri dishes of cells.
(a) lysed in 0 . U  V/V Triton N101, 30 mM Hepes K0H, ImM DTT,
6 mM Mg(00CCH3)2 and various concentrations of KC1.
(b) lysed in 0.1% V/V Triton N101, 30 mM Hepes KOH, 1 mM DTT,
90 mM KC1 and various concentrations of Mg (00CCH3)2.
O  endogenous incorporation
®  incorporation in presence of 40 yg/ml SFV mRNA
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varying the assay, rather than extraction, conditions (data not shown), so 
there were no major irreversible changes due to making the extract under 
different conditions. Thirdly, the magnesium optimum, of about 4 mM in the 
assay, is about the same as that found by other workers using non gel-filtered 
suspension L929 cell extracts (Friedman et al 1972a). The increase in protein 
synthesis with potassium chloride concentration probably reflects an effect 
on elongation of polypeptide chains (Mathews and Osborne 1974), so the 
concentration was kept low to favour initiation (Villa-Komaroff et al 1975).
The conditions chosen for further experiments were 4mM or 6mM magnesium 
acetate (that is, about 3mM or 4mM in the assay mixtures) and 90mM potassium 
chloride (total of 105mM K+ ions, or 75mM in the assays).
The endogenous and mRNA-stimulated rates are low in comparision with 
mRNA-stimulated preincubated extracts, prepared from suspension L929 cells 
by conventional proceedures (e.g. Clegg and Kennedy 1974 obtained 38000 cpm/
5pl aliquot using SFV 25S mRNA). However, these comparisons must be made 
on a molar basis, because the pool sizes of non-radioactive ami noacid in the 
extracts are probably different. Fig. 32 shows the results of an experiment
3
in v/hic'n the methionine pool size was estimated by isotope dilution. H leucine
32
incorporation was not altered by the addition of as much as 8uM S methionine,
OC
but the S methionine incorporation was reduced by half, independantly of
whether endogenous or SFV mRNA-stimulated incorporation was measured. These
results enable the pool size of S methionine in the extract to be estimated
at 10-12uM (Fig.32, and other data),meaning that 0.8 to 0.9 pmoles of
methionine were incorporated per 50yl assay (30 min incubation at 30°C,
endogenous rate). This compares favourably with the 26S mRNA-stimualted
rate found by Clegg and Kennedy (1974), which calculates at about 2 pmoles
per 50ul assay (100 min incubation at 30°C; calculation assumes negligible 
32S methionine present in the gel-filtered extract).

6.4. EFFECT OF ADDED mRNA
Adding total polyA(+) RNA from the cytoplasm of SFV-infected BHK 21
35cells (SFVmRNA) resulted in a stimulation of incorporation of S methionine 
into hot acid insoluble material (Table 9). A 26S fraction of this mRNA 
(26S mRNA) was similarly stimulatory, as was the polyA(+)RNA from rabbit 
reticulocyte polysomes (globin mRNA).
When increasing amounts of 26S mRNA were added to the extract, it was 
found to saturate at a concentration of about 30mM (molecular weight 
1.6-1.8 x 106 daltons) or about 25 pmoles per mg extract protein (Fig. 33).
26S mRNA and globin mRNA were added at near-saturating concentrations, and 
the products analysed on SDS polyacrylamide gels (Fig. 34). Identification 
of the products is rendered difficult by the heterogeneity of endogenous 
products, but the band marked on the 26S mRNA-stimulated track co-electrophoresed 
with SFV capsid protein labelled in infected cells, and the band marked on 
the globin mRNA-stimulated track co-electrophoresed with the endogenous product 
of a reticulocyte cell-free system. Identification on a one-dimensional gel 
is not conclusive, and either two-dimensional separation, peptide mapping, 
antiserum precipitation, or column chromatography (for globin), is required.
This analysis could be facilitated if a more highly labelled product were
t
obtained, for example by using an aminoacid which occurs with high frequency 
in proteins.
The most important conclusion from Fig. 34 is that discrete products 
are made by the system, and that the polypeptides directed by added mRNAs 
resemble the products formed in other systems (see Fig. 1). This shows that 
the detergent extracts can utilise added mRNA and can initiate correctly, but 
it is also clear that some of the stimulation is due to increased incorporation 
into products encoded by the endogenous mRNA.
Two other questions are of interest. Firstly, for how long can the 
extract continue to initiate new polypeptide chains? Secondly, how much of 
the stimulation by added mRNA can be explained by competition for ribonucleases?
FIG.33. Dependance of protein synthesis on concentration of
mRNA
50 pi incubations containing 75 yg of extract protein, 10.9 yCi 
35$ methionine, various concentrations of 26S mRNA, and other 
components for protein synthesis, were incubated for 30 min at 
30°C before taking triplicate 2.5 yl aliquots for acid 
precipitation.

FIG.34 Products of cell-free protein synthesis.
3550 pi incubations containing 27 pCi S methionine, 48 pg extract 
protein, and other components for protein synthesis, were incubated 
with 2 pg of globin or 26S mRNA for 30 min at 30°C. Samples were 
taken for acid precipitation and the remainder treated with RNAse A 
and prepared for electrophoresis (section 2.6.2). The dialysed 
incubations were loaded onto 7.5 - 30% gradient gel, and electrophoresed 
at 14 mA for 18 hr. The gel was impregnated with PPO and fluorographed 
at -70°C for 4 days (section 2.6.3).
A, endogenous products, 22000 cpm loaded
B, 26S mRNA stimulated, 56000 cpm loaded
C, globin mRNA stimulated, 54000 cpm loaded.
The markers, run on parallel tracks, were SFV envelope (single arrow) 
and capsid (double arrow) proteins, and rabbit globin (triple arrow).

6.5. INITIATION OF POLYPEPTIDES
The fact that fluoride inhibits protein synthesis in these extracts 
(Table 9) implies that polypeptide chain initiation is required for continued 
synthesis (Obrig et al 1971) Edeine is a better characterised inhibitor than 
fluoride, and has been shown to inhibit initiation at the stage of 60S joining, 
with excellent discrimination between elongation and initiation (Obrig et al 
1971).
Fig. 35a shows the kinetics of protein synthesis with or without 
SFV mRNA and with various concentrations of edeine. Edeine at 2yM can 
prevent most of the stimulation due to added mRNA. The residual stimulation 
could be due to some of the mRNA entering initiation complexes before the 
edeine inactivates the ribosomes, or due to non-specific effects on 
incorporation by the added mRNA.
Fig. 35b shows the stimulation due to added mRNA when edeine is added
35before the mRNA and S methionine. When 2yM edeine is added 2 to 5 min 
before mRNA, all stimulation is abolished. The fact that all stimulation 
can be inhibited implies that all the stimulation requires peptide chain
initiation.
Experiments were then designed to determine the length of time for
*
which initiation is possible. Two alternative approaches were considered.
Firstly, the time at which edeine could be added and no longer cause 
inhibition would be the time when no new initiation was occurring. However, 
this_would be affected by the stability of mRNA, because the absence of 
initiation could reflect the absence of intact initiation sites.
The alternative approach is to add mRNA and label at different times 
after the incubation is started, and to look for stimulation over the 
endogenous rate. Because all stimulation requires initiation (Fig. 35b), 
the time when added mRNA does not stimulate is the time when initiation is 
no longer occurring. The results shown before (controls in Fig. 35b) 
suggested that this approach would be successful, and that about 50* of
FIG.35. Protein synthesis initiation in detergent extracts
(a,b) Effect of edeine on protein synthesis. Different extracts were
used.
(a) 50 yl incubations containing 99 yg extract protein 10.3 yCi
S methionine, 0 or 2 yg SFV mRNA, and other components for protein 
synthesis, were incubated at 30°C with 0, 1 or 2 yM edeine. 5 yl 
aliquots were taken as required for acid precipitation.
0 yM edeine O  endogenous and •  SFV mRNA stimulated
1 yM □  a
2 yM A A
(b) 100 yl incubations containing 202 yg extract protein and other
35
components for protein synthesis, but lacking S methionine and mRNA,
were incubated at 30°C. At 2 min, edeine was added to 0, 1 or 2 yM
and incubation continued. After a further 15, 60, 120 or 300 s, 10 yl
35
aliquots were removed to vials containing 1.8 yl of S methionine and
water or SFV mRNA. These incubations were continued for a further
30 min, when two 3 yl aliquots were taken for acid precipitation. These
35final incubations contained 440 yCi/ml S methionine and 0 or 40 yg/ml 
SFV mRNA. Incorporation is plotted against the time between addition 
of edeine and addition of isotope and mRNA.ibrO and 2 yM edeine incubations, 
the 1 yM edeine results were intermediate between these.
0 yM edeine; O  endogenous and •  SFV mRNA stimulated 
2 yM A A
(c) Effect of time of preincubation before adding isotope and mRNA on 
stimulation of protein synthesis.
A 400 yl incubation containing 582 yg extract protein and other components
35for protein synthesis, but lacking S methionine and mRNA, was incubated
at 30°C. At various times, 21.5 yl aliquots were removed to vials containing
354.5 yl of S methionine and water or SFV mRNA. These incubations were continued
for a further 30 min, when two 3 yl aliquots were taken for acid precipitation.
35These final incubations contained 440 yCi/ml S methionine and 0 or 40 yg/ml 
SFV mRNA. Incorporation is plotted against the time of preincubation before 
the addition of isotope and mRNA.
O  endogenous 
•  SFV mRNA stimulated 
X  stimulation over endogenous
35 S cpm ( x10 3 )
the initiation capacity was lost after 6-7 min at 30 C. These observatio 
were repeated in another extract (Fig. 35c), in which SOX of the Initiation 
capacity decayed in about 5 min, and very little renamed after 15 20 m
50 yl incubations containing 91 yg extract protein, 39 yCi 35S methionine 
various concentrations of globin mRNA or tRNA, and other
components for protein synthesis, were incubated at 30°C for 30 min 
before taking two 5 yl aliquots for acid precipitation. The remainder 
of each incubation was electrophoresed on a gradient gel (results 
not shown).
FIG.36. Effect of E.coli tRNA on protein synthesis
O + globin mRNA

6.6. RIBONUCLEASE ACTIVITY
Although the stimulation by added mRNA required new peptide chain 
initiation (Fig. 35b), it was partly due to increased translation of 
endogenous mRNA (Fig.34). To check for effects which were not specific 
for mRNA, the stimulation due to E.coli tRNA was compared to that due to 
globin mRNA. Any effect of added prokaryotic tRNA would probably be non­
specific (Aviv et al 1971), and could be caused by competition for nucleases. 
The stimulation was about 35% of that caused by globin mRNA (Fig. 36). 
Polyacrylamide gel electrophoresis showed that the tRNA stimulated the same 
endogenous products as did globin mRNA, but the globin mRNA also coded for a 
product running with the same mobility as rabbit globin (results not shown).
The ribonuclease activity of the extract was estimated by two different 
methods. One was the acid precipitation method used by other workers to 
demonstrate the absence of nuclease activity in conventially prepared cell- 
free systems (Kerr et al 1976). The other was a method which measured the 
integrity of RNA extracted from the system by its ability to be translated 
in a mRNA-dependant cell-free system.
When radioactive 26S mRNA was incubated in the cell-free extract, and
samples taken for acid precipitation at various times, the RNA was less
than 35% degraded after 1 hr (Fig. 37a). The 25% degradation after 30 min
was due in part (10%) to components of the incubation mix other than the
cell extract. There was no degradation of the RNA species present in the
3
cell extract, which had been made from cells labelled with H undine.
When non-radioactive SFV mRNA was incubated in the same cell-free 
extract, and samples taken for RNA isolation and translation in the mRNA- 
dependant reticulocyte lysate (Pelham and Jackson 1976), a different picture 
emerged (Fig. 37b). As the incubation proceeded, the extracted RNA was less 
efficient at stimulating the lysate. The activity dropped to the level 
produced by RNA extracted from an incubation containing only endogenous RNA.
FIG.37. Ribonuclease activity in detergent extracts
Tne same extract, from cells which had been labelled with 5 pCi/ml H uridine
between 50 hr and 20 hr before extraction, was used for both experiments. It
5 3contained 6 * 10 H cpm/ml.
(a) Degradation of labelled mRNA in the extract.
3'P labelled 26 S mRNA (kind gift of S.I.T. Kennedy) was added to 25 pi incubations
4
at about 10 cpm per assay. The incubations also contained 45 pg of extract 
4 3protein (10 H cpm), 1 pg unlabelled SFV mRNA, and other components for protein 
synthesis, including 50 pM 32S methionine. After various times at 30°C, duplicate 
7.5 pi aliquots were taken for acid precipitation. The results are plotted as a 
percentage of the zero time control (3050 cpm) against time of digestion. A
4
background of 930 cpm, for a sample incubated with 0.4 mg/ml RNAse A and 3 x 10 u/ml
RNAse T1 for 30 min, has been subtracted from all samples. There was no reduction
3 32in tne H cpm. O complete system; A  no cell extract; □  P 26S mRNA incubated
alone.
(b,c) Degradation of unlabelled mRNA in the extract.
Two incubations, one of 375 pi and one of 150 pi, were prepared, containing SFV mRNA
at 40 or 0 pg/ml respectively, and other components for protein synthesis. The
kinetics of protein synthesis were normal (data not shown). 50 pi aliquots were
extracted with phenol and chloroform as described (section 2.4.5). The RNA was
precipitated in the presence of carrier E. coli tRNA and assayed for stimulation
of the micrococcal nuclease treated reticulocyte lysate (section 2.3.3). 50 pi
35
incubations contained 10 pi of extracted RNA or control RNA, and 0.9 pCi of S 
methionine. After 30 min at 30°C, two 5 pi aliquots were taken for acid 
precip’tacion and the remainder prepared for gel electrophoresis (section 2.6.2).
(b) Stimulation of the micrococcal nuclease treated reticulocyte lysate corrected 
for efficiency of RNA extraction (60-80%), related to stimulation by 400 ng SFV 
mRNA (100% = 33000 cpm/5 pi) and stimulation by RNA extracted from endogenous 
incuDation (0% = 6000 cpm/5 pi).
Background (i.e. no added RNA) for this lysate was 4000 cpm/5 pi, and it was 
linearly dependant on added SFV mRNA (data not shown).
(c) Products of micrococcal nuclase treated lysate analysed on a 12.5% 
polyacrylamide gel (section 2.6.2). Densitometer scans are shown for A, RNA 
extracted from the SFV mRNA incubation after 0 min; B, after 10 min; C, after 
20 min; D, after 30 min; and E after 60 min. The markers are SFV capsid 
protein (single arrow) and the top of the resolving gel (double arrow).
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The data presented (Fig.37b) has been normalised for 100% recovery of the
3
H uridine-labelled cellular RNA present in the extracts, but the results 
are not substantially different from the data obtained before normalising. 
The mRNA activity is found to decay with a half-life of about 15 min, and 
is fully degraded after 1 hr. This assay is clearly very sensitive - minor 
changes to the mRNA structure must render it completely inactive, because 
the cell-free products of degraded mRNA are identical to the products of 
undegraded mRNA, and are just reduced in quantity (Fig. 37c).
The results obtained with the translation assay for integrity of the 
mRNA reflect the course of protein synthesis in the detergent extract. The 
particular incubations from which the RNA samples used in Fig. 37b were 
extracted were monitored for protein synthesis, and showed the usual 
kinetics (as in Fig. 30a). The reduction in protein synthesis after about 
20 min could thus be partly due to degradation of mRNA.
' *
6.7.- PROTEIN KINASE ACTIVITY
In view of the possible involvement of protein phosphorylation in the 
control of translation (Ernst et al 1976), transfer of the y phosphate 
of ATP into proteins was analysed. Some of these experiments were performed 
under conditions where protein synthesis was not characterised, for example,
at 37°C and in the absence of the usual components for protein synthesis.
32 32 .Fig. 38a shows the kinetics of P incorporation from ATP y P into
acid insoluble material. The incorporation is maximal at about 5 min, the 
subsequent decrease implying phosphatase activity. Fig. 38b,c shows that 
even though cold acid precipitates more radioactivity than hot acid, all 
of the cold (and hot) acid insoluble material is pronase sensitive yet 
DNAse and RNAse insensitive. This implies that all the incorporated label 
is bound to protein, some being released by hot acid. This was corroborated 
by phenol extraction of the incubation mixture - the radioactivity recovered 
from the phenol layer by acetone precipitation equalled the hot acid 
insoluble radioactivity present (data not shown).
When the incubation mixture was treated with SDS, reduced with 
8 mercaptoethanol, and fractionated on SDS polyacrylamide gels, many discrete 
bands were seen (for example, Fig. 47). These bands remained even when the 
gel was boiled in TCA (Aierbach and Pederson 1975).
The implication that this material represents phosphate covalently 
bound to proteins could be confirmed by showing that all the acid insoluble 
radioactivity is contained in phosphorylated aminoacid residues.
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-IG. 38. Kinetics of incorporation of P and the nature of the 
acid insoluble product.
A detergent extract was made, and assayed without storage, according to
the procedure described (section 2.3.7). 100 pi incubations contained
32
90 pi of extract and 10 pi of about 20 mCi/ml ATPY P. 5 pi aliquots 
were taken for acid precipitation as required, and at 15 min 5 pi 
aliquots were taken to 1 ml DNAse buffer (2 mM Mg (OOCCH^» 50 mM NaCl, 
10 mM tris HC1 pH 7.5) or 1 ml tris buffer (50 mM tris HC1 pH 7.5).
These were treated with DNAse at 0 or 50 pg/ml (in DNAse buffer), or 
with 100 pg/ml RNAse A + 1000 u/ml RNAse T1 (in tris buffer), or with 
100 pg/ml pronase (in tris buffer), at 37°C for 30 min before making 
10% with TCA and filtering.
32(a) Time course of P incorporation into hot acid insoluble cpm 
at 37°C.
32(b and c) Results of enzyme treatments on acid insoluble P
(b) hot acid insoluble cpm.
(c) cold acid insoluble cpm.
»
In each case the treatments were: A; controls (DNAse buffer or 
tris buffer); B, DNAse treated; C, RNAse treated; D, pronase treated.
32
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6.8. DISCUSSION
It is possible to obtain a cell-free protein synthesising system from 
monolayer grown L929 cells by lysing the cells on the petri dish with a 
non-ionic detergent. The procedure is technically straight forward and 
very rapid - cell-free systems from cells treated in eight different ways 
can be prepared in 30 min and assayed directly. Other methods for monolayer 
grown cells, involving sonication in isotonic buffer (C. Preston, personal 
communication 1976) or douncing in hypotonic buffer (N.F.Moore , personal 
communication 1976), may not be applicable to all strains of L929 cells and 
are more laborious and time consuming.
The system will elongate polypeptide chains which were initiated before 
cell breakage. Synthesis using endogenous mRNA, involving some reinitiation, 
continues for up to 30 min until limited by run-off or by nuclease activity 
(Fig. 30a).
There is surplus initiation activity to utilise exogenous mRNAS.
Globin mRNA, SFV 26S mRNA and EMC mRNA (results not shown) all stimulate 
protein synthesis, and this stimulation is sensitive to edeine, an inhibitor 
of peptide chain initiation (Fig. 35a,b). The products directed by globin 
and 26S mRNA electrophorese with the cell-free products directed in other 
cell-free systems.
Initiation activity is labile, continuing for 15-20 min (Fig.35c).
Other cell-free systems seem to be limited by mRNA degradation rather than 
survival of initiation activity (Ball and White 1976), although measurement 
of sensitivity to initiation inhibitors added at different times may imply 
that initiation is short lived, possibly because of mRNA degradation. For 
example, Eggen and Shatkin (1972) found that a preincubated ascites system 
was insensitive to pactamycin after 20 min incubation.
Various modifications were tried to extend the life of the system (data 
not shown). Addition of reticulocyte ribosomal salt wash factors, prepared
according to Schreier and Staehelin (1973b; see section 2.3.10), and either 
added crude or as separate fractions A and Bl, had no beneficial effects 
on SFV mRNA-stimulated incorporation. Addition of hemin to 50pM (Weber 
et al 1975) or glucose to 2mM (R.J. Jackson, personal communication 1975;
Giloh and Mager 1975), was not stimulatory. Lowering the magnesium 
concentration by 1.4mM and replacing it with 80pM spermine (Atkins et al 
1975) did not promote SFV mRNA translation. It is possible, however, that 
the effects of some of these treatments were masked by other changes in 
the system, and probably a better test for prolonged initiation would be to 
assay for ability to utilise mRNA added after, say, 30 min of incubation.
The presence of non-ionic detergent in the system does not seem to be 
detrimental. Addition of extra detergent does not inhibit protein synthesis, 
and other cell-free systems are active under these conditions. The 
reticulocyte lysate is inhibited only 25% by 0.08% v/v Triton N101 (the 
maximum concentration present in assays using the detergent extract) and 
the kinetics suggest progressive deterioration of the system rather than 
specific inhibition of initiation (data not shown). Recently, Briendl and 
Holland (1975) have published evidence that the ascites and wheat germ 
systems are inhibited 25% by 0.1% v/v Nonidet P40.
The detergent may have an indirect effect on protein synthesis by 
releasing lysosomal ribonucleases and proteases. Protease activity was 
probably only slight. More important was the ribonuclease activity, which 
destroyed all active mRNA in 60 min (Fig. 37b). However, the nuclease 
activity measured by acid precipitation of radioactive mRNA (Fig. 37a), 
compares favourably with published data (Kerr et al 1976). The sedimentation 
profiles of reovirus mRNA presented by Graziadei et al„(1973a) showed 50% 
degradation after about 15 min in their L929 cell system. It is possible 
that the effects of nuclease activity could be reduced by assaying protein 
synthesis in the presence of E.coli tRNA (Fig. 37), 5'CMP (Cuatrecasas et al
1967) or EGTA (Pelham and Jackson 1976).
The relationship between protein concentration and protein synthesis 
(Fig. 30b) implies that more concentrated extracts are desirable. G. Thomas 
(personal communication 1976) has shown that the supernatant from WI38 
fibroblasts, lysed on the petri dish with 1% Triton X-100, contains only 
a small proportion of the total polysomes, the remainder being strongly 
attached to the nuclear membrane and cytoskeleton. 0. Levin has suggested 
a modification to the basic procedure, in which the cells are scraped off 
the dish, pelleted at low speed, resuspended in one packed-cell volume of 
isotonic buffer, and lysed with the addition of detergent to 0.13. The 
nuclei are spun out at low speed and the supernatant assayed. In my hands 
this protocol produced extracts with 5-6 times the protein concentration 
of the standard extracts. Protein synthesis was about 3 times that of the 
standard extracts, which, considering the pool concentration of methionine 
is probably 5-6 times higher, represents a considerable improvement. However, 
the kinetics of synthesis were similar, implying that short-lived initiation 
and high nuclease activity were still a problem.
The benefits of the detergent procedure arise from its speed and ease 
of handling, enabling comparison of in vivo and in vitro changes under a 
range of conditions. The procedure may find application in the study of 
control of translation under conditions of growth control, virus-induced 
shut off, and interferon action (section 7). The method has been used, 
without modification, to obtain an active cell free system from monolayer 
grown Hela cells (results not shown).
It is interesting that, when the endogenous synthesis by 25 extracts 
was surveyed, the synthesis rate was found to depend on the history of the 
cells. Extracts of cells grown overnight in 23 serum were only one third 
as active as cells grown in 103 serum (results corrected for protein 
concentration; results significant at 993 level of confidence). Whether 
this arises from differences in pool sizes, availability of mRNA, or activity 
of the ribosomes, is not known. Hassell and Engelhardt (1973) reported a 
similar difference in cell-free elongation systems from Vero cells.
SECTION 7
CORRELATION OF IN VIVO AND IN VITRO
EFFECTS OF INTERFERON AND dsRNA
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7 . CORRELATION OF IN VIVO AND IN VITRO EFFECTS OF INTERFERON AND dsRNA
7.1. INTRODUCTION
Cell-free systems from interferon-treated cells are highly sensitive 
to dsRNA (Kerr et al 1974b). Unlike the other effects observed in vitro 
(Falcoff et al 1972, Content et al 1974, Gupta et al 1974, Samuel and 
Joklik 1974), the dsRNA effect is found in non-preincubated cell-free 
systems, and is thus unlikely to be an artefact of preincubation or 
gel filtration (Sen et al 1976). Inhibition by dsRNA could be the basis 
for the antiviral effect of interferon, because some cytoplasmic dsRNA is 
produced during replication of most viruses, and this could trigger a 
translation block and prevent viral multiplication (Kerr et al 1973,
Kerr et al 1974b). Indeed, cell free systems from interferon-treated,
infected cells, show the same characteristics as interferon-treated
cell extracts which have been incubated with dsRNA (Friedman et al 1972a,b).
The in vitro effect of dsRNA might also be involved in the increased 
toxicity of dsRNA towards interferon-treated cells (Stewart et al 1972a).
If dsRNA entered the cells and inhibited protein synthesis, toxicity 
could result either directly, or from the accumulation of some regulatory 
component. Alternatively, the translational inhibitor might be capable 
of other effects in vivo, for example, by causing membrane disintegration. 
Thus, even though no evidence for gross inhibition of protein synthesis 
early in the cytotoxic effect has been found (section 5.6), it was still 
possible that the translational inhibitor might be present, and might 
correlate with the development of toxicity.
Another system which is highly sensitive to dsRNA is the reticulocyte 
lysate, in which the inhibitor acts at initiation (Darnbrough et al 1972).
In this system, the inhibition is probably due to a protein kinase, which 
phosphorylates an initiation factor (Ernst et al 1976, P. Farrell,
K. Balkow, T. Hunt, R. Jackson, personal communication 1975). For this 
reason, the experiments described here were designed with two aims in view.
Firstly, to establish an assay for the interferon and dsRNA dependant 
inhibitor, to characterise it and compare it with the reticulocyte 
inhibitor, and to compare its formation in_vivo and injntro. Secondly, 
to search for changes in patterns of protein phosphorylation which 
might correlate with the cytotoxic effect.
FIG.39. Effect of interferon and dsRNA on in vitro protein synthesis
140 mm petri dish cultures of cells were treated for 17 hr with 200 u/ml
interferon, or an equivalent concentration of "mock-interferon", in GMEM/2% CS.
The cells were then washed and detergent extracts made as before (section 2.3.5)
or by scraping the cells into conical centrifuge tube, pelleting at 3750g,
adding an equal volume of 90 mM KC1, 30 mM Hepes K0H, ImM DTT, 4mM Mg^OCCH^^»
pH 7.4, making 0.1% v/v in Triton N101, douncing gently, and taking a 4200g
supernatant (D. Levin, personal communication 1976). Two different batches
of cells were used, one for the "conventional" extracts, and one for the
"concentrated" extracts, and they were assayed on separate occasions.
.35
50 yl incubation mixtures contained 35 yl of extract, 17.8 yCi S methionine,
0 or 40 yg/ml SFV mRNA, and dsRNA as required. Aliquots were withdrawn as 
required for acid precipitation.
O  endogenous, no dsRNA 
•  endogenous, + dsRNA 
□  + SFV mRNA, no dsRNA 
■  + SFV mRNA, + dsRNA
(a,b) "conventional" extracts from (a) interferon-treated cells (assays 
contained 133 yg extract protein) or (b) "mock-interferon"-treated cells 
(114 yg extract protein) and 0 or 250 ng/ml poly rl.rC.
5 yl aliquots were used for acid precipitation.
(c,d) "concentrated" extracts from (c) interferon-treated cells (231 yg 
extract protein) or (d) "mock-interferon" treated cells (212 yg extract 
protein) and 0 or 100 ng/ml P. chrysogenum dsRNA.
3 yl aliquots were used for acid precipitation.
time ( min)
0 10 20 30
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7.2. EFFECTS OF INTERFERON ON IN VITRO PROTEIN SYNTHESIS
When extracts from interferon-treated and control cells were assayed 
for endogenous or SFV RNA stimulated protein synthesis, no significant 
differences were found (Fig 39 a,b), as expected for uninfected extracts 
(Friedman et al 1972a,b). However, these extracts were insensitive to 
dsRNA (Fig 39a,b) although significant inhibition has been observed by 
other workers (Kerr et al 1974b, Content et al 1975). P. chrysogenum 
dsRNA was tested at concentrations in the range 5 x io ” °  to 5 x 10 g/ml, 
and found to be ineffective (data not shown). Extracts prepared by a 
different procedure (D. Levin, personal communication 1976, see section 
6.8) and having a higher protein concentration, were also insensitive 
to dsRNA (Fig. 39c,d).
Moreover, extracts made from cells which had been treated with 
both interferon and dsRNA, or under control conditions, were equally 
active in protein synthesis (Table 10). Absence of inhibition may mean 
that no inhibitor is present, but could be explained if the system is 
insensitive to the inhibitor. The kinetics shown (Fig. 39) do not 
exclude the formation of an initiation inhibitor after more than 15 min 
incubation, because after this time initiation ceases in control extracts 
(section 6.5). For this reason, experiments were designed to assay for 
translational inhibitor formation during incubation of interferon-treated 
cell extracts with dsRNA.
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7.3. ASSAYS FOR A TRANSLATIONAL INHIBITOR
Interferon or mock-treated cell extracts, an energy supply, and 
poly rl.rC at 250 ng/ml, were incubated under conditions suitable for 
protein synthesis for 15 min, and then diluted ten-fold into fresh 
incubations containing control cell extract, energy supply and aminoacids. 
After 5 min incubation, radioactive methionine and SFV RNA were added, 
and acid insoluble radioactivity measured after a further 30 min. This 
protocol allowed 15 min for the formation of an inhibitor, and at least 
5 min for its action, but even so, no inhibition of the stimulation by 
SFV RNA could be detected (data not shown).
It was decided to use a system with linear kinetics to assay for 
the production of inhibitor.
The reticulocyte lysate is linear for at least 30 min and initiation 
of new polypeptide chains continuesthrough this period. However, the 
lysate is sensitive to small amounts of dsRNA, so any assay for a dsRNA- 
dependant inhibitor must use conditions where preformed inhibitor is 
active but the lysate inhibitor is not formed. High concentrations of 
dsRNA are not inhibitory (Legon et al 1974) but can only partly reverse 
the inhibition due to low amounts of dsRNA (Hunter et al 1975), and it 
is likely that high concentrations of dsRNA prevent the formation of the 
lysate inhibitor (Hunter et al 1975; P. Farrell, personal communication 
1976).
Fig. 40b shows that dsRNA at 10 ng/ml inhibits the lysate with 
biphasic kinetics. However, at 1 pg/ml or higher concentrations, the 
inhibition is much reduced (Fig. 40c). Thus an assay system containing 
10 pg/ml dsRNA is insensitive to the addition of low concentrations of 
dsRNA (Fig. 40a) and can be used for the assay of preformed inhibitor.
When cell extracts were incubated with 100 ng/ml dsRNA and an 
energy supply, and then assayed for their ability to inhibit the lysate 
in the presence of 10 pg/ml dsRNA, the result depended on the source of
FIG.40. Reticulocyte lysate assay for protein synthesis inhibitor
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(a) Lysate assay in the presence of 10 pg/ml P. chrysogenum dsRNA and 
aliquots of various preincubations.
Preincubations contained cell-extract protein from interferon or "mock-interferon"
treated cells (same preparations as in Fig. 39a,b), or extraction buffer alone,
energy supply,and P.chrysogenum dsRNA at 0 or 100 ng/ml (see section 2.3.9).
After 30 min at 30°C, 5 pi aliquots were taken to 50 pi incubation mixtures
containing reticulocyte lysate, 10 pg/ml dsRNA, and components for protein 
35synthesis, including S methionine at 35 pCi/ml. After various times at 
30°C, 3 pi aliquots were removed for acid precipitation.
The preincubations contained
cell extract dsRNA (ng/ml)
buffer alone 0 A
100 A
interferon 0 O
100 •
"mock-interferon" 0 □
100 ■
(b) Lysate assay in the absence of high concentrations of dsRNA.
The "buffer alone" preincubations from part (a) were also assayed in an 
incubation containing no additional dsRNA. The final concentrations of 
dsRNA were thus: A  0, and A 10 ng/ml.
(c) Effect of various concentrations of P. chrysogenum dsRNA on protein
synthesis. In a separate experiment, the lysate was incubated with various
35concentrations of dsRNA and 28 pCi/ml S methionine. Duplicate 5 pi
*
aliquots were taken for acid precipitation after 30 min, and the incorporation 
is plotted against concentration of dsRNA. The broken line shows the 
incorporation in the absence of dsRNA.
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extract (Fig. 40a). Extracts from cells treated with "mock-interferon" 
were somewhat inhibitory, whether incubated with or without dsRNA.
Extracts from cells treated with interferon were similarly inhibitory, 
this inhibition probably resulting from ribonuclease activity or some 
other non-specific effect. However, interferon-treated extracts pre­
incubated with dsRNA contained an inhibitor which shut off protein 
synthesis by the lysate within 10 min of incubation (Fig. 40a). The 
kinetics of inhibition are similar to those seen with low concentrations 
of dsRNA (Fig. 40b), but the high concentration of dsRNA masks the 
inhibition due to dsRNA in the preincubations. Interferon-treated extracts 
are thus able to form a protein synthesis inhibitor when incubated with 
dsRNA. Inhibitor formation can be quantitated by comparing protein 
synthesis in the presence of inhibitor (i.e. extract incubated with 
dsRNA) with that in the presence of a control (i.e. extract incubated 
without dsRNA); in this experiment there was 44% inhibition by the 
interferon-treated cell extract incubated with dsRNA.
The inhibitor formed can also be quantitated by titration in the 
lysate, in the presence of 10 pg/ml dsRNA. Interferon-treated extracts, 
produced by either of two different proceedures, could form inhibitor 
still detectable at 30-50 fold dilution in the lysate (Fig. 41a,c).
However, mock-treated extracts produced much smaller amounts of inhibitor, 
barely detectable at 10-fold dilution (Fig. 41b,d).
It is thus clear that the lysate assay is capable of detecting an 
inhibitor, generated in interferon-treated cell extracts by incubation with 
100 ng/ml dsRNA, even though there was no effect on protein synthesis in 
these extracts (Fig. 39).
! f \ i \ HUiaili
9t
wt
FIG.41. Titration of dsRNA - dependent inhbitors
Inhibitors were formed in extracts of interferon and "mock-interferon" 
treated cells as described (section 2.3.9) and assayed, after dilution,
in the presence of 10 yg/ml dsRNA (section 2.3.9). The assays contained 
3535 pCi/ml S methionine, and 3 yl aliquots were removed after 30 min 
incubation for the determination of acid insoluble radioactivity. The 
incorporation in the presence of a given concentration of "inhibitor" 
(preincubation containing 100 ng/ml dsRNA) is expressed as a percentage 
inhibition, relative to the incorporation in the presence of a preincubation 
containing no dsRNA, and assayed at 100 yl/ml incubation (0% inhibition).
The extracts used were the same as those described before (Fig.39).
(a) "Conventional" extract from interferon-treated cells. The concentration 
of protein in the preincubations was 2.66 mg/ml and "0% inhibition" was 
19900 cpm.
(b) "Conventional" extract from "mock-interferon" treated cells. The 
concentration of protein in the preincubations was 2.28 mg/ml and "0% 
inhibition" was 20000 cpm.
(c) "Concentrated" extract from interferon-treated cells. The concentration
»
of protein in the preincubations was 4.62 mg/ml and "0% inhibition" was 19900 cpm.
(d) "Concentrated" extract from "mock-interferon" treated cells. The 
concentration of protein in the preincubations was 4.24 mg/ml and "0% 
inhibition was 21400 cpm.
%
 
in
hi
bi
ti
on

135
7.4. REQUIREMENTS FOR INHIBITOR FORMATION
The requirements for forming the interferon and dsRNA dependant 
inhibitor were investigated. As little as 10 ng/ml dsRNA allowed 
formation of detectable inhibitor, but 20 ng/ml was required for 
half-maximal, and 40-80 ng/ml for maximal formation (Fig. 42a). Formation 
was essentially complete after 15 min at 30°C, with a half-time of 3-5 min 
(Fig. 42b). Negligible formation occurred at 0°C, or after the extract 
had been diluted into the lysate assay mixture (results not shown).
The only component provided by the energy mxiture was ATP ; GTP 
or a mixture of creatine phosphate and creatine phosphokinase were 
ineffective (Fig. 42c). The creatine phosphate and kinase should be 
adequate to keep all the endogenous ATP phosphorylated, yet cannot replace 
ATP in inhibitor formation, suggesting that high concentrations of ATP 
are required.
Once formed, the inhibitor is stable; that is, it could be kept at 
30°C for 30 min, or at -20°C for several weeks, and frozen-and-thawed
without loss of activity.
HAHUttU
FIG.42. Requirements for inhibitor formation.
^reincubations, containing "conventional" cell extract from interferon-treated
FI (
“  cells, and P. chrysogenum dsRNA and energy supply as required (section 2.3.9),
 ^ Q
were performed for various times at 30 C before diluting 10-fold into
a p reticulocyte lysate assays containing 10 yg/ml dsRNA (section 2.3.9) and
t oc 0
S methionine at 50.3 yCi/ml. After 30 min at 30 C, 3 yl aliquots were
Q( 6
removed for acid precipitation. The incorporation in the presence of a
A
wt given preincubation is expressed as a percentage inhibition, relative to the
a incorporation in the presence of a preincubation containing all the usual
11 components but no dsRNA (0% inhibition = 28600 cpm).
II •
(a) Dependence on concentration of dsRNA. Percentage inhibition of the lysate 
w is plotted against the log concentration of dsRNA present in the preincubation.
1 (b) Dependence on time of preincubation at 30°C. Aliquots of the preincubation
1 were removed at various times and kept at 0°C until all the samples were ready
( for assay.
a (c) Dependence on energy supply. The following components were present in
( the preincubation:
creatine phosphate creatine kinase ATP GTP CTP
( (mM) (yg/ml) (mM) (mM) (mM)
A 10 25 1.0 0.1 0.6
B 10 • 25 0 0.1 0.6
C 10 • 25 1.0 0 0.6
1 I D 0 0 1.0 0.1 0.6
i E 0 0 0 0 0
t F 10 25 0 0 0
G 0 0 2.0 0 0
H 0 0 0 2.0 0
% inhibition
N)cn K)cn
cn
o
-log ( g/m
l)
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7.5. ACTION OF THE INHIBITOR IN THE LYSATE ASSAY
The inhibitor was active in assays using three different reticulocyte 
lysates. The biphasic kinetics, with shut off as early as 5 min after the 
start of incubation, resembled the kinetics of inhibition by low 
concentrations of dsRNA, oxidising agents, or hemin deficiency (section 
4.2). These three sets of conditions are all reversed when high 
concentrations of certain purines are added to the lysate (Legon et al 
1974).
When 2-ami nopurine was included in the assay, it was somewhat 
inhibitory, but reduced the inhibition by a low concentration of dsRNA 
from 66% to 20% (Table 11). It also reduced the inhibition caused by the 
interferon and dsRNA - dependant inhibitor, from 36% to 8%. 5 mM cAMP
was also effective (P. Farrell, personal communication 1976).
It was thus possible that the inhibitor interfered with protein 
synthesis by the same mechanism as dsRNA, oxidising agents, and absence 
of hemin. Samples were sent to P. Farrell for analysis by three 
proceedures, all in the presence of high concentrations of dsRNA. Firstly, 
sucrose density gradient analysis showed that the inhibitor prevents
OC
binding of S met tRNAp to 40S ribosomal subunits, as has been shown 
for dsRNA (Darnbrough et al 1972). This step depends on IF-E2, the 
met tRNAp binding factor (Schreierand Staehelin 1973a), and IF-E2 reverses 
the inhibition due to hemin deficiency (Balkow et al 1973) or dsRNA 
(Kaempfer 1974). The effect of IF-E2 on inhibition of protein synthesis 
by the inhibitor was tested. A large dose of IF-E2 reversed the inhibition, 
although not so effectively as it reversed the effects of hemin deficiency.
The third proceedure involved a qualitative study of the 
phosphorylation of crude reticulocyte ribosomes and associated factors, 
under conditions where the factors are inactivated (Fig. 43). The y 
phosphate of ATP is transferred to several proteins, but two proteins 
(molecular weights 35000 and 67000 daltons) are phosphorylated only in 
the presence of low concentrations of dsRNA or in the absence of hemin.
TABLE 11: Effect of 2-aminopurine on inhibition of the lysate
Expt. Additions to the incubation incorporation
No. dsRNA 
(yg/ml)
inhibitor control 2-amino
purine
(mM)
cpm % inhibition
1. 10 - + 0 5446 (0)
10 + - 0 4030 36
10 - + 7 4810 (0)
10 + - 7 4360 8
2. 0 - - 0 49906 (0)
0.01 - - 0 16795 66
0 - - 7 43235 (0)
0.01 - - 7 34759 20
In Expt. 1. "inhibitor" (preincubation containing interferon-treated
cell extract, energy supply, and 100 ng/ml dsRNA) or "control" (control
cell extract, energy supply, and 100 ng/ml dsRNA) were assayed in the
35 olysate,in the presence of 10 yg/ml dsRNA and S methionine, at 30 C 
for 30 min.
In Expt. 2. inhibition by 10 ng/ml dsRNA was assayed in the same lysate, 
using 3H leucine at 30°C for 30 min.
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The 35000 protein has been identified as the small subunit of IF-E2, and 
the 57000 protein is another ribosome-associated protein (P. Farrell,
T. Hunt and R. Jackson, unpublished results). In the presence of the 
inhibitor, the 35000 protein was phosphorylated, and this was not prevented 
by high concentrations of dsRNA (Fig. 43). There was no phosphorylation 
when control incubations, containing no dsRNA,were added, and there was 
only partial phosphorylation when an incubation containing untreated cell 
extract and dsRNA was tested (Fig. 43). This is in agreement with the 
formation of small amounts of inhibitor by control extracts (Fig. 41b,d).
These results suggest that the inhibitor is a protein kinase, or 
a kinase activator, which can phosphorylate IF-E2 and thus create a lesion 
at polypeptide chain initiation.
FIG.43. Phosphorylation of reticulocyte proteins by the inhibitor.
Preincubations containing interferon or control cell extracts, energy supply,
and 0 or 100 ng/ml dsRNA were performed at 30°C for 30 min. Crude ribosomes
were prepared from a hemin-treated lysate by gel-filtering on Sepharose 6B in
a buffer containing 25 mM KC1, 10 mM NaCl, ImM MgCl2> 0.25 mM DTT and 10 mM
tris HCl pH 7.5. Phosphorylation assays contained, in 20 pi: 16 pi of
ribosomes or buffer; 0,0.05, or 20 pg/ml P. chrysogenum dsRNA; additional
100 mM KC1 and 0.5 mM MgCl,; 50 pM ATP 3ZP at 10 Ci/mmole; and 1 pi of each
c y . 0
preincubation as required. Phosphorylation was allowed for 20 min at 30 C,
before adding SDS and analysing the products on a 15% polyacrylamide gel
(section 2.6.2). The gel was fixed, stained, and autoradiographed overnight.
The tracks contained:
preincubations
control . interferon ribosomes dsRNA
(ug/ml- dsRNA + dsRNA - dsRNA + dsRNA
1 + _ _ - - 20
2 - + - - - 20
3 - - + - - 20
4 - - - + - 20
5 + - - - + 20
6 - + - - + 20
7 - - + - + 20
8 - - - + + 20
9 - - - - + 0
10 - - - - + 20
11 - - - - + 0.05
12 + - - - - 0
13 - + - - - 0
14 - - + - - 0
15 - - - + - 0
16 + - - - + 0
17 - + - - + 0
18 - - + - + 0
19 - - - + + 0
The proteins which are phosphorylated in track 11 but not in tracts 9 and 10 
are at 67000 daltons (single arrow) and 35000 daltons (double arrow), and the 
35000 daltons protein is identical to the small subunit of IF-E2 (data not shown) 
Autoradiography of the gel for longer periods showed that there was no interferon 
and dsP.NA specific phosphorylation in tracks 1-4 or 12-15.
* Experiment performed by P. Farrell.

7.6. CHARACTERISTICS OF THE INHIBITOR
The above results are consistent with a number of hypotheses for 
the chemical nature of the inhibitor. It could be a new compound generated 
de novo by the interferon-treated cell extract. Alternatively it could be 
an oxidising agent, a hemin chelator, or dsRNA modified in some way to 
escape the high dsRNA control.
Inhibition occurred in the presence of either 25 yM or 50 pM hemin 
(results not shown). It is thus unlikely to involve complexing or 
degradation of hemin. Inhibition was net reversed by DTT, glucose, or 
fructose-l,6-diphosphate'» compounds which reverse the inhibition due 
to oxidising agents (P. Farrell, personal communication 1976).
The resistance of the inhibitor to two degradatory enzymes was 
investigated. The choice of enzymes was limited to those whose activity 
could be prevented by an inhibitor, such that neither the enzyme nor its 
inhibitor would effect protein synthesis.
Trypsin complexed with soybean trypsin inhibitor does not effect 
the lysate. When the interferon and dsRNA-dependant inhibitor was 
treated with trypsin, at about 50 pg trypsin per 1 mg cellular protein, 
at 30°C for 30 min no reduction in inhibition was observed (Fig. 44a).
If the inhibitor has a protein moiety, it is resistant to trypsin under 
these conditions.
Micrococcal nuclease is a calcium-dependant nuclease (Cuatrecasas 
et al 1967), and does not effect the lysate providing a chelating agent 
is present (Pelham and Jackson 1976). Incubation with this nuclease at 
280 pg/ml in 5mM CaCl^, partly degrades dsRNA as shown by a reduction in 
its ability to inhibit the lysate (Fig. 44b). When an inhibitor preparation 
was treated under the same conditions, it was completely destroyed (Fig.44b). 
Thus it seems that the inhibitor contains a micrococcal nuclease sensitive 
moiety.
pi^.44. Sensitivity of the inhibitor to a protease and a nuclease.
"InniDitor" was formed as usual (section 2.3.9), and assayed after treatment with 
trypsin or micrococcal nuclease. The enzymes were inactivated before assay. 
Incorporation, after 30 min at 30°C, is expressed as a percentage inhbition, 
relative to the incorporation in the presence of a preincubation containing no 
dsRNA (0% inhibition).
(a) Sensitivity to trypsin. "Inhibitor" preparations formed by preincubating 
interferon-treated cell extract with 100 ng/ml dsRNA were digested with one-half 
volume of 200 pg/ml trypsin at 30°C for 30 min, before adding an equal weight of 
trypsin inhibitor and assaying in the lysate. "0% inhibition" was 13900 cpm.
addition at 0 min. addition at 30 min
"inhibitor" trypsin trypsin
inhibitor
trypsin trypsin 
inhibi tor
! I
(d ) Sensitivity to micrococcal nuclease. dsRNA at 100 ng/ml in extraction buffer, 
an "inhibitor" preparation, or a "control" preparation (preincubation of control 
cell extract with 100 ng/ml dsRNA), were digested with one-half volume of 400 ug/ml
nuclease and 15 mil Ca Cl 2 at 30°C for 30 min. K^EGTA was added to 12.5 i
assaying in the lysate. The inhibition due to dsRNA was assayed in lysa
the addition of extra dsRNA.
addition at 0 min addition at 30 min
dsRNA "inhibitor" "control " nuclease EGTA nuclease
+ CaCl2 + CaCl2
A _ - - + +
A + - - - “ -
C + - - - + +
D + - - + + -
E + - - - -
F + - - + +
G + - + + -
H - + - - -
I - + - + +
J * + ♦ +
f>f
rfsr,
■ol
ug/ml
fore
thout
%  inhibition
iN) hO cn ccn o cn o cn c
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7.7. IS AN INHIBITOR FORMED IN VIVO?
If an inhibitor can be formed when dsRNA is added to an interferon- 
treated cell extract, then it is possibly formed in vivo, when dsRNA is 
added to interferon-treated cells.
Extracts of interferon and dsRNA treated cells were prepared, and 
tested without preincubation in the lysate assay system (Table 12). No 
inhibitor could be detected, in agreement with the failure to detect 
changes in protein synthesis in vivo (section 5.6) or in vitro (Table 10).
These cells were not incapable of forming the inhibitor, however.
When the cell-free system was preincubated with ATP an inhibitor was 
generated (Table 12). The kinetics of inhibition, and the failure to 
greatly increase the inhibition with extra dsRNA (Fig. 45), suggest that 
the inhibitor formed in this way is identical with the inhibitor described 
before. It is thus possible that the extracts from interferon and dsRNA 
treated cells contain sufficient dsRNA to allow maximal inhibitor 
formation in vitro.
This hypothesis was tested by taking interferon or mock-treated cell 
extracts and mixing them with dsRNA-treated or control cell extracts, and 
incubating them with ATP. Inhibitor was only formed when components from 
both interferon-treated cells and dsRNA-treated cells were present (Table 
13), suggesting that the endogenous dsRNA in the dsRNA-treated cell 
extracts is sufficient to promote inhibitor formation. It is likely 
that inhibitor is not formed in the intact cells because the interferon- 
depend^mt component and dsRNA cannot interact, and only after cell lysis 
can this occur.
In order to eliminate the formation of inhibitor as a cause of the 
cytotoxic effect, assays were performed using cell extracts made at 
various times during the development of the effect, and extracts made 
from cells treated with various doses of interferon (Fig. 46). Even as 
much as 3000 u/ml of interferon was inadequate to allow inhibitor formation
TABLE 12: Assay for inhibitor in extracts of interferon and dsRNA treated cells.
FIG. 45. Kinetics of inhibition of the lysate by preincubated extracts 
from dsRNA-treated cells.
Preincubations contained extracts from interferon or "mock-interferon" and 
poly rl.rC treated cells (see legend tp Table 12),an energy supply, and 
0 or 100 ng/ml dsRNA. After 30 min at 30°C the preincubations were diluted
10-fold into reticulocyte lysate containing 10 ug/ml dsRNA and 53 yCi/ml
35S methionine. 3 pi aliquots were acid precipitated as required.
A  extraction buffer
□  extract from control, dsRNA-treated cells, 
preincubated alone
3  extract from control, dsRNA-treated cells 
preincubated with added dsRNA
O  extract from interferon and dsRNA-treated 
cells, preincubated alone
9  extract from interferon and dsRNA-treated 
cells, preincubated with added dsRNA.
»f
>
TABLE 13: Requirement for components from both interferon-treated 
and dsRNA-treated cells to form inhibitor in vitro
% inhibition of lysate by preincubations containing
extract A
extract
B
interferon 
and dsRNA
interferon "mock-interferon" 
and dsRNA
"mock-interferon"
interferon 
and dsRNA 46 47 NDa 36
interferon 10 41 18
"mock-interferon' 
and dsRNA 13 18
"mock-interferon'1 20
Extracts from interferon or "mock-interferon" and dsRNA or control cells
(see legend to Table 12) were mixed together in equal amounts and
preincubated with an energy supply at 30°C for 30 min. No extra dsRNA
was added. The preincubations were then diluted 10-fold into reticulocyte
35
lysate containing 10 pg/ml dsRNA and 40 yCi/ml S methionine. After 
30 min at 30°C, duplicate 3 pi aliquots were taken for acid precipitation. 
The incorporations are expressed as percentage inhibitions relative to 
a control assay containing non-preincubated extract from interferon and 
dsRNA-treated cells, 
a) NO = not done.
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in dsRNA-treated cells, despite the fact that these cultures proceeded 
to loose 41% of cellular protein due to the cytotoxic effect. Inhibitor 
formation was readily detected when the extracts were preincubated 
(Fig. 46a) and could have been detected even if present in only 41% 
of the cells.
When extracts were made at various times after dsRNA treatment,
no inhibitor could be detected (Fig. 46b). This excludes inhibitor
formation at any time in the population of cells resistant to the toxic
effect (section 5.3), but cannot exclude inhibitor formation shortly
(less than 15 min) before cell loss from the monolayer. These extracts
were also able to form inhibitor when incubated in vitro (data not shown).
If inhibitor formation was necessary for the toxic effect, changes
in protein kinase activity might be seen. However, when interferon and
32
dsRNA-treated cell extracts were labelled with ATPy P, under conditions 
known to phosphcrylate proteins (section 6.7), and analysed on 
polyacrylamide gels, no changes were found (Fig. 47). However, no changes
were detected when interferon-treated cell extracts were incubated in vitro
32with dsRNA and ATPT P (results not shown), suggesting that the protein 
kinase may not be able to modify 1929 cell proteins under these conditions, 
perhaps because of prior phosphorylation by ATpY ^p. The changes which 
were seen (Fig. 47) were dependent on interferon but not dsRNA. Molecular 
weight markers were not run on this gel, but similar gels suggested that 
band X is in the range of 60-70,000 daltons, and band Y in the range 
30-40,000 daltons.
The above experiments d a  not exolude the possibility that the 
inhibitor is present in vivo but is rapidly degraded during cell breakage. 
This possibility oould only be adequately controlled for if conditions were 
found where the inhibitor could be detected in freshly-lysed oells.
1 ! . t J
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Fig.46. No inhibitor in non-preincubatad extracts of interferon and dsRNA 
treated cells.
Detergent extracts of cells treated with interferon and dsRNA were assayed, 
without praincubation, in reticulocyte lysate containing 10 yg/ml dsRNA and 
59 yCi/ml 35S methionine. After 30 min at 30°C, duplicate 3 yl aliquots were 
acid precipitated. The incorporation is expressed as a percentage inhibition, 
relative to a control containing interferon treated, but not dsRNA treated, 
cell extract (part a, 0% inhibition = 10800 cpm), or to a control containing 
extraction buffer (part b, 0% inhibition = 9500 cpm).
(a) Effect of concentration of interferon. Cultures were treated overnight 
with various concentrations of interferon or with "mock-interferon" (M),
and then with 50 yg/ml poly rl.rC for 60-70 min, before making detergent extracts 
(see Expt. 2., Table 12). These extracts were assayed directly, or after 
preincubation with an energy supply for 30 min at 30°C. Preincubation had 
little effect on the control incorporation
9  assayed without precincubation 
A  assayed after preincubation
(b) Effect of time of dsRNA treatment. 24 cultures were treated with 300 u/ml 
interferon, and 4 with "mock-interferon", for 16-17 hr. After washing to 
remove serum, the cells were treated with 0 or 50 yg/ml poly rl.rC and, at 
various times, duplicate plates were taken and detergent extracts made. The 
extracts were assayed without preincubation and each point represents the 
percentage inhibition caused by a separate cell extract, plotted against the 
time of addition of poly rl.rC.
^  cells treated with interferon and poly rl.rC 
O  cells treated with interferon
31 cells treated with “mock-interferon" and poly rl.rC 
□  cells treated with "mock-interferon"
All the extract« ware assayed at 10-fold dilation in the lysate; 
details of those used for part(a) are given in Table 10 (Expt.2), 
and the toxicity in part(b) was normal.
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FIG. 47. Phosphorylation of proteins by extracts from interferon and 
dsRMA-treated cells.
Cells were treated overnight with 100 u/ml interferon or "mock-interferon", 
and then with 0 or 50 pg/ml poly rl.rC for 30-35 min (see Expt. 1 in Table
10). 90 pi of extract was incubated with 10 pi of water containing about
3250 pCi of ATPy P at about 8 Ci/m mole (i.e. about 55 pM), for 5 min at 
37°C before removing two 5 pi aliquots for acid precipitation and treating 
the remainder with SDS. These samples were dialized exhaustively before 
analysing on a 7.5-303 gradient polyacrylamide gel (section 2.6.2). After 
electrophoresis at 15 mA for 14 hr the gel was dried without fixing, and 
exposed to Kodirex for 24 hr.
A, cells treated with interferon and dsRNA
B, cells treated with interferon
C, cells treated with "mock-interferon" and dsRNA 
0, cells treated with "mock-interferon"
32
Each track was loaded with about 270000 hot TCA insoluble - P cpm. The 
bands marked "X" and "Y" were estimated to correspond to molecular weights 
of 60-70000 and 30-40000 daltons respectively, by comparison with molecular 
weight markers run on similar gels.
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7.8. DISCUSSION
A reticulocyte lysate assay has been developed which can detect 
preformed inhibitory factors but is not influenced by dsRNA. Using this 
assay, an inhibitor can be detected when interferon-treated cell extracts 
are incubated with dsRNA and ATP, but not when incubated with ATP alone. 
Control extracts cannot generate the inhibitor.
The lysate assay differs in several respects from the L cell extract 
assay used by Roberts et a! (1976). When partly-purified inhibitor from 
an interferon-treated L cell S-100 (kindly provided by I.M. Kerr) was 
assayed in the lysate, it was not detectable at a 1000 fold dilution, 
although at this concentration it strongly inhibited L cell protein 
synthesis (I.M. Kerr, personal communication). This is possibly due 
to the presence in the lysate of higher concentrations of initiation 
factors, ribosomes, and so on, requiring more inhibitor for inactivation. 
On the other hand, it may reflect a different mechanism for inhibition.
Despite its lower sensitivity, use of the lysate facilitates an 
investigation of the mode of action of the inhibitor, because more is 
known about mechanism and control of protein synthesis in the lysate 
than in L cell extracts, and the system is highly active. The inhibitor 
acts at initiation (P. Farrell and J.A.C.), by preventing met tRNAp 
binding to the 40S subunit. This lesion is overcome by pure IF-E2, 
suggesting that the inhibitor inactivates that factor. Phosphorylation 
of the 35000 dalton subunit of IF-E2 has previously been correlated with 
inhibition by dsRNA, absence of hemin, and oxidising agents (P. Farrell,
K. Balkow, 1. Hunt and R. Jackson, personal communication 1975) and 
phosphorylated IF-E2 may be inactive in met tRNAp binding (B. Hardesty, 
personal communication 1976). In agreement with the proposed mechanism 
of inhibition by the interferon and dsRNA-dependant inhibitor, 
phosphorylation of this subunit was observed (Fig. 43). The absence 
of phosphorylation of the 67000 dalton protein during action of the 
L cell inhibitor suggests that this phosphorylation is not directly
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involved in the dsRNA inhibition, but may represent a step in amplification 
of the response.
It is likely that this inhibitor is identical with the one recently 
described (Kerr et al 1976), which was formed in dialysed cell sap from 
interferon-treated cells by incubation with dsRNA and ATP. Indeed, such 
an inhibitor preparation (kindly provided by I.M. Kerr) was able to 
inhibit protein synthesis in the lysate assay, and the inhibitor 
described here inhibited protein synthesis in an L cell extract programmed 
with EMC mRNA (I.M. Kerr, personal communication 1976). The only differences 
in the preparations are in cell growth conditions (suspension or monolayer), 
source and dose of interferon, and method for making cell extracts. The 
conditions for forming the inhibitor, in terms of time, ATP and dsRNA 
requirements, are similar (Kerr et al 1976).
The identity of the inhibitor is uncertain. If its primary action 
is to phosphorylate IF-E2, one could postulate that the inhibitor is a 
protein kinase or an activator for a protein kinase present in the lysate.
It is resistant to trypsin, and also to aminopeptidase and heat (I.M. Kerr, 
personal communication), suggesting it is an activator rather than a 
kinase. As well as being sensitive to micrococcal nuclease, it is of 
low molecular weight (Kerr et al 1976), and could thus be a modified 
nucleotide or oligonucleotide. In prokaryotic systems, guanosine 
tetraphosphate is an important coordinator of protein synthesis initiation 
and elongation and RNA synthesis (Travers 1976), and cAMP is a well known 
modulator of protein kinases in pro-and eukaryotes (Jost and Rickenberg 
1971). In this case, however, cAMP can be ruled out, as the phosphorylation 
of IF-E2*1s independant of cAMP (Traugh et al 1976).
The original hypothetical roles for the inhibitor, were that it 
mediated the antiviral effect and the interferon-enhanced toxicity of 
dsRNA (Kerr et al 1974b). The work presented here throws no light on the 
antiviral effect, but seems to exclude any involvement in the toxic effect. 
Cultures treated in such a way as to produce a marked toxic effect contained
r
undetectable levels of inhibitor; that is, the extracts were estimated 
to contain less than 5% of the amount of inhibitor that they were capable 
of forming in vitro (Fig. 46a and Fig. 41). The simplest explanation 
for this is that the dsRNA does not enter the cytoplasm in a form able 
to interact with the "inhibitor generating system". Presumably dsRNA 
formed intracellularly by a virus is able to cause inhibitor formation, 
giving rise to the effects observed by Friedman et al (1972a,b). However, 
the inhibitor formed in vivo in infected, interferon-treated cells must 
be shown to be identical with the one formed in vitro (when interferon- 
treated cell extracts are incubated with dsRNA), before the relevance 
of the inhibitor to the antiviral effect can be established.
The final point to arise from this work is the significance of
the protein phosphorylation recently reported by other workers (Roberts
et al 1976, Zilberstein et al 1976, Lebleu et al 1976). The consensus of
opinion is that the phosphorylation of two proteins present in the
ribosome wash fraction may be important in the control of translation
(Roberts et al 1976, Zilberstein et al 1976) or nuclease action (Lebleu
et al 1976). The phosphorylation of a protein of about 67000 daltons
molecular weight is probably interferon-dependant, but only marginally
dsRNA-dependant. On the other hand, the phosphorylation of another
protein, of about 35000 daltons molecular weight, is dsRNA dependent,
e-
and also more or less dependent on interferon. Although Zilberstein et al 
(1976) have correlated these changes with a block in the formation of 
met tRNAp.40S initiation complexes, it was not clear whether these changes 
were causally related. The present work has shown that an interferon and 
dsKNA-depend^ht L cell inhibitor can prevent met tRNAp.40S formation in 
the reticulocyte lysate, at the same time causing phosphorylation of a 
35000 laiton ribosome-associated protein. The same protein is 
phosphorylateci u . c o n d i t i o n s  of dsRNA-dependknt inhibition of the
1
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lysate, and has been shown to be identical with the small subunit of 
IF-E2 (P. Farrell, K. Balkc«, T. Hunt and R. Jackson, personal 
communication 1975), This phosphorylation inactivates the factor 
(B. Hardesty, personal communication 1975). Thus it is probable that 
the 35000 dalton protein which is phosphorylated in L cells (Kerr et al 
1976; Zilberstein et al 1976) or ascites tumour cells (Lebleu et aT 
1976), corresponds to this initiation factor, and is causally related 
to the inhibition of protein synthesis. Disacreement over the detailed
A
pattern of phosphorylation probably results from variation in the level
31of prior phosphorylation with P orthophosphate and in the concentration 
of ATP used in the phosphorylation assay (Lebleu et al 1976).
SECTION 8 
general discussion
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8. GENERAL DISCUSSION
Despite a survey of macromolecular synthesis and of ion transport 
rates, the molecular basis for the cytotoxic effect is unclear. It 
is apparent that protein synthesis is not inhibited, and no protein 
synthesis inhibitor can be detected in cell extracts. No other 
quantitative or qualitative changes were found, perhaps because a
no correlation of toxicity with lysosomal activation (J. Werenne,
G. Rousseau and J. Bartholeyns, personal communication 1975), and 
further investigation of the mechanism of cell death awaits a testable 
alternative hypothesis. The apparent absence of a protein synthesis 
inhibitor in dsRNA treated cells, when one is readily detected in dsRNA 
treated extracts, is circumstantial evidence that dsRNA does not enter 
the cell, although there are other explanations. If this is so, it is 
possible that dsRNA acts directly at the plasma membrane, causing cell 
lysis either by an ionic mechanism, or by activating an enzyme system 
capable of altering membrane lipids or proteins to produce an unstable 
membrane.
We have confirmed that interferon-treated cell extracts can form an 
inhibitor of protein synthesis, and characterised its action in the 
reticulocyte lysate. Clemens et al (1976) have recently reported a 
similar activity in a fraction derived from untreated ascites cells, 
and it is possible that such inhibitors are present in other cells and 
are modulated by dsRNA and hemin (C. Baglioni, personal communication 
1976). These inhibitors prevent binding of initiator tRNA to the 40S 
ribosomal subunit, that is, a stage prior to mRNA binding. Metz 
(1975b) nas suggested that interferon treatment might allow the cell to 
discriminate against high efficiency mRNAs, yet inhibition of initiation 
will actually promote the relative translation of high efficiency mRNA 
(Nuss et al 1975; Lodish 1974). Possibly the dsRNA-induced inhibition is
proportion of the cells resist the toxic effect. Other found
sufficiently complete to slow viral replication to a stage where it
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becomes uncoordinated or susceptible to other interferon dependant 
effects, such as impaired méthylation or mRNA-specific nucleases. However, 
such speculation assumes that the in vitro inhibitor and the one operating 
in virus infected cells are the same, and this needs to be verified by 
co-purification and characterisation. If this is so, presumably interferon 
mRNA translation proceeds with very high efficiency, otherwise production 
of interferon by viruses in primed cells would not be possible.
The role of protein kinases in the inhibition has been clarified, and 
the interferon and dsRNA dependant inhibitor can be classed with dsRNA, 
hemin deprivation, and oxidising agents in terms of its effects on the 
reticulocyte lysate. Control of protein phosphorylation may be relevant 
in viral inhibition of host protein synthesis (Kaerlein and Horak, 1976), 
density dépendit inhibition of growth (Leader et al 1976), the control 
of enzyme systems (Jost and Rickenberg 1971), and control of transcription 
(Jost and Averner 1975). It is thus possible that non-antiviral effects 
of interferon are modulated by protein kinases, especially since interferon 
is known to modulate cAMP levels (Weber and Stewart 1975). Interferon 
treatment may induce new enzyme systems, or modify existing ones, which 
are triggered by dsRNA to produce a protein kinase activator. The variety 
of interferon actions may be mediated by a variety of kinases. If the 
activator can be purified, it would be interesting to introduce it into 
intact cells and see which of the specific effects of interferon and
dsRNA resulted.
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